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Rationale Dengue, the most rapidly spreading flavivirus, threatens to affect almost half of 
the human global population. We previously showed that dengue-2 protects canine kidney cells 
(MDCK) from cytotoxic chemicals. We showed, independently, that cell protection as well as 
viral replication and maturation are positively regulated by PI3K-dependent autophagy. 
However, we had not identified the specific pathway that induces autophagy in infected cells. 
The current study explores the role of a specific branch of endoplasmic reticulum (ER) stress-
mediated Unfolded Protein Response (UPR), the PERK/eIF2α/ATF4 pathway in induction of 
autophagy by Dengue. We studied the relation between PERK pathway and induction of 
autophagy in infected MDCK and MEF cells. We extended this study to determine whether 
PERK activity correlates with protection of infected cells. Finally, we identified Ataxia 
Telangiectasia Mutated (ATM), a DNA damage response (DDR) protein as an upstream 




Methods We measured the expression of markers and regulators of ER stress and 
autophagy in infected mammalian cells (MDCK and MEF) using qPCR, immunoblotting and 
immunohistochemistry. When applicable, infected cells were pretreated with chemical regulators 
of ER stress, PERK, ATM and autophagy, with a goal to trace the relationship between these 
pathways and the life cycle of virus. To quantify cell protection, we measured cell viability using 
trypan blue exclusion assay. 
 
Results We first recorded the induction of global ER stress in infected cells, and much of 
this activation diminished when cells were treated with inhibitors of PERK pathway. We 
observed a rise in the expression level of different markers of PERK pathway in infected cells. 
We used chemical inhibitors and genetic knockouts to establish that an active PERK pathway is 
essential for increased autophagy flux and cell protection, as well as viral replication and 
maturation. ATM kinase was separately identified as an upstream regulator of three distinct 
processes: PERK activation, autophagosome formation and cell protection. However, we still 
need to investigate whether ATM executes these functions through a single pathway or multiple 
pathways. 
 
Interpretation Our data show that, when dengue infects cells, ATM is an early regulator that 
activates PERK, autophagy and cell protection. Since PERK and autophagy have been 
implicated in viral production, the current study identifies several putative targets for antiviral 
therapy, although these targets also serve multiple housekeeping functions (stress response, 
protein folding, and homeostasis) in the cell. Future studies should focus on the links between 
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6.1. DIFFERENT PATHWAYS OF CELL DEATH The demise of a cell can be broadly 
classified into Accidental Cell Death (ACD) and Regulated Cell Death (RCD) [1]. As the names 
suggest, ACD is used to denote an acute form of cell death that takes place in response to 
physical or mechanical assaults to the cell. In sharp contrast, RCD is the consequence of a 
coordinated activation of signals that acts as an adaptive stress response to intracellular or 
extracellular disturbances, or due to physiological reasons like cell division, development or 
differentiation; the latter, physiological, form is also known as Programmed Cell Death (PCD) 
[1]. Though identified as early as mid-19th century, when Carl Vogt observed loss of notochord 
in amphibian metamorphosis, the idea of cells dying through a regulated pathway was not greatly 
appreciated for almost a century [2, 3].  
 
The negligence of regulated cell death during the first decades of its recognition, at least 
until the 1960s, can be attributed to the shortage of tools to document or visualize dying cells, 
since an apoptotic cell is often visible only up to 20 min after death. In spite of this shortcoming, 
scientists were gathering evidence of RCD in diverse model organisms as Dictyostelium, insects, 
and chicken [4-6]. The identification, naming, and further characterization of apoptosis (RCD 
type 1) as a morphological process common to most types of RCD in the period between 1972 
and 90s made it impossible to ignore, anymore, the importance of RCD in AIDS, Huntington's, 
Parkinson's, Alzheimer’s and viral infection [7-9]. With identification of even more types and 
pathways of RCD, classification became essential, and the most common parameters used were 
morphological. Based on the associated morphological features, RCD was classified into type I 
(apoptosis), type II (autophagy) and type III (necrosis). Type I cell death is usually characterized 
	 2 
by plasma membrane blebbing, chromatin condensation (pyknosis), nuclear fragmentation 
(karyorrhexis) and type II involves the lysosomal degradation of certain double membraned 
vesicles containing a “cargo” to be recycled. Type III death exhibits none of these features. As 
more pathways were identified, so did studies linking these processes to the pathogenesis of 
various diseases, including tumorigenesis, diabetes, and viral infection [10-17].  
 
Besides, dying cells release certain molecules called DAMP (Danger Associated Molecular 
Pattern) that can help other threatened cells, hence the organism, by acting as an alarm to which 
the threatened cells respond by augmenting whatever defenses they can muster [18-21]. 
 
Testimony to the expanding horizon of cell death studies can simply be judged by the fact 
that The Nomenclature Committee on Cell Death (NCCD) recognized over the last decade several 
novel pathways of programmed death. The NCCD now lists the following as accepted forms of 
cell death (Table 1): extrinsic apoptosis, intrinsic apoptosis, mitochondrial permeability 
transition (MPT)-driven necrosis, necroptosis, ferroptosis, pyroptosis, parthanatos, entotic cell 
death, NETotic cell death, lysosome-dependent cell death, autophagy-dependent cell death, 
immunogenic cell death, and non-lethal processes as cellular senescence and mitotic catastrophe. 
Since the approach of classification based solely upon the morphology needs extensive revision, 
NCCD is stressing the importance of molecular, genetic and pharmacological parameters [1]. 
Moreover, since traditional markers of RCD were associated with non-lethal conditions as well, 
the same committee has also suggested a re-evaluation of the defining hallmarks for a dead cell: 
complete disintegration of the cell membrane and engulfment by phagocytosis [22]. 
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Table 1: Different forms of cell death, as recognized by NCCD 
TYPES OF CELL DEATH MAJOR CHARACTERISTICS 
                                                     LETHAL 
Extrinsic Apoptosis Associated with extracellular perturbations that 
leads to caspase 8 activation and optional 
mitochondrial outer membrane permeabilization 
(MOMP)  
Intrinsic Apoptosis Associated with mitochondrial outer membrane 
permeabilization (MOMP) and activation of 
executioner caspases (CASP-3) brought about by 
changes in the internal and external environment.  
MPT-Driven Necrosis Associated with cyclophilin D (CYPD) that is 
activated due to intracellular modifications 
Necroptosis Associated with increased activity of Mixed 
Lineage Kinase Domain-Like Pseudo Kinase 
(MLKL) and Receptor Interacting Serine 
Threonine Protein Kinase 3 (RIPK3) in response 
to changes in intracellular or extracellular 
homeostasis 
Ferroptosis A form of cell death linked to the oxidation status 
of the cell, that can be blocked by iron chelators 
and lipophilic antioxidants 
Pyroptosis Characterized by the formation of cell membrane 
pores by gasdermin family proteins 
Parthanatos Associated with increased Poly [ADP-Ribose] 
Polymerase (PARP)-1 activity in response to 
DNA damage induced by Apoptosis Inducing 
Factor (AIF) and Macrophage Migration 
Inhibitory Factor (MIF) 
Entotic Cell Death A lysosomal process that leads to cell-in-cell 
internalization 
NETotic Cell Death A ROS-dependent mechanism associated with the 
release of Neutrophil Extrusion Traps (NET)  
Lysosome-Dependent Cell Death Associated with Lysosomal Membrane 
Permeabilization (LMP) and requires the 
involvement of Cathepsins (CTS) 
Immunogenic Cell Death Responsible for mounting an adaptive immune 
response in immunocompetent host cells 
Autophagy-Dependent Cell 
Death 
A form of cell death that can be blocked by 
pharmacological and genetic inhibition of the 
macroautophagy pathway 
                                                  NON-LETHAL 




6.1.1. APOPTOSIS The earliest recognized form of RCD, apoptosis (Greek: falling of leaves), 
was first reported, albeit not identified, by Walter Fleming [3]. Kerr et al characterized apoptosis 
and described it as a general process mistakenly previously identified as an arcane form of death 
that Kerr had described as ‘shrinkage necrosis’ [7]. Apoptosis (RCD type I) involves 
fragmentation of the nucleus, chromatin condensation, blebbing of the cell membrane, followed 
by the engulfment of the apoptotic cell by phagocytic cells (efferocytosis). The recognition of 
apoptotic cells by the phagocytes involves the externalization of an inner membrane lipid of the 
cell membrane, phosphatidylserine (PS) - a process mediated by the regulation of scramblase 
and flippase enzymes. This event precedes all the phenotypes described above, however 
identification of non-apoptotic PS externalization casts a shadow of doubt on the status of PS 
externalization as a defining hallmark of apoptosis [23-25]. 
 
Apoptosis follows either of two distinct pathways, the extrinsic (death receptor) and intrinsic 
(mitochondrial) pathway [26]. Apoptosis is responsible for the elimination of presumptively 
nonessential cells, sculpting of digits, and degradation of presumptively unnecessary tissues and 
organs [27].  
 
1. Extrinsic apoptosis According to the recent NCCD guidelines, extrinsic apoptosis is defined 
as the ligand-mediated activation of plasma membrane receptors in response to external factors, 
and the culmination of this process is the activation of executioner caspases and in some cases, 
mitochondrial outer membrane permeabilization (MOMP). The receptors associated in this 
branch of apoptosis are classified as 1) death receptors, and 2) dependent receptors [1, 28-34].  
	 5 
 
In case of death receptors, specific cognate ligands (TNF-α, FasL, TRAIL) are 
responsible for the activation of their respective receptors (TNF RI, Fas/CD95, DR3, TRAIL 
R1/DR4, or TRAIL R2/DR5) on the cell surface [26, 35-37]. This interaction results in the 
homotrimerization and activation of the preformed receptors at the intracellular side. An 
extensive assembly process ensues that culminates in the formation of a death inducing signaling 
complex (DISC) that activates initiator caspase CASP8. The caspase proteins (Cysteine-
dependent Aspartate-directed Proteases = C-ASP-ASES) are central to the entire apoptotic 
machinery within the cell. They are also integral to the dependence receptors as well as the 
intrinsic pathway is discussed later [38-46].   
 
The formation of the DISC and the subsequent initiation of the caspase-cascade follow 
different courses in case of different death receptors. In case of the FAS and TRAIL receptors, 
which are activated by FAS ligands (FASL) and Tumor Necrosis Factor apoptosis-inducing 
ligands (TRAIL) respectively, the activation of homotrimer at the intracellular side involves the 
interaction of an amino acid sequence common to the partners of the trimer called the FAS-
associated Death Domain (FADD) that is instrumental in the formation of FAS-specific DISC II 
complex. The formation of this complex is followed by the c-FLIP mediated activation of 
CASP8, which involves autoproteolytic cleavage as well as homodimerization. Apart from 
cFLIP isomers, CASP8 can also be regulated by phosphorylation and deubiquitylation. The 
downstream effects of CASP8 take different courses in “type I” cells (lymphocytes and 
thymocytes) and “type II” cells (most cancer cells, pancreatic cells, hepatocytes).1 In case of the 
																																																								
1 Authors have defined the terms "type I" and “type II” differently. 
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former, there is apparently no crosstalk between CASP8 activity, manifested as maturation of 
CASP3/7, and the BCL-2 proteins that are involved in the mitochondrial intrinsic apoptosis 
(discussed later). In contrast, in “type II” cells there is compelling evidence of extensive 
crosstalk between CASP8 and the key players of the intrinsic pathway, especially XIAP and BID 
[38-65]. 
 
In comparison to the FADD pathway, the downstream effects of the interaction between 
Tumor Necrosis Factor-α (TNF-α) and Tumor Necrosis Factor-α Superfamily member 1A 
receptor (TNFR1) are more diverse and subject to more layers of cellular regulation. Unlike 
FADD, the TNF-associated death domain (TRADD) is responsible for the formation of DISC 
complex I, which recruits and ultimately is composed of heterogeneous proteins like TNF 
receptor associated factor 2 (TRAF2), RIPK1, cIAP1, TRAF5 and a linear ubiquitin chain 
assembly complex (LUBAC1). RIPK1 is crucial for maintaining a balance between extrinsic and 
intrinsic apoptosis in a cell, as well as the balance between pro-survival and pro-apoptotic 
signals. Post-translational modifications of this protein determine the fate of both apoptosis and 
the cell itself, e.g., phosphorylation, polyubiquitination (by LUBAC) or deubiquitylation, which 
determine the nature of extrinsic apoptosis and the type of DISC involved [66-84].  
 
Dependence receptors (DCC, PTCH1, NTRK3, UNC5A) are activated when their ligands 
drop below a threshold concentration. This occurrence activates two modes of regulation that are 
often used by anti-apoptotic proteins, especially in neoplastic cells: 1) restoration of the ligands, 
and 2) silencing or down-regulation of the receptors and associated proteins.  Here, as in the case 
of death receptors, caspases play an important part, complemented by overlapping roles played 
	 7 
by mitochondrial components of the intrinsic pathway. Depending on the type of receptor, 
dependence-mediated apoptosis can be mediated by otherwise intrinsic pathway via the CASP9-
CASP3 cascade (e.g., DCC, UNC5B, and NTRK3), Death Associated Protein Kinase 1 
(DAPK1), or CASP9 (PTCH1) [85-95].  
 
2. Intrinsic apoptosis According to the most recent definition proposed by NCCD, intrinsic 
apoptosis is a type of RCD characterized by mitochondrial outer membrane permeabilization 
(MOMP) and activation of executioner caspases (caspases that attack vital cytoplasmic proteins), 
both induced in response to certain intracellular perturbations [1].  The intrinsic branch is almost 
entirely regulated by the mitochondria, in response to DNA damage, growth factor withdrawal, 
loss of contact with the extracellular matrix, endoplasmic reticulum (ER) stress, oxidative stress, 
alterations of microtubules, anomalous replication or mitotic defect. In addition to the size of 
mitochondria, the lipid composition (especially ceramide) of the mitochondrial membrane is also 
crucial for pro-apoptotic signaling. The central component of this pathway is the irreversible 
permeabilization of the outer membrane of mitochondria – an event called mitochondrial outer 
membrane permeabilization (MOMP). The intrinsic apoptosis pathway is tightly regulated by 
interactions between antagonistic (pro- and anti-apoptotic) proteins belonging to the Bcl-2 
family, a group of proteins that possess one or more of the four Bcl-2 homology (BH) domains.  
Effectors, which are pro-apoptotic Bcl-2 proteins that directly bring upon MOMP, facilitate 
cellular demise; these proteins contain all four BH domains (BH-1, 2,3,4). Other pro-apoptotic 
proteins called activators and sensitizers help in the functioning of the effectors by binding to 
anti-apoptotic proteins also known as guardians [96-105].  
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The two effectors that have been extensively studied are Bcl-2 associated X (BAX) and 
Bcl-2 apoptosis killer (BAK); a recently isolated protein BOK has been shown to work 
independently of BAX and BAK. Under normal conditions, BAX shuttles between the outer 
mitochondrial membrane (OMM) and cytosol. In contrast, BAK is localized in the OMM by 
virtue of interaction between its hydrophobic C-terminal and the OMM lipid bilayer. When the 
cell is perturbed by any of the intracellular stimuli of apoptosis, BAX retro-translocation into the 
cytoplasm is stalled and the mitochondrial effector pool increases [106-118]. The activators in 
turn are induced in response to the pro-apoptotic cellular stimuli. PUMA, BIM, and NOXA are 
activated by transcriptional regulation, whereas BID is activated by post-translational 
modification. The BH3-only activators (PUMA, NOXA, BIM, BID) then interact with BAX and 
BAK and result in the rearrangement of their molecular structure (dissociation of the core and 
latch domains) [112, 119-135]. This rearrangement further leads to the oligomerization of BAX 
and BAK, which may form either homo- or hetero-dimers in different settings. All these events 
are responsible for the rearrangement of the mitochondrial membrane, which involves the 
formation of pores (by BAX dimers) in OMM and the eventual initiation of MOMP [136-141].  
 
As a counter-reaction, the pro-survival proteins, more commonly known as anti-apoptotic 
guardians of the cell, block the apoptotic response (MOMP and pore-formation in the OMM). 
Like the effectors they block, the guardians are also Bcl-2 family proteins that contain all the 
four BH-domains, a feature most important from a structural and functional point of view as 
these domains (especially 1,2,3) enable the proteins to insert into the mitochondrial and ER 
membranes and interact directly with the effectors. These proteins block apoptosis directly by 
sequestration of the effectors or indirectly by the inactivation of the activators, which in some 
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conditions results in the depletion of the mitochondrial Bax/Bak pool. Apart from physical 
sequestration and inactivation of pro-apoptotic proteins, the guardians also promote cell survival 
through Ca2+ homeostasis (ER), increased ATP synthesis and regulation of redox balance [97, 
99, 103, 142-163]. A third class of BH3-only pro-apoptotic proteins, the sensitizers, blocks the 
activity of the anti-apoptotic proteins by binding to them and limiting their capability to 
sequester the pro-apoptotic proteins. In this context, it is important to acknowledge that the 
sensitizers (proteins like BAD, HRK, and MRF) are not always functionally distinct from the 
activators (PUMA, NOXA, BID, BIM) as the latter also bind anti-apoptotic proteins and 
inactivate them.  However, in most cases, the sensitizers act upstream of the activators. The 
importance of the BH3-only proteins in cell survival and as a consequence in tumor formation 
can be demonstrated by the fact that several BH3-mimetics have been shown to inhibit tumor 
formation [131, 140, 155, 164-169].  
 
BAX/BAK mediated MOMP is not however limited to the regulatory effects of BH3-
only proteins, as has been demonstrated in knockout cells. More “non-canonical” pathways of 
BAX/BAK activity are being studied and other proteins like PIN1, P53 and ATR have been 
identified as activators [170-174]. The importance of the ER in this regard is very important, as 
both BAX and BAK can impact its physical structure, and affect its permeability. The resultant 
leakage of chaperones and Ca2+ ions, coupled with the mitochondria-associated ER membranes, 
can offer an alternative to the classical model of BAX/BAK activation in intrinsic apoptosis. The 
identification of the ER-resident BOK as a third effector that has shown very little indication of 
dependence on BAX/BAK has further highlighted the importance of ER in RCD [175]. The 
classical sensitizers and activators do not regulate BOK; instead it is controlled by signals 
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exclusive to the ER, e.g., ER-associated degradation (ERAD) and inositol-1, 4,5-trisphosphate 
(IP3) receptors.  
 
The downstream effect of the permeabilization of mitochondria is the subsequent release 
of HTRA2/Omi, Apoptosis-Inducing Factor, Endonuclease G, cytochrome c (CYCS), direct IAP 
binding mitochondrial protein with low pI (DIABLO) and secondary mitochondrial activator of 
caspase (SMAC) from mitochondria into the cytosol. The CYCS binds to apoptotic peptidase 
activating factor type 1 (APAF-1) and the zymogen pro-caspase 9 (CASP9) to form the 
apoptosome, a supramolecular complex. SMAC binds to a class of proteins called inhibitor of 
apoptosis proteins (IAP) that includes X-linked IAP (XIAP), which binds to the apoptosome.  
 
The apoptosome functions by the interaction between the respective caspase recruitment 
domains (CARDs) of APAF-1 and CASP9, which subsequently activates CASP9 [176-180]. 
CASP9 acts as an initiator caspase, which then activates the executioner caspases CASP3 and 
CASP7. Recent studies suggest that CASP6, hitherto regarded as executioner, may well function 
as an initiator. CASP3 and CASP7 represent the culmination of the mitochondrial apoptosis 
cascade and are responsible for most of the biochemical, morphological and molecular hallmarks 
of this process; e.g., CASP3 is essential for phosphatidylserine (PS) externalization. However, 
intrinsic apoptosis can switch modes to other forms of RCD if caspases are dysfunctional 
because of either non-competitive inhibitor (like zVAD-FMK) or genetic mutation/knockout. 
Cells can also exhibit partial adaptation to caspase activity in a condition known as anastasis, 
where cells survive in spite of normal caspase activity.  Since executioner caspases also 
influence the release of DAMPs from dying cells, they can regulate the immune response of a 
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cell as well. This is important to appreciate, especially in the light of tumor formation. Anoikis, a 
form of intrinsic cell death that initiates when cells lose integrin-dependent attachment, is 
regulated by executioner caspases like CASP3, thus highlighting the relevance of these proteins 
in metastasis and tumorigenesis. Yet another paradox is the existence of BAX/BAK-independent 
pathway of CASP3 activation, which is probably mediated by mitochondrial ceramide levels and 
other possibly unidentified factors.  
 
6.1.2. NECROSIS  Some forms of necrosis are programmed and controlled through a specific 
set of signal transduction pathways and degradative mechanisms. Cell death by specific necrosis 
can also contribute to embryonic development and adult tissue homeostasis [181]. Necrosis can 
be triggered by the same death signals that induce apoptosis [182]. The difference between 
apoptosis and specific necrosis lies in the rapid cytoplasmic swelling and release of extracellular 
components, seen in specific necrosis, which is often due to extreme physiochemical stress, 
osmotic shock, mechanical stress and high concentration of hydrogen peroxide [183].  When a 
cell is under such conditions, which can be produced by physiological or developmental 
situations, cell death occurs accidentally and uncontrolled. Necrosis signaling complex forms by 
interaction of receptor interacting protein 1 (RIPK1) with the receptor interacting protein 3 
(RIPK3) [183]. Necrosis does not depend on caspase activation. In a study done by 
Nikoletopoulou et al. 2013, two different cell lines were treated with a tumor necrosis factor-α. 
In one cell line, apoptosis was triggered, whereas in another cell line it induced necrosis [184].  
 
6.1.3. NECROPTOSIS Another form of cell death, associated with necrotic morphotype, 
is necroptosis. Various death receptors associated with extrinsic apoptosis, including (but not 
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limited to) FAS, TNFR1, TRAILR1 and TRAILR2, have been shown to induce necroptosis in 
different cell types. Furthermore, necroptosis can be instigated by the members of the pathogen 
recognition receptor (PRR) family, which are responsible for sensing pathogen-associated 
molecular patterns (PAMP) [182]. Studies have shown that this form of RCD, apart from being 
an important mode of stress adaptation, also play key role in developmental and immunological 
homeostasis [185-195].  
 
The best studied among these stimuli is the interaction between the extracellular ligand 
TNF and its specific receptor TNFR1. The activation of TNFR1 results in the formation of the 
necrosome, which contains RIPK1 and RIPK3, the latter being a non-redundant molecule in this 
pathway. The formation of necrosome is tightly regulated by post-translational modification 
(ubiquitination, phosphorylation) of the RIPK proteins. The inhibition of RIPK3 by CASP8 and 
IAPs presents a form of interaction between intrinsic apoptosis and necroptosis [1, 195-205]. 
 
The central effector molecules of necroptosis are RIP kinase RIPK3 and mixed lineage kinase 
domain-like pseudo kinase (MLKL). In the presence of an inactive CASP8, RIPK1 activates 
RIPK3 through interaction between their respective homotypic interaction motifs (RHIMs). 
RIPK3 can also be activated in a RIPK1-independent fashion through RHIM-mediated 
interaction with Z-DNA binding protein (ZBP-1). Active RIPK3, in turn, activates MLKL by a 
monomer-oligomer transition; the active MLKL is translocated to plasma membrane where it 
initiates its permeabilization [186, 187, 190, 196, 198, 201, 206-210]. 
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The translocation of MLKL to the plasma membrane, followed by the disintegration of 
the membrane, is associated with an increased Ca2+ influx into the cell as well as externalization 
of PS. The latter might point to a potential crosstalk between MLKL and CASP3 but this relation 
must be studied. Apart from the shedding of plasma membrane-associated proteins, MLKL has 
also been reported to form Mg2+-permeant channels in the membrane [211-215]. 
 
6.1.4. MPT-DRIVEN NECROSIS  This is a specific form of cyclophilin D (CYPD)-
dependent necrosis driven by membrane permeabilization transition (MPT, or permeabilization 
of the inner mitochondrial membrane (IMM)) in response to intracellular perturbations. This 
form of RCD is initiated by the opening of the permeabilization transition pore complex 1 
(PTPC1), a super-complex spanning the IMM and OMM, in response to intracellular conditions 
like oxidative stress or an overload of cytosolic Ca2+. CYPD is thought to play an important role 
in this process, although other proteins have also been identified. One such protein is the F1-F0 
ATPase, which interacts with CYPD as well as Ca2+ ions, thus leading to the permeabilization of 
the IMM to smaller solutes. However, studies with ATP synthase deficient cells indicate that this 
protein might be redundant in MPT-driven necrosis [216-232]. 
 
MPT-driven necrosis is also modulated by components of the PTPC, some of which overlap 
with the intrinsic apoptosis pathway, including both pro-apoptotic (BAX/BAK/BID) and anti-
apoptotic (BCL-1/BCL-XL) proteins. Other key molecules involved in PTPC activity are DRP-1 
(activated by the calcium/calmodulin dependent kinase CaMKII) and p53 (shown in cardiac 
ischemia). Since Ca2+ homeostasis is an important trigger for MPT, calcium uniporters present in 
the IMM also play an important role in MPT-driven necrosis. Like intrinsic apoptosis, this form 
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of necrosis also highlights the importance of mitochondria in maintenance of cellular integrity in 
the face of severe stress [233-242]. 
 
6.1.5. NETotic CELL DEATH This is a less studied form of RCD, characterized by a 
ROS-dependent extrusion of neutrophil extrusion traps (NETs) from cells infected with 
pathogens. NETs, which are biochemically networks of chromatin and histone-containing fibers 
bound to cytoplasmic and granular proteins, serve as extracellular platforms designed for 
microbial degradation. Besides neutrophils, NETs are also released by eosinophils and mast cells 
[243-250]. 
 
The function of NETs is strictly dependent on the activation of NADPH oxidase and the 
resulting ROS production. This activation is regulated by mitogen activated kinase type 2 
(MAPK2), ERK2 and a proto-oncogene RAF1. In infected cells, ROS activates elastase 
neutrophil expressed (ELANE) which culminates in the disintegration of filamentous-actin (F-
Actin), as well as histone degradation and chromatin decondensation.  A combination of all these 
events is manifested in the form of NET release from infected cells [251-258]. 
 
6.1.6. LYSOSOMAL CELL DEATH  This form of RCD is characterized by 
lysosomal membrane permeabilization (LMP) that culminates in the release of the lysosomal 
protease Cathepsin (CTS) in the cytosol; this permeabilization might involve MOMP and 
caspases. Lysosomal cell death is induced in response to an alteration in cellular homeostasis that 
can trigger the loss of lysosomal membrane integrity. It is an important signaling pathway in 
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pathophysiological conditions related to ageing, neurodegeneration, cardiac failure, as well as 
essential developmental processes like post-lactation involution of mammary glands [259-261].  
 
The central role in this RCD is certainly executed by the cathepsins (CTS) released into 
the cytoplasm in an apoptosis-dependent or independent manner. Although demonstrated to be 
upstream of LMP in certain experimental settings, the involvement of RCD is dispensable in 
lysosomal cell death. However, in several instances, CTS activity in the cytosol can activate 
MOMP and intrinsic apoptosis, in which case LMP must have occurred upstream of apoptosis.  
A more universal trigger seems to be ROS production, which is instrumental in the alteration of 
the lipid content as well as the Ca2+ channels in the lysosomal membrane. In special conditions, 
as in post-lactation mammary glands, STAT-3 induces the expression of cathepsins B 
(CTSB/CtsB) and L (CTSL/CtsL) in cytosol. Lysosomal cell death also maintains a balance 
between autophagy and other cell death pathways in stress conditions. It is therefore believed to 
be a signaling mechanism that has the ability to interact with both apoptosis and autophagy [259-
272].  
 
6.1.7. IMMUNOGENIC CELL DEATH This is a form of RCD that initiates adaptive 
immune response, when certain DAMPs are released by dying cells in response to exogenous 
(virus, pharmacological chemicals) and endogenous factors. Six types of DAMPs are associated 
with ICD: 1) Calreticulin (CALR) which when exposed reveals an “eat me” signal, 2) ATP, 
which when extracellular acts as a “find me” signal, 3) type I IFN, frequently released by cancer 
cells, 4) Nucleic acids (dsRNA, DNA), also released by cancer cells, 5) High mobility group box 
1 (HMGB-1), and 6) Annexin1 (ANXA1) [273-289].  
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CALR, an ER-resident protein that senses Ca2+ homeostasis, is transported to the outer leaflet 
of plasma membrane due to one or more signaling pathways, like PERK-dependent eIF2α 
phosphorylation, CASP-8 mediated BAX/BAK activation, and exocytosis. Extracellular ATP, 
which exhibits an immunostimulatory effect, is expressed on the plasma membrane following 
autophagy-mediated ATP localization in the lysosome, translocation of LAMP1 to the plasma 
membrane, ROCK-induced membrane blebbing and the opening of PANX1 channels. Type I 
IFN is expressed in dying cancer cells that detect endogenous dsRNA/DNA (by TLR3/cGAS) 
for ICD. Apart from boosting immune response in cells expressing the IFN alpha receptor 
(IFNAR), IFN also induces a paracrine/autocrine signaling in malignant cells, a mechanism that 
is also involved in nucleic acid mediated ICD of cancer cells. HMGB1 and ANX1 are thought to 
induce adaptive immune response, resulting in antigen processing and presentation. Since certain 
caspases such as CASP8 and CASP3 has been shown to suppress ICD, more investigation should 
be carried out on this interconnection especially in cancer cells [290-305]. 
 
6.1.8. FERROPTOSIS In response to alteration in intracellular homeostasis, cells undergo 
a ROS-mediated RCD that can be inhibited by iron chelators and lipophilic antioxidants. This 
process, known as ferroptosis, arises due to events like lipid peroxidation, which destabilize the 
internal homeostasis of the cell [306-309].  
 
6.1.9. PYROPTOSIS Proteins of the gasdermin family are involved in the plasma 
membrane permeabilization of infected cells, an RCD pathway referred to as pyroptosis that in 
certain cases might be regulated by inflammatory caspases [310]. 
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6.1.10. PARTHANATOS A distinct form of RCD, parthanatos, is triggered by AIF- and 
MIF- dependent DNA damage and the hyperactivation of PARP-1 [311]. 
 
6.1.11. ENTOTIC CELL DEATH This is a form of cytoskeleton-dependent cell cannibalism 
(cell-cell internalization) that is carried out by lysosomes [312]. 
 
6.1.12. AUTOPHAGY-DEPENDENT CELL DEATH This is a form of RCD associated 
with autophagy – thus inhibition (pharmacological/ genetic) of autophagy can delay this type of 
cell death. As we shall explain in the following paragraphs, autophagy is mostly regarded as a 
cytoprotective mechanism in spite of being characterized initially as a form of “type II cell 
death”. However, in special cases like developing Drosophila larva or in specific 
pathophysiological conditions, blocking the activity of autophagy genes can result in a delay in 
RCD, which is usually necessary for developmental events like larval midgut degradation. 
Another form of autophagy-dependent cell death – autosis, frequently observed in hypoxic and 
starved cells, involves the Na+/ K+-ATPase present in cell membrane [22, 313-324]. 
 
As mentioned above, autophagy is regarded as a recycling process that is mostly 
cytoprotective, contributing to RCD only in rare cases (non-protective autophagy). In the 
following section we shall expound upon the pro-survival aspect of various forms of autophagy 
that has been identified till date [325]. 
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6.2. AUTOPHAGY IS A RECYCLING PROCESS THAT IS IMPORTANT FOR 
MAINTENANCE OF CELL HOMEOSTASIS The paradox of classifying autophagy as a 
form of RCD lies in the fact that the inhibition of specific forms of autophagy (e.g., 
macroautophagy) by pharmacological or genetic means can facilitate cellular demise, although in 
a few instances distinct waves of autophagy–a protective “mild” and “lethal”– have been 
identified in virus-infected cells [325, 326]. The apparent contradiction in the classification of 
autophagy as a form of “type II cell death” can also be attributed to the fact that in the earliest 
phase of autophagy studies, researchers observed dying cells with a high accumulation of 
autophagosomes or autolysosomes. Noting the difference between this cells and apoptotic cells, 
they decided to classify it as a form of RCD. This is a living testimony to the diverse pathways 
and effects involved in autophagy, which was named in the 1960 by the Belgian scientist 
Christian De Duve after the Greek word for a “self-eating” cell [325]. Today, we certainly have 
more evidence that suggests that autophagy is much more than a self-degradation process; a 
significant portion of this evidence came from studies conducted in yeast in the early 90s by the 
2016 Nobel Laureate Yoshinuri Ohsumi. It is a highly conserved catabolic process that is 
believed to have preceded apoptosis in evolution [327]. As more studies delineate the mechanism 
of different pathways of autophagy, it is essential to characterize its unique features and 
distinguish it from other degradative processes as pinocytosis, phagocytosis and endocytosis or 
homeostatic processes like proteasome degradation. The authors of a 2017 review sought to 
broadly define autophagy as a cellular homeostatic mechanism that involves the uptake of 
endogenous or exogenous particles or proteins by cytosolic vesicles and their subsequent 
degradation in the lysosomal compartment (or in late endosomes, in special cases) [325]. As 
autophagy is deregulated in several pathophysiological conditions as ageing, autoimmunity, 
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cardiac diseases, viral infection, and different forms of tumorigenesis, it is a viable therapeutic 
target that needs to be fully understood and explored. In Table 2, a comprehensive list of the 
different forms of autophagy as well as their salient features has been summarized. 
Table 2: Different forms of autophagy, and their unique characteristics 
Types of autophagy Salient features 
MACROAUTOPHAGY Formation of autophagosomes involving a subset of 
genes from the ATG family 
MICROPHAGY LAMP2A-independent pathway leading to direct 
invagination on lysosomes or late endosomes and 
the internalization of cargo inside these vesicles 
CHAPERONE-MEDIATED  Translocation of substrates across the lysosomal 
membrane in a HSPA8- and LAMP2A-dependent 
fashion 
MITOPHAGY Specific removal of damaged, superfluous or 
malfunctioning mitochondria  
PEXOPHAGY Targets and degrades peroxisomes either through 
macroautophagy or microphagy 
NUCLEOPHAGY Specific removal of nucleus that involves 
components of either microphagy or 
macroautophagy 
AGGREPHAGY Specific removal of anomalous protein aggregates  
RIBOPHAGY Degradation of ribosomes 
RETICULOPHAGY  
(ER-PHAGY) 
Removal of selected parts of the endoplasmic 
reticulum (ER) 
LYSOPHAGY Specific degradation of lysosomes 
XENOPHAGY Removal of bacteria that escapes the phagocytic 
machinery, as well as viral components in the 
cytoplasm 
LIPOPHAGY Specific degradation of neutral lipid droplets 
PROTEAPHAGY Removal of inactive proteasomes 
MYELINOPHAGY Removal of myelin (Schwann cells) 
GRANULOPHAGY Removal of zymogen granules 
ZYMOPHAGY Removal of stress granules 
FERRITINOPHAGY Degradation of ferritin 
 
 
Ø Macroautophagy  The most widely studied form of autophagy is the one that involves the 
formation of large double membrane vesicles called autophagosomes. Macroautophagy is a 
surveillance process that is involved in the recycling of basic biomolecules, the transport of 
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proteins, lipids, and organelles to double-membrane vesicles (autophagosomes) and thence to 
lysosomes for subsequent degradation [328, 329]. This process reaches its apogee in a stressed 
cell. The prime mediators of autophagy signaling comprise sensors of cellular energy (like 
AMPK/adenosine monophosphate-activated protein kinase) and nutrition (like 
mTOR/mammalian target of rapamycin). As has been shown in Figure 1, the process can be 
categorized broadly into five steps: 1) the nucleation of phagophore, the recruitment of a piece 
of membrane borrowed probably from ER, Golgi or plasma membrane; 2) Expansion of the 
phagophore membrane around the target ‘cargo’ by mechanisms involving LC3II and ATG9 
proteins; 3) closure of the membrane, thus forming the autophagosome; 4) the fusion of the 
autophagosome and lysosome, thus forming the autolysosome: and 5) hydrolase-mediated 
degradation of the cargo stored inside the inner autophagosome membrane, followed by 
permease-mediated efflux into cytosol [330-332]. Macroautophagy is monitored by two 
ubiquitin-like conjugation systems. The first system employs E1-like enzyme Autophagy Related 
Gene 7 (ATG7) and E2-like enzyme ATG10 to promote the conjugation of ATG5: ATG12 (E3-
like protein) and further build a complex of ATG5/ATG12/ATG16L1.  
 
The second system recruits E1-like ATG7 and E2-like ATG3, alongside the 
ATG5/ATG12/ATG16L1 complex, to transfer phosphatidylethanolamine (PE) to the 
microtubule-associated protein 1 light chain 3 beta (MAP1LC3B, or simply LC3B). This 
lipidation of LC3B is characterized by its cleavage into a shorter form, known as LC3II, which 
colocalizes with the membrane of the expanding autophagosome. The formation of LC3 puncta 
(autophagosomes), identified through fluorescence microscopy, is used as a marker of 
autophagy. However, recent studies have also demonstrated the involvement of LC3II in 
	 21 
processes as diverse as the fusion of autophagosome and lysosome and lysosomal degradation as 
well as autophagy-independent processes as LC3-associated phagocytosis (LAP) [325]. The 
identification of six homologues of LC3 (MAP1LC3A, MAP1LC3B, MAP1LC3C, etc.) has also 
added to the complexity of the nature and function of these proteins [333-351].  
 
 
Figure 1: The different pathways converging at the formation of autophagosome 
A detailed diagram showing the different upstream regulators and components that are 
involved in the initiation of autophagosome formation and the subsequent degradation of 
autolysosome. 
 
Following its nucleation, the pre-autophagosome membrane (PAS)/ phagophore is still 
expanding/ elongating prior to its closure around the target ‘cargo’; this ‘pre-initiation’ depends 
heavily upon the formation of several complexes, including the ULK1 (Unc-like kinase/ATG1 in 
yeast) complex, the beclin-1–VPS34 (vacuolar protein-sorting protein 34; class III 
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phosphatidylinositol 3-kinase)–AMBRA1 (autophagy/beclin-1 regulator) complex, the ATG9–
WIPI (WD repeat domain, phosphoinositide interacting/ATG 18 homolog) transmembrane 
complex and the ubiquitin-like ATG12–LC3 (microtubule-associated protein 1 light chain 3) 
complex [352]. These represent a major checkpoint in the formation of the autophagosome 
membrane, as they are tightly regulated in a healthy cell by the inhibitory effect of mammalian 
target of rapamycin complex 1 (mTORC1).  
 
In a normal/ healthy cell, mTORC1 restricts autophagy to a baseline level by imposing 
inhibitory phosphorylation on Unc-51-like kinase (ULK1/Ser 757) and ATG13 [335, 337, 338, 
344, 345, 347, 353-357]. Under stress, this block is removed by several factors, such as PTEN, 
AMPK, and TSC2. AMPK, an upstream regulator of mTORC1 can induce autophagy by 
activation of the Ulk1 protein [353, 358-360]. Activation of ULK1, which forms a complex with 
ATG13/FIP200/ATG101, leads to the nucleation of the pre-autophagosome structure (PAS). 
This nucleation involves the phosphatidylinositol-3-kinase class III (PI3K III)–VPS34–Beclin 1 
(BECN1/ATG6) complex and the product of VPS34, phosphatidyl-3-inositol phosphate (PI3P) 
[361, 362]. Overall, ATG3, ATG5, ATG7, ULK1, BECN1, VPS34 and PI3P are regarded as 
strictly required for the formation and maturation of the autophagosome, although this theory has 
been challenged recently through studies showing the existence of macroautophagy responses 
that were independent of these proteins [363-383].  
Another set of regulators for the mTOR pathway is the death-associated protein kinase 
(DAPk) and DAPk-related protein kinase (DRP-1), members of the DAPk subfamily implicated 
in programmed cell death. These are Ca+2/calmodulin-regulated Ser/Thr death kinases that 
promote membrane blebbing and autophagy.  
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DAPK phosphorylates Beclin 1 on the BH3 domain leading to its dissociation from Bcl-xL 
and increase in autophagy and activation of PI3 Kinase. Another member of this family, DAP1, 
is tightly regulated in response to starvation and negatively regulates autophagy. DAP 1 is 
dephosphorylated when mTOR is activated leading to down-regulation of autophagy [384, 385].  
 
In most cases, however, these coordinated and combined steps accomplish the formation of 
a mature autophagosome that then fuses with a lysosome through a canonical endocytic pathway 
[26, 386-388]. The fusion of these giant membrane-bound compartments is controlled by 
proteins involved in the endocytic pathway, e.g., the GTPase RAB7A, syntaxin 17 (STX17), 
SNARE, as well as autophagy proteins like LC3 (phosphorylated and lipidated), ATG14 and 
lysosomal proteins like LAMP2B. The fusion is followed by a drop in the pH of the lysosomal 
lumen, which is regulated by a vacuolar (V)-type ATPase. This activates the lysosomal 
hydrolases that then catabolize the cargo completely into individual units, as opposed to 
proteasomal degradation where the end products are usually oligopeptides (8-12 amino acids). 
SQSTM1/p62 is a proteasome-associated receptor protein that is degraded during the final phase 
of autolysosomal degradation. It is commonly used in studies as an indicator of the rate of 
autolysosomal degradation, commonly referred to as the ‘autophagy flux’. The exact role of p62 
is still being studied; in some cases it has been reported to colocalize with the LC3II molecule on 
the autophagosome membrane, yet other studies have shown that p62 undergoes self-
oligomerization and localizes to the ER-associated autophagosome formation site and interact 
with ULK1 in an LC3II-independent fashion [389-410]. 
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Ø Microphagy Although Microphagy is the least studied of all the variants of autophagy, we 
nevertheless have enough information to characterize it as a homeostatic process that does not 
rely strictly on autophagosome formation; instead the cytosolic cargo is taken up by a vesicle 
(vacuole in yeast/plants, or lysosome) through membrane invagination. This process has been 
demonstrated in several model organisms, including S. cerevisiae (yeast), D. melanogaster (fruit 
fly), and C. elegans (worms) as well as plants and mammalian systems. This form of autophagy 
degrades anthocyanin (plants), mitochondria, lipid droplets, nucleus, peroxisomes, and several 
other organelles. In yeast and other systems, several macroautophagy proteins like ATG7, ATG8 
and ATG9 have been shown to regulate this autophagy [411-418].  
 
In special cases, this process is more selective (endosomal microautophagy) and it relies on 
the endosomal protein sorting system to degrade proteins containing the KFERQ-motif. This 
selectivity has been recorded in several model systems, including yeast, flies and mammals, and 
it involves proteins from the endosomal-sorting complex required for transport (ESCRT) system. 
Endosomal microautophagy is also dependent on the activity of heat shock protein 70 (HSP70) 
family member HSPA8; however, it is independent of the lysosomal protein LAMP2A [418-
423].  
 
Ø Chaperone-mediated autophagy (CMA)  CMA is somewhat similar to endosomal 
microautophagy and has been extensively studied; it probably is the most well characterized 
form of autophagy after macroautophagy. This process can be broadly defined as a chaperone-
mediated transport of proteins from the cytosol directly to the lysosome for degradation. Since 
30% of the cytosolic proteins are degraded through CMA, it is crucial for maintenance of 
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genome integrity and healthy ageing, as well as pathophysiological conditions like oncogenesis 
and neurodegeneration. In CMA, the HSP70 member chaperone HSPA8 protein selectively 
binds proteins containing a KFERQ-like motif. The substrate proteins are then transported to the 
lysosomal lumen, by the action of the lysosomal translocation protein LAMP2A that switches 
from an inactive monomer form to an active oligomer [424-436].  
 
The LAMP2A-substrate conjugate is then transported across the lysosomal membrane into 
the lumen where the lysosomal HSPA8 binds to the cargo and prevents its retro-translocation 
back to cytosol. The cargo is then degraded in a lipid-rich environment that involves cathepsin A 
mediated LAMP2A degradation. As in macroautophagy, this process is also strictly regulated by 
other proteins, notably AKT serine/threonine kinase (AKT) as well as mTORC2. These negative 
regulations are removed by the action of pro-CMA proteins like glial fibrillary acidic protein 
(GFAP) and PHLPP1 [424, 437-442]. 
 
Ø Selective autophagy These processes can be, at times, selective towards a specific pathogen or 
a cell organelle. Such pathways have been observed in various model organisms, including 
yeasts, worms, mammals and even plants [325].  
 
• Mitophagy One of the most well studied of all the selective processes is Mitophagy, which 
removes superfluous or degraded/cytotoxic mitochondria through an autolysosomal pathway. It 
is crucial for tissues with a high metabolic rate to eliminate from their intracellular environment 
any theoretically cytotoxic organelle like dysfunctional or permeabilized mitochondria. The 
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selective removal of mitochondria is also important for several physiological processes like 
maturation of erythrocytes, embryonic development, and metamorphosis [414, 443-451].  
 
Several proteins that facilitate the uptake and degradation of ‘troublesome’ mitochondria 
have been identified across various model systems. As in most selective pathways, both micro- 
and macroautophagy have been observed in this case. In yeast, proteins belonging to the SUN 
family (UTH1) have been implicated in microautophagy-dependent Mitophagy, whereas ATG32 
has been linked to the macroautophagy branch. In mammals, the role played by yeast ATG32 is 
performed by the homologous BCL2L13, along with classical members of macroautophagy like 
LC3, p62, and optineurin (OPTN). Proteins that interact with autophagy receptors like LC3 
include PTEN induced putative kinase (PINK1), and Parkinson disease 2 parkin (PARK2). In 
response to some stimuli, the mitochondrial lipid cardiolipin has been observed to interact with 
the LC3 protein [414, 452-464]. 
 
• Xenophagy Autophagy acts rapidly against viral and bacterial infections, with the earliest 
observations dating back to the early 1990s. Viruses are eliminated through a specific pathway 
known as Virophagy (viral xenophagy). This Virophagy has been validated in ATG5-/- and 
BECN1-/- cells where viral titer increased in the absence of a mature autophagosome. Apart 
from the core machinery, proteins involved in the fusion and degradation of autophagosomes, 
like P62, SMURF1, act as receptors for viral components. Besides degrading the viral 
components directly, autophagy can also function in innate and adaptive antiviral responses, 
including activation of TLRs and IFNs, and mediating antigen processing to T-cells. The relation 
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between autophagy and viral infection is expounded in more detail in the following sections 
[465-469]. 
 
Bacterial Xenophagy is quite similar to Virophagy. This process is targeted against 
cytoplasmic bacteria that managed to evade phagocytosis. Unlike in phagocytosis, in Xenophagy 
bacteria are not hidden from the cytoplasmic proteins, especially the ones involved in 
autophagosome formation. Several proteins like P62, NDP52, OPTN can act as receptors of 
cytoplasmic bacteria, although some of these proteins may also take part in autophagosome 
expansion around the bacteria. NDP52 interacts with LC3A and B to form a mature 
autophagosome, a process in which other macroautophagy components like WIPI also take part. 
Interestingly, there is a significant crosstalk between macroautophagy and endosomal pathways 
in this context: proteins involved in the tagging of endosomes, like Galectin 3 and Galectin 8, 
have been implicated in this pathway. Consequently, as a counter-response, several bacteria have 
evolved to subvert the Xenophagy pathway [470-479]. 
 
• Lipophagy The selective degradation of lipid droplets through autophagy is an important 
pathway that is often hijacked by viruses, because lipid droplets can offer a rich source for 
production of membranes as well as energy for the intruding pathogen. In yeast, components 
from both microautophagy (ESCRT) as well as macroautophagy (ATG7) have been linked to 
lipid degradation. In mammals, the process is regulated by transcriptional control of specific 
genes as peroxisome proliferator-activated receptor alpha (PPARα) and cAMP responsive 
element binding protein (CREB). Components of the CMA, especially those involved in 
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degradation of lipid droplet associated proteins, has also given rise to the possibility of a 
crosstalk among different branches of autophagy in this process [418, 429, 480-486]. 
 
• Other forms of selective autophagy Apart from the processes described above, other 
forms of selective autophagy have also been identified, albeit to a lesser extent. These include 
Pexophagy (removal of peroxisomes), Proteaphagy (degradation of nonfunctional proteasomes), 
Lysophagy (degradation of toxic/nonfunctional lysosomes), Reticulophagy (ER degradation 
believed to be distinct from both micro- and macro-autophagy), Nucleophagy (chromatin 
degradation), Ribophagy (degradation of ribosomes), Aggrephagy (degradation of protein 
aggregates), Myelinophagy (myelin/Schwann cells), Zymophagy (zymogen granules), 




6.3. ENDOPLASMIC RETICULUM IS A MAJOR REGULATOR OF STRESS RESPONSE 
IN MAMMALIAN CELLS 
 
6.3.1. WHAT IS ER STRESS? Endoplasmic reticulum (ER) is a major cell organelle that 
regulates many functions, such as maintenance of Ca2+ homeostasis, transportation of cellular 
materials, secretion, expansion of surface area and production of proteins, steroids, and fats. One 
of the major productions and quality control centers of a cell, the ER is loaded with ribosomes 
(for translation) as well as chaperones and foldases (to ensure proper folding), especially in 
differentiating and secretory cells. This centrality also makes the ER vulnerable to a change in 
Ca2+ balance, impaired protein glycosylation, interruption in the ER-Golgi transport, and viral 
infection, some of which can be chemically induced for in vitro studies. For instance, we have 
used tunicamycin to block protein glycosylation. Since the quality control machinery ensures 
that only properly folded proteins are transported to the Golgi apparatus for secretion, disruption 
of folding creates an alert in the ER and leads to the induction of a holistic response known as 
the ER stress response [10, 525-528].  
 
Misfolded proteins are channeled through a distal secretory pathway called the ER-Associated 
Degradation (ERAD) pathway, a retro-translocation from ER to the cytoplasm through Cdc48p-
p97. Two distinct types of ERAD have been identified: a type I Ubiquitin-Proteasome and a type 
II Autophagy-Lysosome [529-532] pathway. The former mostly targets and eliminates soluble 
misfolded proteins and involves the canonical ubiquitin enzymes (E1, E2, E3) and a 26S 
proteasome that degrades K48-specific polyubiquitin proteins. In contrast, ERAD II eliminates 
both soluble and insoluble misfolded proteins through autophagy adaptors like HDAC6 and p62 
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that degrade both K48- and K63-specific polyubiquitin chains in the autophagolysosomal vesicle 
[533, 534]. The latter mechanism represents one of the many connections between ER stress and 
autophagy, a theme that is expounded upon in the following sections. Besides ERAD, misfolded 
proteins also trigger the Unfolded Protein Response (described in detail in the following section).  
 
6.3.2. UNFOLDED PROTEIN RESPONSE (UPR) - A MAJOR BRANCH OF ER 
STRESS Membrane rearrangement and anomalous protein folding in the ER activates one 
or more branches of the Unfolded Protein Response (UPR), a combined effect of three distinct 
yet interconnected pathways, in addition to triggering pro-apoptotic pathways as BOK, NOXA 
and PUMA pathways [175, 535, 536]. The pro-apoptotic role of ER stress has been observed in 
several types of tumor (prostate, glioblastoma) cells, linking ER stress to possible therapeutic 
interventions for these diseases.  
 
The downstream implication of UPR ranges over several pathways that are triggered in 
response to infection, from expression of Type-I Interferon (IFNs) to induction of autophagy. 
Three branches of UPR have been characterized so far: 1) PERK (protein kinase R like 
endoplasmic reticulum kinase), 2) ATF6 (Activating Transcription Factor 6), and 3) IRE1α 
(Inositol Requiring Enzyme 1 α) [525]. Each of these pathways has links to cell survival/death 
(apoptosis, autophagy) pathways e.g., PERK activates pro-apoptotic pathways in hypoxia-
induced tumor progression [537-547]. Thus, the downstream effects of endoplasmic reticulum 




6.3.3. PERK PATHWAY IS AN IMPORTANT COMPONENT OF THE UPR Like other 
key players of the UPR, such as ATF6 and IRE1α, PERK is also bound to the chaperone 
GRP78/BiP under stress-free conditions. Numerous stress conditions, some of which are 
associated with tumor microenvironments, cause the release of the type I ER transmembrane 
receptor PERK, which contains a serine-threonine cytoplasmic domain [548, 549]. Once PERK 
is disassociated from the BiP protein, it undergoes self-dimerization and auto-phosphorylation. 
This transition activates the kinase domain, which was otherwise non-functional as long as it was 
bound to BiP/GRP78; all these events now allow PERK to phosphorylate eIF2α at Ser-51. This 
phosphorylation leads to a suppression of global protein translation, and a major mechanism 
involved is inhibition of CyclinD1 activity (G1/S transition – G1 progression into the S phase) 
that results in slower cell division. These events present an important regulation step that is 
critical to cope with the stress and decrease the translational “load” on the ER [550-554]. 
 
However, some proteins are exempted from this shutdown, one of them being the transcription 
factor ATF4. The role of ATF4 is interesting in the light of the biochemistry of a stressed cell. 
During shorter periods of ER stress, ATF4 enhances the expression of pro-survival proteins 
responsible for nutrient uptake and antioxidation [555, 556]. However, in prolonged ER stress, 
the cell slowly switches to a pro-apoptotic mode. ATF4 translocates to the nucleus and increases 
the expression of pro-apoptotic CHOP and GADD34 (a phosphatase) among other proteins that 
act as chaperones and foldases [557-559]. CHOP has frequently been linked to suppression of 
anti-apoptotic proteins and activation of pro-apoptotic proteins and has been implicated in 
numerous pathogenic conditions such as tumor formation, diabetes and neurodegeneration [560, 
561]. The role of CHOP is crucial in this entire pathway because it can switch the response to ER 
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stress from pro-survival to pro-apoptosis, and is likely targeted by flavivirus [562, 563]. Apart 
from its proapoptotic features, CHOP also activates GADD34, which dephosphorylates eIF2α 
and promotes translational recovery; thus, it acts as a negative feedback mechanism to increase 
the ER load [558, 559].  
 
6.3.4. WHAT IS THE LINK BETWEEN ER STRESS AND AUTOPHAGY? ER stress is 
linked to ROS-mediated autophagy. Monocyte chemotactic protein-1 (MCP-1), known to 
mediate cardiac injury, induces ROS, ER stress, and autophagy in cardiac myoblasts (H9c2 cells) 
[564]. In most cases, as in mouse disease models, induction of autophagy by ER stress serves as 
a protective mechanism against apoptotic cell death [565]. One of the most important branches 
of ER stress/unfolded protein response (UPR) signaling – eukaryotic translation initiation factor-
2α (eIF2α/protein kinase R-like endoplasmic reticulum kinase (PERK)) – is activated in response 
to accumulation of proteins with polyglutamine repeats and functions in LC3 lipidation and 
autophagosome formation [566]. PERK-induced autophagy also protects mouse and human 
lymphomas during pathogenic conditions (Myc-induced tumorigenesis) [567]. Downstream ER 
stress components like C/EBP homologous protein (CHOP), a PERK-regulated protein, and 
inositol-requiring protein 1 (IRE1) also increase autophagy in colon cancer cell lines like HT29 
(human colon adenocarcinoma cell line), SW480 (human colorectal adenocarcinoma cell line) 










Figure 2: Autophagy and PERK 
Different pathways have been reported that connect ER stress/ UPR and autophagy. For the sake 
of convenience, we have focused only upon the links between PERK and autophagy here. 
 
 
ER stress can also trigger autophagy by other means. Ca2+ influx, ceramide signaling, IRE1𝛼, 
PERK pathways all contribute to the induction of autophagy either through canonical mTOR or 
the alternate DAPK1 – Beclin1 pathway. Ca2+ release from the ER can trigger kinases (CaMKK) 
that can activate AMPK to induce autophagy [569]. Alternatively, ceramide-induced PP2A 
activates DAPK, which can dissociate Beclin1 from Bcl-2 and cause autophagy [570]. The IRE1 
branch of UPR leads to JNK activation and increased Bcl-2 phosphorylation, thus releasing 
Beclin-1, which can then take part in formation of autophagosome [571-573]. As shown in 
Figure 2, The PERK pathway can trigger autophagy through ATF4-dependent expression of 
ATG12 [566, 573-575]. As an alternate pathway, CHOP (mediated by ATF4) can activate the 
pseudo kinase TRB3, which can cause autophagy through inhibition of Akt-mTOR [575-577]. 
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Although macroautophagy is the form of autophagy most commonly linked to UPR responses, 
other forms of autophagy are also modulated by different UPR responses. In animal models of 
Parkinson’s Disease, CMA is activated by the PERK/eIF2α/p38 pathway, a phenomenon that 
has been referred to as ER-stress induced CMA (ERICA) [578]. 
  
	 35 
6.4. ATAXIA TELANGIECTASIA MUTATION (ATM) KINASE - A POTENTIAL 
UPSTREAM REGULATOR  
 
6.4.1. ATM KINASE AND ITS ASSOCIATION WITH AUTOPHAGY  
 Ataxia Telangiectasia Mutation (ATM) kinase is a serine threonine kinase that acts 
downstream of various factors like ionizing radiation (IR), radiomimetic agents, or reactive 
oxygen species (ROS) that induce DNA damage. A major component of the DNA damage 
response (DDR) milieu, ATM is a nuclear protein that is responsible for the maintenance of 
genome integrity and cell survival when DNA is destabilized by double-strand breaks (DSBs), 
single-strand breaks (SSBs), impaired DNA replication, or other processes. An important DNA 
damage sensor, ATM kinase also functions in chromatin organization, gene expression and 
DNA/RNA/protein metabolism [579]. Another important protein in this regard is the ATM and 
Rad53 related (ATR) kinase, which, like ATM, belongs to the phosphatidyl-3-inositol phosphate 
like kinase (PIKK) family. In the face of genotoxic stress like ROS, RNS (Reactive Nitrogen 
Species), or radiation, ATM activates a series of phosphorylation that primarily induce cell cycle 
arrest (S phase or G2/M phase). Both CHK1 and CHK2 proteins are activated by 
phosphorylation, and they induce cell cycle arrest by various mechanisms, including inactivation 
of CDC25 phosphatase, impaired mitotic spindle formation and stabilization of the tumor 
suppressor Tumor Protein 53 (TP53/p53). Other downstream proteins like NRF2 are induced in 
response to high intracellular ROS. All these inductions and activations lead to cell cycle arrest--
which has also been harnessed for anticancer drug therapy. Loss of ATM activity leads to a 
pathological condition known as the Ataxia Telangiectasia, which is characterized by 
neurodegeneration, premature ageing, and susceptibility to tumorigenesis.  Disease progression 
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correlates with elevated levels of ROS in these patients. Studies with ATM-/- mice and cells have 
shown the importance of ATM kinase in scavenging ROS. Although the cytosolic involvement 
of ATM is still being studied, it is clear that high ROS production leads to the formation of ATM 
dimers in the cytosol, possibly through disulfide bonds. The active dimers participate in ROS 
clearance by numerous cytosolic mechanisms, including primarily Pexophagy, regulation of 
glutathione level, and activation of pentose phosphate pathway [360, 579-588].  
 
All these studies have established ATM as a prominent tumor-suppressor protein, although this 
view has also been challenged, following a report of ATM promoting tumor formation in HER2 
positive breast cancer cells [589]. The same study also showed a link between the activities of 
ATM kinase and an ATG4C protease, the only protein of autophagy that acts as an oxidative 
stress sensor [589]. Induction of ATM correlates with autophagy in cells exposed to stress 
factors like ROS, RNS, and hypoxia. Under these circumstances, ATM is exported from nucleus 
to the cytoplasm, where among other functions, it blocks the activity of mTOR through a cascade 
of phosphorylation involving liver kinase B1 (LKB1), AMPK and the tumor suppressor tuberous 
sclerosis 2 (TSC2). TSC2 inhibits the GTPase Ras homolog enriched in brain (RHEB), thus 
blocking the activity of mTOR and its downstream targets like p70 ribosome S6 kinase 
(p70S6K) and eukaryotic initiation factor 4E-binding protein 1 (4EBP1) [331, 360, 362, 590-
596]. The relation between ATM and autophagy has further been demonstrated in several cell 
types, including lymphocytes from Ataxia Telangiectasia patients, colorectal cancer cells, 
budding yeast, and cadmium (Cd)-treated mouse spermatocyte (GC-2) cells. Notably, ATM 
interacts with the autophagy pathway through an energy sensor protein like AMPK (activated 
under conditions of low ATP). AMPK is an important transcriptional and epigenetic regulator of 
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autophagy, through its interactions with SMPK 2  and coactivator-associated arginine 
methyltransferase 1 (CARM1). In budding yeast, ATM activation induces a distinct form of 
autophagy independent of the mTOR-dependent branch. This distinct form was termed 
Genotoxic stress Targeted autophagy (GTA) and genome analysis indicated that ATG11 (rather 
than any members of the mTOR-dependent macroautophagy) was important for this pathway 
[360, 590, 591, 597-603].  
 
Many investigators have linked ATM activation to forms of autophagy other than the 
canonical mTOR-dependent macroautophagy, in different types of cell, from yeast to higher 
eukaryotes. These other forms of autophagy include selective forms like Mitophagy and 
Pexophagy, which is not surprising, given the fact that mitochondria and peroxisomes are the 
two most abundant sources of ROS in cell.  Direct interaction between ATM and the effector 
molecules of Mitophagy (PINK1-Parkin) and Pexophagy (PEX5) has been demonstrated, thus 
highlighting the relevance of ATM in the maintenance of redox homeostasis and proteostasis. 
Whether these processes depend on DDR needs to be studied [588, 604-608].  
 
6.4.2. THE RELATION BETWEEN ATM KINASE AND ER STRESS The relation 
between ATM kinase and ER stress or UPR pathways is a theme that has not been extensively 
explored. In spite of the scarcity of studies, we have a basic idea how these pathways interact in 
certain scenarios. Initial studies, in the 2000s, using ATM-deficient thymocytes, astrocytes, and 
fibroblasts showed increased ROS production and ER-stress in these knockout cells. Restoration 
of expression of ATM in these cells blocked ER-stress induced intrinsic (Bax/Bak) apoptosis in 
																																																								
2 An F-box protein of the SCF E3 ubiquitin ligase complex 
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response to ionizing radiation and other genotoxic stress agents. In the same study, PERK-
eIF2α-ATF4-CHOP axis was also negatively regulated in presence of an active ATM kinase. As 
described earlier, CHOP is one of the primary checkpoints that determine the switch between the 
antagonistic effects of transient ER stress (pro-survival/pro-adaptive) and prolonged ER stress 
(pro-apoptotic). Hence CHOP is a potential target for ATM mediated damage repair [609-611].   
 
However, the relation between ATM activity and ER stress is not straightforward; it possibly 
depends on the cell type and methods used to detect ATM activity. Tunicamycin-induced ER 
stress causes upregulation of UPR-related genes EIF2AK3, ERN1 and ATF6 and the activation 
of the ATM pathway [612-614]. Recent studies using specific inhibitors for ATM, ATR and 
PERK as candidate anticancer drugs suggest that these serine-threonine kinases may crosstalk to 
a certain degree in progressing tumors. This argument is based on the observation that among all 
the ER stress or UPR effector molecules, PERK is the most closely related to cell cycle changes 
like arrest of cell division. PERK also activates proteins (CaMKII, Ero1α, NOX2) involved in 
ROS generation, which may act as a trigger for accumulation of ATM in the cytosol. Thus, 
PERK can potentially mediate the DDR and non-DDR effects of ATM kinase activity. In Gallic 
Acid (GA)-treated oral cancer cells (SSC-4), induction of ER-Ca2+-dependent ROS led to the 
activation of ATM kinase. Although most of these studies place ER stress and UPR upstream of 
ATM activation, others suggest ATM-dependent ER stress.  When Quercetin, an inhibitor of 
lipo-oxygenases, is supplied, p53-dependent ER stress as well as ATM activation are suppressed, 
thus indicating that these latter are instrumental in radio sensitization of human ovarian cancer 
cells. As activation of ATM kinase is one of the primary triggers for stabilization of p53, ATM 
kinase could theoretically act upstream of p53-dependent ER stress [389, 615-617]. However, 
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more studies are needed to delineate the relationship between ATM activity and ER stress 




6.5. FLAVIVIRUS AND THEIR ROLE IN THE MODULATION OF THE STRESS 
RESPONSE AND HOMEOSTATIC MECHANISMS OF THE HOST CELL 
 
6.5.1. FLAVIVIRUS – A GENERAL INTRODUCTION Flaviviridae are responsible 
for serious pathological conditions in human and other important mammals. The family is 
comprised of four distinct genera: Flavivirus, Hepacivirus, Pegivirus and Pestivirus. The largest 
and clinically the most relevant of three, Flavivirus contain almost 70 members, most of them 
transmitted to humans by mosquitos or ticks. Among the mosquito-borne are the most virulent 
viruses like dengue (DENV) [618, 619], West Nile (WNV) [620], Japanese encephalitis (JEV) 
and Yellow fever (YFV) [184]. Although dengue is the most threatening of all, other members of 
the Flaviviridae family are also known to affect humans. For instance, Flavivirus like West Nile 
Virus (WNV), Japanese Encephalitis Virus (JEV), and Zika virus (ZIKV), are neurotropic and 
cause neural disorders whereas Hepacivirus like Hepatitis C virus (HCV) is responsible for liver 
diseases [621].  
 
Members of Flaviviridae family are icosahedral, enveloped (+)-single stranded (ss) RNA 
viruses measuring approximately 500Å in diameter. The typical Flavivirus (Latin flavus – 
yellow, indicating Yellow Fever) virion is composed of the genetic material surrounded by the 
capsid protein and 180 copies of two glycoproteins. The average genome size of the Flavivirus is 
11kb, coding for a single polyprotein. The amino terminal accounts for the structural proteins: 
capsid (C), membrane precursor (prM) and envelope (E), and the remaining genome gives rise to 
the non-structural proteins (NS1, 2A, 2B, 3, 4A, 4B, and 5) that form the viral replication 
complex (RC) [622, 623].  
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Dengue has been declared endemic in more than 100 countries [624] and nearly two-thirds of 
the global human population is at risk of being infected. Recent WHO statistics have placed the 
count of reported cases at 40 million per year [625, 626]. Widespread infections, especially in 
hyper-endemic areas of the tropics and sub-tropics, cost an estimated 9 billion USD per year 
[627]. In the last half century, this virus has spread widely thanks to an increase in global trade, 
transportation, human migration and urbanization, especially the emergence of densely populated 
quarters with low quality hygiene [628].  
 
A wide range of viruses from different families (Poxviridae, Adenoviridae, Retroviridae, 
Picornoviridae, Flaviviridae, Orthomyxoviridae) have life cycles that intertwine with critical 
pathways involved in cell death and survival. As the aim of the virus is to reproduce and, in 
doing so, it affects the cell death or survival pathway, having discussed cell death we now 
address Flavivirus – structure, infectivity, replication and cell survival. In the following sections, 
we shall discuss about the three most widely studied flavivirus, - West Nile (WNV), Japanese 
Encephalitis (JEV), and Dengue (DENV). 
 
1. WEST NILE VIRUS West Nile virus (WNV), first encountered in the New World in New 
York City (1999), has been the cause of three major arboviral neuroinvasive outbreaks in the 
United States [629, 630]. It belongs to the same flavivirus serocomplex as the Japanese encephalitis 
virus (JEV) and St. Louis encephalitis virus 15, following a bird-mosquito-bird transmission cycle. 
In the United States, Culex pipiens serves as the major arthropod vector. The human is a ‘‘dead-
end host’’ for WNV due to low serum viremia [630]. WNV consists of five phylogenetic lineages, 
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of which 1 and 2 have been associated with significant outbreaks. The earliest targets are 
keratinocytes and specialized skin dendritic (Langerhans) cells; the latter migrate to visceral organs 
and the central nervous system. The neurovirulence of WNV is dependent on varying factors -- its 
ability to cross the endothelium of blood-brain barrier (helped by cytokine mediated increased 
vascular permeability), the transport of infected macrophages into the CNS (Trojan horse 
mechanism) and viral retrograde transport from peripheral neurons to CNS [631-633]. 
 
Like dengue, outcome of infection varies from mild fever (WNV fever), accompanied by 
headache and diarrhea, to neurological symptoms (WNV neuroinvasive disease). While only 1% of 
infected individuals develop the latter, mild fever can be seen in 25%. However, neuroinvasive 
infections have a 10% fatality, which classifies the virus as extremely lethal. The serious 
pathological conditions (meningitis, encephalitis, acute flaccid paralysis) are also accompanied by 
chills, rash and visual disturbance. The severity is higher in elder patients, as is evident from the 
higher death rate (17%) in individuals’ aged at least 70 than in those in their mid-40s (0.8%) [630, 
634]. Complete recovery following acute infection is extremely rare, and fatigue, cognitive 
difficulties, depression and muscle aches have been reported even after a year [635-638]. 
Diagnosis is dependent on detection of IgM levels in the cerebrospinal fluid by MAC-ELISA, 
although false positive results have been reported during infection with related flavivirus [639, 
640]. To date, treatment has been supportive, relying on vector control, and no vaccine is licensed 
for human use.  Since humans are a ‘‘dead-end host’’, future vaccinations will not prevent 
spreading of the virus in nature [641-643]. It is extremely important that molecular mechanisms 
adopted by the virus, like manipulation of the cell survival pathway, be studied. This would help in 
developing an effective antiviral therapy. 
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2. JAPANESE ENCEPHALITIS VIRUS Japanese encephalitis virus (JEV) is spreading 
throughout Asia, China, India, Australia, and Pakistan and is responsible for between 12,500 to 
17,500 deaths reported annually. JEV is transmitted by a primary mosquito vector (Culex 
tritaeniorhynchus) and secondary mosquito vectors (Culex gelidus, Culex fuscocephala and Culex 
vishnui) that primarily target domestic animals and human hosts [644]. Humans are a “dead end 
host” since they cannot infect the feeding mosquitoes because of low viremia. Children are at 
higher risk for an infection with Japanese encephalitis than adults, especially in rural areas. They 
are also at higher risk for death due to their weaker immune system as compared to the adults. In 
addition, people who visit Asia and Indonesia are particularly prone to this viral infection since 
they lack the protective antibodies. Asymptomatic infection depends on host’s age, immunity, 
general make-up and current health status. Symptoms include headache, fever, tremor, 
gastrointestinal discomfort as well as severe conditions of encephalitis and Parkinson-like seizures 
[645]. The means of the entry of the virus into the system plays an important role on the progress 
of the infection. If the carrier, the mosquito, bites directly into the blood vessel, it is easier for the 
virus to spread directly to the central nervous system. Efforts to make a vaccine against JEV have 
been impeded by frequent climate changes. Wind-blown mosquitoes, bird migration and people 
traveling with infected virus, which further spread the disease, assist the spread of Japanese 
encephalitis virus. Programs in underdeveloped countries are established to prevent the increasing 
number of yearly deaths caused by Japanese encephalitis virus. These programs include mosquito 
control by using pesticide, mosquito nets, cattle segregation and vaccination of cattle as well as 
humans [644, 646]. 
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3. DENGUE VIRUS In the current study, we have focused on the most widespread of all the 
Flaviviruses - Dengue (DENV). In the following paragraphs we shall present a synopsis of the 
epidemiology and molecular biology of this virus.  
 
EPIDEMIOLOGY Five serotypes of Dengue have been identified, although only the 
first four (Dengue 1-4) are reported to infect humans [647]. These serotypes display 65-70% 
amino acid homology and they have all spread to every corner of the tropical/subtropical belt, 
owing to increased trade and transportation [648, 649]. Dengue infection can range from a mild 
fever (dengue fever/DF) to severe hemorrhage (DH) that can further progress into endothelial 
permeability (dengue shock syndrome/DSS) characterized by multi-organ failure.  The severity 
of infection depends mostly on the age of the afflicted, with infants being the worst affected; in 
fact, dengue-induced hemorrhage (DH) remains the most lethal form of hemorrhage in the Asia-
Pacific region [647]. In other regions like the South Americas, elderly patients are also badly 
affected. The most common source of dengue-related lethality in healthy adults is secondary 
infection – when primary infection by one serotype is followed by secondary infection with a 
different serotype. This leads to a condition known as Antibody-Dependent Enhancement (ADE), 
also referred to as Antigenic Sin, where the antibodies developed during the primary infection 
bind to the virus particles and facilitate their transport throughout the body, instead of 
neutralizing them [626, 650, 651]. Such a complicated interplay among different serotypes and 
the host immune system makes it difficult for vaccines to act against infection. In fact, the only 
commercial vaccine (developed by Sanofi) is also facing serious challenges because of 
complications in immuno-compromised individuals and it has been shown to exert different 
effects in primary and secondary infections [652].  
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Among the members of Flavivirus family, Dengue is transmitted to humans (in urban 
areas) and other primates (in forests) by the urban-adapted mosquito strain Aedes aegypti 
(primary vector) and the emerging Aedes albopictus [653]. Dengue has been declared endemic in 
approximately 100 countries with 40 percent of the global population susceptible to infection. 
Dengue infection has doubled over the last two decades, and current annual figures have risen to 
50-100 million humans affected [654]. The four antigenically distinct serotypes (DENV 1-4), 
each having multiple phenotypes, originated in different parts of the globe [655]. The 
distribution of these serotypes has spread alarmingly since 1970, when only South Asia had all 
four [656]. This spread has added to the complexity of dengue-induced pathogenesis since very 
little cross-immunity has been recorded between these serotypes, leading to multiple sequential 
infections and overwhelmed immune response [657, 658]. DF, the most important arboviral 
disease in humans, features rapid onset of fever, accompanied by headache, retro-orbital pain, 
myalgia, and gastrointestinal irritation [659, 660]. DHF, which claims more lives (5% mortality) 
than any other hemorrhagic fever, is characterized by bleeding, thrombocytopenia, increased 
vascular permeability beyond the usual DF symptoms [661]. An equally lethal condition, DSS, is 
also characterized by vascular leakage, which is more pronounced in young children, and very 
low blood pressure [662]. Autopsies conducted on patients (predominantly children) dying from 
DSS have revealed a broad range of dengue susceptible tissues as shown by virus infecting skin, 
liver, spleen, lymph node, kidney, bone marrow, lung, thymus and brain [663-666]. 
 
GENOMIC STRUCTURE The genetic material of all Flaviviridae members is a 
positive-strand RNA. In dengue and in most Flavivirus, this 11kb RNA codes for a polyprotein 
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that consists of three structural proteins: Capsid (C), membrane (pr-M), Envelope (E); and seven 
non-structural proteins: NS1, 2A, 2B, 3, 4A, 4B and 5. This contiguous polypeptide is then 
cleaved by viral and host proteases (Furin) to release the individual proteins. The structural 
proteins are involved in binding/attachment and internalization into the host cell, whereas the 
non-structural proteins are enzymes that help in the replication and maturation of the nascent 
virus. Some of the non-structural proteins insert into the membrane of the ER, thereby 
precipitating a massive rearrangement and triggering severe stress responses, as will be discussed 
later [648, 667-670].  
 
Dengue has a genome of 10.7 kb positive sense single strand RNA that contains a type I 
cap at its 5’ terminus [671]. The enveloped icosahedral virion measures 50nm in diameter. The 
RNA is translated by the host cell machinery into a 3391-amino acid polyprotein that undergoes 
co- and post-translational processing by viral (NS2B-3) and cellular proteases [672-674]. The 
first quarter of the viral genome from the 5’ end codes for the structural proteins C (capsid), prM 
(membrane), and E (lipopolysaccharide envelope), leaving the rest to code for eight non-
structural proteins (NS1, 2A, 2B, 3, 4A, 2K peptide, 4B, 5) which are expressed only inside the 
host [675]. While the structural proteins are involved in determining the shape of virion, their 
non-structural counterparts govern the replication machinery inside the host. They are involved 
in the formation of replication complex (RC: NS1, NS4A), post-transcriptional modification 
(NS5) and post-replication assembly of mature virion (NS2A). They also function as viral 
protease (NS2B/NS3) and antagonist of host interferon response (NS4B).  
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One of the least studied among flavivirus proteins, dengue NS4A (~16kD) has four 
internal hydrophobic domains used to associate with membranes. An important component of the 
membrane-bound viral RC, NS4A promotes curvature of the ER membrane. The proteolytic 
cleavage of its C-terminal domain (2K fragment) is essential for inducing membrane alterations. 
Although role of NS4A in viral replication has been established, the specific mechanism is 
poorly understood. NS4A docks itself into the ER membrane with the help of its trans-membrane 
domains (pTMS1, 2, 3, 4), the N terminal protruding into the cytoplasm and the C terminal (also 
called 2K) serving as a localization signal for NS4B.  The proteolytic removal of the C terminus 
of NS4A seems to help in membrane alterations, which are important for the RC formation. 
 
REPLICATION AND MATURATION The life cycle of the Dengue virus cycles 
between the vector Aedes aegypti (or Aedes albopictus) and the human or primate host. It is 
likely that the virus switched hosts to human, from a non-human primate, in the rainforests of 
Asia and Africa. The mosquito vector plays an important role in virus pathogenesis; a female 
mosquito bites a viremic human host and the virus is deposited in the midgut and other tissues of 
the vector, where it reproduces. After approximately one week, the virus reaches salivary glands 
of the mosquito, and from there it is transmitted to a healthy host [628, 676, 677]. 
 
The primary response against viral infection is launched by the innate immune system, 
followed by a concerted defense launched by interferon. Since the virus is transmitted into the 
bloodstream of a healthy individual by an infected female mosquito, the earliest targets are 
almost always the keratinocytes, the most common cell type found in our skin [678]. Once the 
keratinocytes have been infected, the virus spreads to other cell types like macrophages and 
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monocytes, leading to viremia. As the infected lymphocytes spread to different parts of the body, 
other cells are also infected and some, especially epithelial cells (liver, kidneys), develop a high 
viral load [679]. There is also evidence that the virus can reduce interferon type I response in 
human dendritic cells [680]. 
 
Figure 3: The life cycle of DENV inside host cell 
In this diagram we have summarized the life cycle of the DENV inside the host cell and its 
interaction with the pathways described above. 1) The virus is internalized by receptor-mediated 
endocytosis. The virus travels inside the endosome until the LATE ENDOSOME reaches the 
acidic interior of the cell. 2) The RNA is released and it translocates to the rough endoplasmic 
reticulum (RER) where it undergoes translation and replication. 3) The structural and non-
structural proteins, thus translated, are engaged in building new progeny virus and ensuring a 
smooth replication, respectively. 4) The assembled, but not yet mature, virus translocates to the 
trans-Golgi network where the prM is cleaved by the furin protease. 5, 6) The mature virion is 









The structural proteins, especially the glycoprotein envelope (E) play a crucial role in 
binding to the host cell membrane. The most important of mammalian host receptors involved in 
attachment of the virus are heparin sulfate (HS) and endocytic C-type lectins (DC-SIGN, L-
SIGN); however other molecules such as Laminin receptor, CD-14, PtdSer receptors (TAM, 
TIM), and heat shock proteins (HSPs) 70 and 90 have also been identified in different cells 
[681]. The virus is internalized into early endosomes (EE) using a clathrin-mediated endocytosis 
(Figure 3, 1) [573, 626]. The fusion of the viral E protein and the endosomal membrane is an 
important step that has been targeted for the development of antiviral therapy [682]. Once the 
fusion is complete, the EE vesicle travels deep inside the cell until it matures into Late 
Endosome (LE) and an acidic pH triggers the release of the viral RNA into the cytoplasm of the 
host cell (Figure 3, 2). The RNA then undergoes translation on ribosomes attached to the rough 
Endoplasmic Reticulum (RER) [626].  
 
The resultant polyprotein undergoes co- and post-translational processing by viral and 
host proteases to give rise to the individual proteins. The structural proteins then assemble on the 
ER surface along with the RNA that is replicated on intracellular membranes (Figure 3, 3). This 
is then cleaved into three structural and seven non-structural proteins. The viral RNA and capsid 
(C protein), collectively known as nucleocapsid, enters the endoplasmic reticulum (ER) where it 
is joined by the envelope (E) and membrane (M) proteins. [683-689]. The non-structural 
proteins, each displaying a distinct enzymatic property, have attracted attention for mining 
antiviral targets for therapeutic purposes [690, 691]. As in other RNA viruses, dengue NS 
proteins are also involved in the formation of a platform, primarily in the endoplasmic reticulum 
(ER), to replicate the viral genome. The virus uses the ER as a replication complex (RC), 
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forming vesicles inside the lumen commonly referred as double membrane vesicles (DMV), 
vesicle packets (VP) or paracrystalline arrays.  Others argue that dengue induces the formation of 
spherical single-membrane vesicles (80-100 nm diameter) in the lumen of ER [692-696]. 
Proteins like NS4A and NS4B change the conformation of the ER membrane through insertion; 
this change is responsible for the induction of ER stress and downstream induction of unfolded 
protein response (UPR) [697, 698]. NS2B acts as a cofactor to the protease NS3; together they 
form a protease complex (NS2B-NS3pro) that is important for release of individual proteins 
from the polyprotein chain. NS1 and NS5 are involved in RNA replication; NS5 has multiple 
enzymatic properties including methyl-transferase, and RNA-dependent RNA polymerase 
(RdRp) [696, 697, 699, 700].  
 
Following replication, assembly of the virus takes place in the ER, where encapsulation 
of the genome into the progeny virus is initiated. Encapsulation is accompanied by the assembly 
of 180 copies of E and the prM each, forming in the process 60 trimeric (heterohexameric) 
spikes. The immature virus is then transported to the trans-Golgi network where the pr-M protein 
is cleaved by the host protease Furin (Figure 3, 4). An efficient cleavage of the M protein is 
essential for the infectivity of the released virion. The mature infective virion, once released by 
exocytosis, has a smooth surface, being devoid of the prM spikes. However, based on the host 
cell type, immature or partially mature virions (containing spikes) are also released by exocytosis 
(Figure 3, 5,6). The latter types of virus are compromised in their ability to infect other host cells 





6.5.2. FLAVIVIRUS DERIVES A SIGNIFICANT PORTION OF ITS PATHOGENCITY 
BY SEVERELY AFFECTING CELL SURVIVAL AND DEATH Flaviviruses among 
others interact with the cell death pathways in that they often protect cells from death while the 
virus is replicating, and may later activate specific cell death pathways to affect their escape from 
the cell. The following section contains a discussion on the effects of viral infection on the cell 
survival and stress response pathways, and vice versa. For the sake of brevity and convenience, 
we have focused on the three most widely studied members of the Flavivirus genera - WNV, 
JEV and DENV. 
 
1. WHAT IS THE CELL SURVIVAL SCENARIO LIKE DURING WEST NILE 
INFECTION? The relationship between WNV infectivity and cell survival pathways has 
been studied for more than a decade. WNV-mediated cell death and cytotoxicity depend on the 
severity of the initial infection. Vero cells infected with many virus particles (multiplicity of 
infection, m.o.i > 10) showed signs of necrosis (leakage of HMGB1 and high LDH activity) 
within 8 h of infection. In contrast, cells infected with a lower load (m.o.i < 10) showed signs of 
apoptotic cell death at a later stage (32 hpi) [701, 702]. WNV induces apoptotic cell death in 
several cell types, such as immune cells (human leukemic-K562), neuronal cells (mouse 
neuroblastoma - Neuro 2a, brain tumors), epithelial cells (Vero, A549), fibroblasts (MEF, 
BHK21), and embryonic cells (HEK293T) [702-704].  
 
WNV can regulate both extrinsic and intrinsic pathways to launch pathogenesis. The 
virus induces Bax-dependent intracellular apoptosis in human leukemic (K562) and mouse 
neuroblastoma (Neuro 2a) cells. UV-inactivated strains were severely compromised in their 
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ability to establish infection as well as initiation of apoptosis [702]. WNV encephalitis in CNS-
derived mouse neurons was highly dependent on the activation of caspase-3, and infection in the 
permissive T98G (brain-derived tumor) cells involved both extrinsic and intrinsic apoptotic 
pathways [703, 704]. Tetracyclines are well-established antiviral compounds, and minocycline 
strongly inhibited WNV infection in three CNS-derived human cell types (HBN, HRPE, and 
T98G). The antibiotic blocked viral replication, apoptosis and the viral activation of JNK/c-jun 
pathway, establishing a link among them [705]. Kobayashi et al proposed that the presence of 
ubiquitinated proteins had functional implication in apoptosis of WNV-infected mouse 
neuroblastoma (Neuro-2a) cells [706]. Migration of CD8+- T lymphocytes to drained lymph 
nodes (dLNs) was hindered in the CNS of Cd22-/- mice, which had a higher viral load than the 
wild type. This finding suggests a role for the B-cell marker, also an important component in cell 
survival, in modulating cellular immunity during infection [707].  
 
Apoptosis often restricts viral replication and infection. Shrestha et al showed the 
beneficial role of TNF-α related apoptosis inducing ligand (TRAIL), produced by CD8+- T cells, 
in limiting WNV infection in mouse central nervous system [708]. CD8+- T cells in TRAIL-/- 
mice encountered difficulty in clearing the viral particles from the neurons. Zhang et al 
demonstrated, using mouse neuron as an infection model, a rise in TNF-α during infection [709]. 
The rise served to down regulate the chemokine CXCR3, which would otherwise bind antiviral 
CXCL10 circulating in the central nervous system (CNS). This interaction results in calcium 
transients that lead to caspase-3 mediated apoptosis in the neurons, an adaptive mechanism that 
limits viral production. Smith et al showed an important aspect of WNV infection in human cell 
culture (HEK293, SK-N-MC) and mouse neuronal tissues - regulation of non-coding microRNAs 
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(miRNAs) [710]. Among several miRNAs, Hs_154 is significantly upregulated in infected cells. 
Two of the targets of Hs_154, CCCTC-binding factor (CTCF) and epidermal growth factor 
receptor (EGFR), are associated with cell survival; this accounts for the role of Hs_154 in 
suppressing apoptosis. While this activation lowers viral replication, apoptotic cell death is also 
the basis for WNV pathogenesis.  
 
As in dengue, both structural and non-structural proteins play a role in survival of infected 
cells. WNV capsid (Cp) protein triggers a caspase-dependent apoptosis, leading to inflammation, 
in mouse brain and muscle [711]. WNV capsid is dependent upon p53 for its apoptotic effects. Cp 
has been shown to sequester HDM2, a negative regulator of p53, into the nucleolus. This results 
in a higher stability of p53, which can then target Bax to induce apoptosis in MEF cells [712]. 
Inhibitor-based studies on four types of mammalian cells (A549, HEK293T, Vero-76, BHK-21) 
suggest a role for WNV capsid (C) protein in the inhibition of apoptosis through 
Phosphatidylinositol-3-kinase (PI3K)-Akt pro-survival pathway [713]. The helicase and protease 
domains of NS3 protein are instrumental in inducing a caspase-8 dependent apoptosis in three 
types of mammalian cells (Neuro 2a, HeLa, and Vero) [714].  
 
Currently there is no evidence for any significant role of autophagy in WNV 
pathogenesis, although we have evidence of PI3K-dependent autophagy in infected mouse brain 





2. HOW IMPORTANT IS CELL SURVIVAL OR DEATH IN JAPANESE ENCEPHALITIS 
INFECTION? JEV-induced apoptotic cell death is reliant on endoplasmic reticulum (ER) 
stress and production of reactive oxygen species (ROS). ER stress-induced activation of UPR 
factors (CHOP-p38MAPK) is essential for triggering the apoptotic response in fibroblasts (BHK-
21) and neuronal cells (N18, NT-2) [717]. Even replication-incompetent strains (UV-JEV), as 
shown by Lin et al, retain their ability to kill neuronal cells (N18, NT-2) by inducing ROS 
production and activating NF-κB [718]. The structural E protein from JEV-YL induces apoptotic 
cytotoxicity in HepG2 and Vero cells [719]. Earlier studies had pointed to a link between non-
structural NS3 protein and induction of apoptosis. Transfection of pEGFP-NS3 1-619 plasmid 
(whole NS3 protein) into Vero cells caused apoptotic cell death. The same study also evaluated 
the role of caspases; NS3 activates only the intrinsic branch (CASP -9, -3) of apoptosis [720, 
721]. Bcl-2 proteins can prevent apoptosis by controlling the release of cytochrome C. 
Overexpression of Bcl-2, however, did not block viral replication and distribution in mouse 
neuroblastoma N18 cells, though it delayed cell death in BHK-21 cells. Moreover, in BHK-21 
and CHO cells, overexpression of the anti-apoptotic Bcl-2 established persistent infection. 
Though JEV induced classical intrinsic pathway in N18 neuroblastoma cells, it activated both 
caspase-8 (part of the extrinsic pathway) and caspase-9 in a predominantly mitochondria-
dependent pathway in MCF cells [722-724].  
 
Japanese Encephalitis virus induces autophagy to facilitate viral replication in certain cell 
types. Li et al showed induction of autophagy by virulent (RP-9) and attenuated (RP-2ms) JEV 
strain in human NT-2 cells. They also showed that of rapamycin-induced autophagy increased 
viral replication and maturation, and suppression of replication when autophagy was blocked 
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[725, 726]. Infection with Japanese encephalitis virus triggers innate immune response (through 
RIG-1/IRF-3 and P13K/NF signaling pathway) and activates inflammatory cytokines, chemokine 
and IFN-inducible proteins. JEV Infection also induces autophagy in a human microglial (CHME-
5) cell line, leading to pro-inflammatory cytokine response [726].  
 
3. HOW IS DENGUE INFECTION INVOLVED IN CELL SURVIVAL OR DEATH? The 
role of cell death in dengue pathogenicity in various cell types has now been studied for nearly 
two decades. Most of the initial studies were done with regard to apoptosis, though it has been 
lately shown that autophagy too plays an important part in some cells. For this reason, more is 
known about apoptosis in the time of dengue infection. Understanding of how dengue affects 
cell survival is central to this thesis. We shall summarize the role of autophagy in dengue 
infection (the central theme of this thesis) in the following paragraphs and conclude the 
section with a discussion on apoptosis in DENV infection. Although the current study 
doesn’t directly look at apoptosis, it is an important aspect of infection and thus needs to be 
revisited.  
 
Autophagy plays an important role in the pathogenicity of dengue virus. Involvement of 
autophagy in dengue infection is a relatively new finding, shown first in 2008, when DENV2 
was linked with ATG5-dependent autophagy in hepatic (Huh7) and fibroblast (MEF) cells. It 
was identified as a mechanism that was conducive to viral replication as well as increased titer. 
Similarly, blocking autophagy in Huh7. a.1, BHK21 cell lines and AG129 mice resulted in a 
heat-sensitive and non-infectious dengue virion. Studies conducted using specific autophagy 
inhibitors like spautin-1 further revealed the role autophagy plays in maturation of dengue virion. 
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However, with more studies it became clear that like apoptosis, the relation between autophagy 
and DENV infection depends on the infected cell type. While most of these studies were aimed 
at looking for viral replication in directly infected cells, studies with human monocytes3 (U937) 
showed that induction of autophagy decreased viral replication. Studies conducted by our lab 
demonstrated that DENV2-mediated autophagy protects canine kidney epithelial (MDCK) and 
mouse fibroblast (MEF) cells from toxic stimuli but not protect murine macrophages, where 
infection leads to apoptotic cell death. Thus it is important to look at the effects of infection on 
the status of autophagy in cell types from different sources [727-729].  
 
In our laboratory we have established a link between autophagy and pathogenicity. Our 
data shows that the ability of all dengue strains to protect epithelial cells or fibroblasts against 
other stressors correlates with their ability to induce autophagy. NS4A was also the sole effector 
behind cell protection by these flavivirus. We showed that expression of dengue NS4A protein, 
like infection with live virus, induces PI3K-mediated autophagy and protects these cells against 
death from toxins. In contrast, expression of other structural and non-structural proteins could 
not produce this protective effect [652]. Most of these proteins (expressed in mammalian cells 
from a pCAGGS-HA plasmid vector) did not protect MDCK (canine renal epithelial) cells from 
Camptothecin; rather NS2A and NS5 killed slightly more. The protection by NS4A is diminished 
in an autophagy deficient background (Vps 34 inhibitor/ Rapamycin/ Beclin1-/-, ATG5-/- 
knockout MEFs) thus correlating autophagy and flavivirus replication [652]. In our current 
study, we have extended this approach to look at the role of PERK pathway - an upstream 
effector of autophagy - on replication and maturation of the virus. Our results also establish 
																																																								
3 The virus does not directly infect these cells. 
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PERK as a mediator of autophagy and cell protection. The same study also demonstrates the 
early activation of Ataxia Telangiectasia Mutated (ATM) kinase, a DNA Damage Response 
(DDR) protein, and its potential role in activating PERK, autophagy and subsequent pro-survival 
in infected cells [10]. In contrast, the virus induces apoptosis of macrophages or neurons, 
suggesting that it functions differently in different cell types. 
 
Apoptosis has been illustrated across a wide range of mammalian cell types infected by 
different DENV serotypes. Studies have shown that DENV 1 (human isolates of dengue type 1 
virus FGA/89 and BR/90, neurovirulent variant FGA/NA d1d), DENV 2 (strain NGC, 16681) 
and DENV 3 (DENV3/5532) all are capable of inducing apoptotic cell death within 25 to 36 
hours post infection. Apoptosis has been recorded in infected cells from the central nervous 
system (human and mice neuroblastoma, murine cortical and hippocampal neurons, human 
cerebral cells), liver (human hepatoma immune system (human peripheral blood mononuclear 
cells like CD8+-T lymphocytes, monocyte-derived macrophages, human mast cells like KU812, 
HMC-1, and primary murine macrophages), vascular system (human umbilical cord vein 
endothelial cells, human microvascular endothelial cells, pulmonary microvascular endothelial 
cells, EA.hy296), digestive system (intestinal cells) and kidney (human embryonic kidney HEK 
293, VERO).  
 
Apoptosis is important in dengue pathogenesis and infectivity, although the effect on 
infected cells is different from DENV-induced autophagy. Unlike lytic viruses that 
indiscriminately trigger cell death, pro-apoptotic variants of dengue may not always kill infected 
cells. The neurovirulent variant FGA/NA d1d kills neuroblastoma but not hepatoma cells [730]. 
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Apoptosis seen during infection of human umbilical cord vein endothelial cells (ECV304) and 
Swiss Webster primary macrophages by Dengue-2 virus strain 16681 is not seen in MDCK, 
HeLa, HEK 293T, Vero or Swiss Webster primary MEF even after 144 hours (6 days) post 
infection [652, 731]. The differences in pathogenicity of dengue outbreaks are partly explained 
by differences in cell killing by clinical isolates. Isolates of virus from a fatal case (Paraguay 
2007; DENV3/5532) had a higher replication rate in monocyte-derived human dendritic cells 
(mdDCs) than isolates of virus from a non-fatal breakout (Brazil 2002; DENV3/290). The former 
also induced more proinflammatory cytokines associated with apoptosis [732]. 
 
Regardless of the status of cell death, it is evident that Dengue derives its pathogenic 
effects by inducing apoptosis. It targets immune cells for apoptotic death, as was shown by an 
increase in the number of peripheral blood mononuclear cells (PBMCs) in dengue-infected 
children. The proportion of apoptotic cells and the mediators of apoptosis (CD95) among the 
circulating PBMCs are much higher in individuals progressing towards hemorrhage (DHF) than 
those developing febrile symptoms (DF), indicating a higher viral load in the former. The 
immune response to increased dengue-induced apoptosis does not always curb virus 
proliferation. Apoptosis, in the context of dengue infection, fails to arrest viral reproduction and 
even correlates with increased virus production [733, 734]. 
 
Both extrinsic and intrinsic apoptosis have been observed in DENV infection. Increased 
levels of pro-apoptotic proinflammatory cytokines (TNF-α and interleukin–10) and 
Apo2L/TRAIL are observed after infection with dengue 3, which the virus possibly induces 
through the TNF-α route [732]. Profiling of genes reveals the activation of death receptors 
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FAS/CD 95, TNFR superfamily member 9/CD 137, TNFRI/TNF-α (caspase-independent) and 
IL-1β/NFκB (caspase-dependent) pathways [733, 734]. Infection with live dengue virus leads to 
differential expression of several interferon-inducible genes, the most important being XAF1. 
XAF1 upregulates caspase 3 thirty-six hours after infection and mediates apoptosis [735]. The 
activation of caspase leads to the characteristic nuclear fragmentation and cytoplasmic blebbing 
of apoptosis. The reactive oxygen species (ROS) O2. - and H2O2, produced in mitochondria, 
increase during infection. Toxic levels of ROS can activate calpains and lead to apoptosis. 
Secondary messenger oxides like nitric oxide (NO) also mediate dengue-triggered apoptosis in a 
caspase dependent manner [736]. As infected cells undergo apoptosis, the extrinsic and intrinsic 
apoptotic pathways converge at the exteriorization of phosphatidylserine (PS), which leads to 
phagocytosis of apoptotic cells by phagocytes [737].  
 
Like whole virus infection, expression of individual viral proteins has also been shown to 
initiate extrinsic and intrinsic apoptosis. Viral protein NS5 interacts with death protein 6 
(Daxx), which among other functions interacts with death receptor FAS, to activate RANTES 
(CCL5), a cytokine closely associated with dengue hemorrhagic fever (DHF) [738, 739]. 
Moreover, transfection with wild type capsid protein increases the expression of CD137, a 
member of the TNFR family. Receptor-interacting serine/threonine protein kinase 2 (RIPK2), a 
master regulator of stress pathways [740], is also necessary for capsid-induced apoptosis [740]. 
Intracellular production of the M protein from all dengue strains activated the intrinsic pathway 
apoptosis in mouse neuroblastoma (Neuro2a) and human hepatoma (HepG2) cells. ApoptoM, a 
nine-residue sequence (M-32 to -40) from the M ectodomain (M-1 to -40), is instrumental in the 
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cytopathic effect of the flavivirus [741]. Differences in cell toxicity among dengue variants have 
been attributed to mutations in the E and NS3 [730].  
 
To summarize, the ability of different strains to induce apoptosis, and consequent cell 
death, depends upon the type and origin of the infected host cell. Although apoptosis has been 
found to be conducive to viral infectivity in most cases, more studies should be dedicated at 
looking into non-conventional pathways of apoptosis like the BOK-induced intrinsic pathway 
and others. This would enable researchers to identify a putative target for antiviral therapy. 
 
 
6.5.3. WHAT ARE THE FUNCTIONS OF AUTOPHAGY, ATM KINASE AND ER 
STRESS IN VIRAL INFECTION? All the pathways described above represent the crux of our 
current study. We have investigated the roles played by these pathways in Dengue-infected cells. 
In the following sections, we shall present a brief overview about the function of these processes 
in viral infection, and then focus on Flavivirus. 
 
1. MACROAUTOPHAGY AND OTHER FORMS OF AUTOPHAGY ARE FREQUENTLY 
MANIPULATED IN VIRAL INFECTION As has been described earlier, autophagy, 
and specifically macroautophagy, can present both pro-viral and antiviral aspects. In viral 
infection, autophagosomes can act as a source of membranes and lipid droplets (through 
Lipophagy) for the viruses; a double membrane vesicle (like ER) is always a potential 
‘replication hub’ for the virus. On the other hand, autophagy can also trigger antiviral immune 
responses and play an instrumental role in the removal of the viral pathogens, especially in viral 
	
	 62 
xenophagy. Thus, the challenge to the virus lies in balancing the outcomes of autophagy in the 
host cell and in turning the ‘autophagy wave’ into its own replication and maturation [485, 742-
744].  
 
Many viruses, especially RNA viruses, either subvert the autophagy apparatus to their 
own benefit, or to block the pathway altogether and block the autophagy-dependent antiviral 
response. Picornaviruses, Coronaviruses, Retrovirus, Flaviviruses, Hepaciviruses, 
Herpesviruses and Orthomyxovirus manipulate different steps or components of macroautophagy 
to facilitate replication and in certain cases, even viral maturation and exocytosis [742]. Many 
researchers identify viral proteins that interact with the autophagy machinery, e.g., Poliovirus 
2BC and 3A, which mediates formation of double membrane vesicles (DMV) and LC3 
lipidation. Other examples include West Nile (WNV) NS4A/NS4B (induce autophagy 
independently of the UPR pathways), Zika (ZIKV) NS4A/NS4B (which activate mTORC-
dependent autophagy) and NS2B-3 (inhibition of Reticulophagy), Hepatitis C virus (HCV) NS4B 
(initiates RUBICON-mediated suppression of autophagosome maturation) and NS5B (interaction 
with ATG5), Dengue (DENV-2) NS4A (PI3K-dependent autophagy/ cell protection) and NS2B-
3 (inhibition of Reticulophagy), Influenza A virus (IAV) matrix 2 (M2)/NS1/HA (interaction 
with LC3) [742, 745-759]. 
 
Since lipid droplets are extremely rich sources of membranes that can serve as 
‘replication hotspots’, as well as free fatty acids that can boost energy (ATP) formation, they are 
often hijacked by viruses to facilitate assembly and replication. Viruses target a selective form of 
autophagy, Lipophagy, which involves degradation of lipid droplets in lysosome, for this 
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purpose. It is believed that RNA viruses like DENV and HCV block the maturation of lipid-rich 
autophagosomes, thereby increasing the cytosolic level of lipid droplets and cholesterol in the 
infected cells. The colocalization of DENV capsid protein in lipid droplets also point to the 
possibility of these being used as a platform for viral assembly and maturation.  In HCV infected 
cells, the autophagosomes have a high density of lipid-raft associated proteins like annexin and 
caveolin, and chemical depletion of cholesterol has been shown to reduce viral titer [760-765]. 
 
Apart from early events like replication, viruses also hijack the autophagy network to 
expedite their release by exocytosis. Both enveloped Flaviviruses as well as non-enveloped RNA 
viruses like Picornaviruses rely heavily upon the autophagosome membranes for exocytosis. 
Lytic viruses like Herpesvirus also use the autophagy machinery to acquire envelopes before 
release from the cells. Both autophagy and exocytosis share molecular machinery like the 
participation of GTPase RAB and SNARE proteins. The presence of LC3 in exosomes also 
highlights the overlap between autophagy and exocytosis in infected cells [751, 753, 756, 766-
773]. 
 
Besides subverting the regular processes involved in autophagy, a second approach is 
also adopted by viruses - to escape autophagy or block the process altogether. This is essential in 
cases when autophagy is intricately linked to both innate and adaptive immune response. 
Autophagy plays an important role in mounting an innate antiviral response, by closely working 
with the Toll Like Receptors (TLR) and mediating the expression of interferons. The TLRs 
(most commonly TLRs 3/8/9) are capable of binding to pathogen associated molecular patterns 
(PAMPs) present on the viruses and inducing production of interferon. This process also 
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activates autophagy by the dissociation of BECN1 from its negative regulator BCL-2; 
autophagy, on the other hand, exerts a positive effect on TLR-mediated IFN production in cells 
infected with Herpes Simplex virus type-1 (HSV-1), vesicular stomatitis virus (VSV) and Sendai 
virus (SEV). The relation between autophagy and immune antiviral response is however 
complicated, because autophagy, especially the ATG5-ATG12 complex formation, blocks 
retinoic acid inducible gene-1 (RIG-1) mediated IFN production [774-780]. 
 
Autophagy is also instrumental in mounting an adaptive immune response against viral 
infection. In several MHC type II positive cells autophagosomes play an important role in the 
degradation and presentation of specific viral proteins (e.g., EBV nuclear antigen 1, HIV-gag 
derived proteins) to CD4+-T cells. In contrast, although MHC type I cells are usually inhibited by 
autophagosome degradation, infection by human cytomegalovirus (HCMV) and HSV-1 can 
induce autophagy to favor MHC type I presentation in a vacuole-dependent pathway. Both these 
viruses block antigen peptide transporter (TAP), thus pointing to a common pathway of antigen 
presentation. Autophagy is also involved in cross-presentation of viral antigen/peptides to MHC 
type I cells through an exocytosis-dependent manner [781-787].  
 
2. ATM KINASE ACTIVITY IS REGULATED DURING INFECTION BY SEVERAL 
VIRUSES ATM kinase, along with the rest of DDR machinery, has long been associated 
with the replication of DNA and RNA viruses. Although the activation of a damage response 
(designed to stall cell cycle and replication) in infected cells seems paradoxical, numerous 
mechanisms suggest that this is just another pathway hijacked by the virus. In other cases, the 
virus, quite expectedly, suppresses the DNA damage mechanism, thereby removing any potential 
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checkpoints from cell replication. Just like autophagy and ER stress, the viral proteins also 
manipulate ATM. Most researchers believe that DNA and RNA viruses differ in their ability to 
manipulate the various DNA damage response proteins, including ATM kinase. DNA viruses are 
more aggressive in their subversion of the DNA repair mechanism; in contrast, RNA viruses 
only indirectly activate ATM, as an antiviral response. However, there is an increasingly large 
body of evidence that supports a more direct role of RNA viruses in ATM activation, and 
different viruses have been found to either activate or suppress the damage response in different 
cell types [788, 789]. 
 
Ebola virus, an RNA virus from family Filoviridae, suppresses ATM kinase. A high 
throughput screening study associated the activation of DNA damage response, specifically 
ATM kinase, with IFN induction. Several topoisomerase inhibitors, including chemotherapeutic 
agents, showed that viral VP35 protein partially suppressed RIG-1 like receptor (RIG-1) 
dependent production of interferon (IFN-α). Blocking VP35 in infected 293T and A549 cells 
effectively bypassed the virus-imposed evasion of innate immune response and released 
production of virus from inhibition. Most of these compounds, including Doxorubicin and 
Daunorubicin, were found to induce IFN-α production in an ATM-p53-dependent manner, thus 
mounting antiviral innate immune response. In this case, ATM exhibited a non-DDR function 
that nevertheless restricted viral growth. In contrast, members of the Flaviviridae family like 
Dengue (DENV), Japanese Encephalitis virus (JEV) and Hepatitis C virus (HCV) all induce 
ATM and related proteins, although the mechanisms of induction are different. Whereas HCV 
induced ROS-dependent DNA damage in liver cells (Huh-7) that further activated ATM, ATR 
and DNA-PK, DENV activated ATM (and, possibly ATR) at a very early stage in a ROS-
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independent fashion. The interaction between HCV proteins (NS3, NS4A, and NS5) and ATM 
kinase, and the activation of ATM-CHK2 in JEV-infected U87 cells further validates the proviral 
nature of the DDR pathways when cells are infected with Flaviviridae. This response was 
observed even in cells harboring a latent HIV-1 virus; proteins involved in DDR and downstream 
pathways, like ATM, CHK2 and P53 were all activated in infected Jurkat-derived cell lines [10, 
619, 620, 761, 790-794].  
 
Among DNA viruses, the relation between human papillomaviruses (HPV) and 
ATM/ATR signaling has been extensively investigated. As explained above, the interaction 
between DNA viruses and ATM kinase is more directly executed than between RNA viruses and 
ATM kinase. ATM directly facilitates replication of varicella zoster (VZV) and polyomavirus. In 
macrophages infected with gamma herpesvirus, replication is upregulated by ATM through 
inhibition of type I Interferon. Inactivation or knockdown of the ATM in these cells not only 
restores type I Interferon, but also increases susceptibility to type II Interferon. This highlights 
the importance of ATM in innate antiviral response, although it is carried out in exactly the 
opposite way of that in Ebola virus infection (described above). ATM is also activated, although 
with different consequences, in HPV infection, especially the high-risk (HR-HPV). HR-HPV is a 
major cause of cervical, ano-genital and oropharyngeal cancers. Unlike healthy cells, in which 
replication is completely stalled until ATM/ATR has repaired the DNA lesions, HPV-infected 
cells usually exhibit ATM activity simultaneously with viral replication, meaning that viral DNA 
continues to be replicated. These findings, coupled with evidence that ATM and other DDR 
proteins are highly localized in these cells, suggest that ATM induction in these virus-infected 
cells is less (compared to chemically damaged cells) and that DDR is probably subverted to aid 
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viral replication and establishment. In HPV infection, several viral proteins appear to be 
associated with induction of DDR. Among these, the E1-E2 replication complex is involved in 
repeated rounds of DNA replication in host cells, thus resulting in the formation of “onion-like” 
structures that are recognized by the DDR system as lesions. E2 interacts with TOPBP1 protein, 
which is involved in the mutual crosstalk between ATM and ATR; E1-E2 can also interact with 
SIRT1 deacetylase in order to activate ATM. Other viral proteins like E6 and E7 also modulate 
downstream pathways of ATM/ATR activation, most notably stabilizing P53. STAT-1 may also 
activate ATM/ATR in infected cells, thus suggesting possible interaction among viral proteins, 
the host DDR response complex, and host transcription factors. Other tumor-causing DNA 
viruses like human cytomegalovirus (HMCV) and hepatitis B virus (HBV), associated with brain 
tumors and liver cancer respectively, activate the ATM-CHK2-γH2AX axis. In the case of the 
oncogenic herpesvirus Epstein Barr (EBV), upregulation of certain micro-RNAs (miR-BART5-
5p, BART7-3p, BART9-3p, and BART14-3p) has been implicated in activation of ATM, a 
prerequisite for the formation of viral replication complex. Localization of phosphorylated ATM 
has been extensively recorded in cells infected with different herpesviruses such as Kaposi’s 
Sarcoma Associated Herpesvirus (KSAV) and Herpes Simplex Virus-1 (HSV-1). 
Pharmacological inhibition of ATM (by KU55933) reduced the incidence of Herpes Simplex 
Virus-1 (HSV-1)-induced keratitis. However, the positive effects of ATM activation, blockage of 
replication of host DNA, are not conserved among all DNA viruses. Some DNA viruses block 
the activation of ATM kinase and its downstream targets like CHK1 and γH2AX. Adenovirus 
core protein VII, which has histone-like properties, and localizes with cellular chromatin, blocks 
the activation of DDR through downregulation of ATM and γH2AX activity. Mechanistic studies 
reveal an interaction between VII core protein and oncogene SET. Since VII protein is active 
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only in the late stage of replication, DDR downregulation may be important after viral 
replication has commenced inside the host cell [792, 795-809].  
 
In brief and in general, RNA viruses appear to affect ATM kinase and other components 
of the DNA damage response indirectly and in some cases through a mechanism that starkly 
contrasts to that of DNA viruses. However, it should also be recognized that more DNA viruses 
have been studied in this regard and therefore it is hard to reach a definite conclusion at this 
moment. Finally, ATM kinase activation has a pleiotropic effect in virus infection, and it is 
strongly regulated by the nature of the virus and the infected host. Apart from acting as a 
surveillance protein that detects genetic lesions and induces cell cycle arrest, this protein has also 
been implicated in mounting immune response as well as maintenance of redox homeostasis. 
Furthermore, the very nature of its function makes ATM kinase one of the most favorable targets 
for antiviral therapy against tumor viruses like HPV, HCMV, HBV, HCV and adenovirus.  
 
3. ER STRESS/ UPR HAVE BEEN IMPLICATED IN VIRAL INFECTION, ESPECIALLY 
IN RNA VIRUSES  Since ER is a major site for replication and translation, it is one of 
the organelles where RNA viruses colocalize and thrive. It is where the virus replicates its 
genome, expresses its proteins, and assembles and prepares the viruses for release by exocytosis. 
ER stress is frequently triggered by Ca2+ imbalance (caused by Viroporins4), accumulation of 
misfolded proteins and the rearrangement and loss of ER membrane. Many RNA viruses, 
including Flavivirus, have been reported to induce one or more of these events. Poliovirus (PV), 
																																																								
4 A class of hydrophobic viral proteins expressed by both DNA and RNA viruses. They 
oligomerize inside the host membrane and form hydrophilic pores, thus disrupting calcium 
homeostasis in infected cells.  
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Coxsackievirus B3 (CBV3), alongside Dengue (DENV) and Hepatitis C virus (HCV) replicate 
within the stressed ER [469, 532, 810-812]. Interference with protein-glycosylation is a 
prominent mechanism used by Influenza A (IAV), Japanese Encephalitis virus (JEV), West Nile 
Virus (WNV) and Hepatitis C virus to induce ER stress in host cells [813-816]. In many types of 
cells, WNV infection increases the influx of Ca2+ into the cells, resulting in the rearrangement of 
the ER [817].  
 
As in apoptosis, individual viral proteins are involved in the induction of ER stress. With 
Rotavirus, the capsid protein VP7 cooperates with VP4 and the nonstructural protein NSP4 to 
‘steal’ some of the ER membrane and to accumulate it into its own structure during assembly and 
release as an infectious triple-layered particle [818]. Viroporins disrupt the integrity of 
membrane-bound vesicles such as the ER [812]. IAV M2 protein, rotavirus NSP4 protein and 
picornavirus 2B proteins disrupt Ca2+ homeostasis in the host cell and use this to improve 
budding and release [819-821]. The enterovirus 71 (EV71) non-structural protein 2C and HCV 
NS4B interact with the ER membrane protein reticulon 3 (RTN3) to induce membrane 
rearrangement to facilitate viral replication [822-824]. DENV non-structural protein (NS2B, 
NS4A) redistributes the ER membrane through a ROCK-dependent vimentin rearrangement 
[825-827]. 
 
An important product of viral infection is an increased “translation burden” on the host 
cell, as the translation machinery is often hijacked by the virus and given the additional task of 
expressing the viral proteins. The mammalian part of the dengue life cycle is remarkably 
compartmentalized, hijacking ER-specific translation but having little effect on cytoplasmic 
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translation, where host proteins continue to be manufactured [828, 829]. The ER responds to this 
situation by turning off global protein translation, employing one or more Unfolded Protein 
Response (UPR) pathways that regulate the activity of the elongation or initiation factors [830]. 
The UPR pathways are also activated in response to TLR signaling, excessive ROS production 
and viral infection [831]. Accumulation of misfolded proteins in the ER lumen, as is often the 
case in viral infection, causes the release of BiP (Binding Immunoglobulin protein)/GRP78 from 
the initiator molecules of all three UPR branches.  
 
4. ER STRESS AND MULTIPLE BRANCHES OF UPR HAVE BEEN RECORDED IN 
FLAVIVIRUS INFECTION Like improper glycosylation, impaired ERAD (ER-
associated degradation) machinery, oxidative stress, and hypoxia, viral infection is a major 
trigger for ER stress; and not surprisingly it has been linked to every branch of the UPR. 
Flavivirus has an intricate and complex relationship with the endoplasmic reticulum [693].  
 
The upstream events leading to apoptotic death in WNV infected cells include 
endoplasmic reticulum (ER) stress. West Nile Virus (WNV) activates the ATF6 and PERK 
pathways in human neuroblastoma (SK-N-MC) and primary rat hippocampal neurons, and as a 
consequence, infected cells activate CHOP-mediated apoptosis [832]. As with apoptosis, 
infection-mediated induction of UPR is strongly dependent upon the strain of the virus and the 
type of host cell. West Nile virus Kunjin strain (WNVKUN) inhibits the PERK pathway and 
interferon-mediated STAT phosphorylation, simultaneously activating ATF6 and IRE1 
pathways. Studies with ATF6-/- and IRE1-/- MEFs reveal a synergetic pattern through which 
infection restricts apoptosis and increases viral load, an effect somewhat akin to dengue 
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protecting MDCK cells and increasing the viral load. The hydrophobic non-structural proteins 
NS4A and NS4B of WNVKUN activate IRE1/ATF6 and inhibit the JAK-STAT signaling branch 
of the host antiviral response. A follow-up study using the same model and knockout cells 
highlighted the relative importance of ATF6, compared to IRE1, in manipulating the PERK 
pathway and restricting apoptosis and antiviral responses [652, 833, 834].  
 
JEV activates UPR-induced apoptotic cell death in BHK21 fibroblasts and neuronal N18 
and N-2 cells, but not in apoptosis-resistant K562 cells. p38 and CHOP mediate the effects of ER 
stress in inducing UPR-dependent apoptosis [835]. One or more UPR pathways are activated in 
JEV infection. JEV SA14-14-2 strain induces apoptosis through an IRE1/JNK pathway in BHK-
21 cells [836]. Other pathways of cell death are also regulated during JEV infection: IRE1-
dependent XBP1 splicing and ATF6 activation are linked to induction of autophagy and cell 
survival in mouse embryonic fibroblasts and neuronal cells [837]. The induction of autophagy, in 
this case, inhibits viral production, in sharp contrast to what we found for dengue in MDCK cells 
[10, 652]. JEV can co-opt the IRE1-dependent decay pathway (RIDD) to increase viral protein 
and viral titer in mouse neuroblastoma cells (Neuro2a) [838]. In Japanese Encephalitis virus 
(JEV) infected BHK21 cells, the BiP protein colocalizes with the viral E (envelope) protein, 
supporting the maturation and release of infective virion particles [839]. Proteomic studies in 
JEV-infected human neural stem cells (hNS1) revealed an increase in the amount of several 
proteins responsible for sustained ER stress, including BiP/GRP78, mitochondrial Prohibitin, and 




Like many other RNA viruses, including members from the Flaviviridae like HCV, IAV, 
JEV, Dengue (DENV) too relies heavily upon their ability to modulate the ER and regulate the 
downstream metabolic processes, i.e., translation, apoptosis, autophagy, ROS production and 
protein folding [525, 841]. Dengue-induced ER stress has been reported in a wide variety of 
cells, including monocytes and liver cells (HepG2) [842, 843]. These processes are believed to 
favor dengue production and cytopathogenicity as well as to suppress the host antiviral response 
[844]. In fibrosarcoma cells, dengue modulates the PERK pathway during early stages of 
infection, first activating this pathway and later turning it off in a time-dependent fashion.  IRE1-
XBP1 and ATF6 pathways are then activated during the mid- and late-stages respectively [829]. 
In this case as in WNV infection, the timeline of UPR regulation varies with the function and the 
type of the host cell. In epithelial cells, the flavivirus replication complex (RC) co-localizes with 
autophagosomes, which are derived from the ER membrane. The accumulation of viral proteins 
on ER membranes causes high ER stress that can activate one or more UPR pathways. Apart 
from mammalian cells, DENV (serotype 2/strain: 16681) NS4B also modulates host immune 
response through UPR activation in Drosophila melanogaster cells [845]. In concordance with 
our results (in MDCK and PERK-/- MEF cells), another group has shown the involvement of 
both PERK-eIF2α and IRE1α-JNK in inducing autophagy and facilitating DENV-2 pathogenesis 
in Huh7 and BHK-21 cells [10, 841]. 
 
Many Flaviviruses modulate the PERK pathway, either specifically or in combination 
with other UPR pathways. In a novel study using Neuro2a and MEF cells, infection with JEV 
(Vellore strain) and WNV induced a PERK-dependent up regulation of a long non-coding RNA 
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Malat1, which is linked to cell survival [846]. This validates numerous findings that have 
suggested that UPR pathways are integral to cell survival in infected cells. 
 
The capability of DENV to induce UPR/PERK can be used as a potential target to block 
viral infection and production, as has been proposed in numerous studies performed on a nuclear 
transport inhibitor (4-HPR) in infected PBMC cells and an ADE-mouse model. 4-HPR inhibits 
the interaction between DENV NS5 and host nuclear import proteins; it manipulates the PERK 
pathway to restrict viral replication and maturation. Apart from PERK pathway, 4-HPR also 
induced nuclear localization of ATF4 and eIF2α phosphorylation in a PERK-independent 
manner, i.e., through the effect of ISR kinases [847, 848]. The evolutionary importance of this 
pathway was recently highlighted by a study where infected mosquito (C6/36) cells activated the 
PERK pathway, which led to increased survival of the host (possibly by turning off pro-apoptotic 
genes) and extended the incubation period of the virus inside the vector [676].  
Since dengue increases the load on host translation, the cell tries to block global 
translation. However, prolonged repression of translation is harmful to the cells; hence this 
process is subject to stringent regulation. In cases like infection by a pathogen, this control of 
translation is even more critical, because of the ongoing “translation”-race. This is where 
GADD34 (protein phosphatase 1 regulatory subunit 15A) plays an important role, as it 
dephosphorylates eIF2α, thereby restoring the function of eIF2α and the function of the host 
translation machinery [543]. In our studies we have used salubrinal as an inhibitor of the 





6.6.  In light of the information provided above, our understanding of how dengue and other 
Flaviviruses affect the different signaling pathways is still in its nascent stage. While in some 
cells dengue induces pro-apoptotic pathways, in other instances it promotes survival, by the 
activation of macroautophagy. As shown by our previous study, this induction of 
macroautophagy results in protection of cells from toxins and other cell-lethal agents, and is 
conducive to production of virus [652]. However the path of this induction was not clear. As 
there is accumulating evidence that ER stress leads to autophagy, we asked if DENV2-induced 
autophagy were the ramification of ER stress induction. Apart from ER stress, ATM kinase also 
acts upstream of autophagy and is also regulated when cells are infected by virus. We therefore 
examined the involvement of ATM in DENV2 infection and induction of autophagy as well. 
 
Our strategy to find the answer presented in this thesis has been to look at different players 
in DENV2-infected cell: ER stress/ UPR and ATM activity, and their relationship with 
autophagy, cellular protection and propagation of virus (Figure 4). We first examined a global 
marker of ER stress activation in infected cells (Figure 4, 1). Next we investigated whether the 
PERK pathway is the mediator of the ER stress (Figure 4, 2). To this end, we looked at 
downstream substrates of PERK: ATF4, CHOP and GADD34 (Figure 4, 3). The involvement 
of PERK activity was then demonstrated in virus replication, cell protection, and autophagy 
(Figure 4, 4,5). Finally, we used chemical inhibitors to demonstrate that early activation of 
ATM is responsible for autophagy, cell protection and PERK activity in infected cells (Figure 4, 
6,7). Our data presented in the RESULTS section below indicate that early activation of ATM 
kinase is responsible for induction of ER stress (in the form of increased PERK activity), which 
in turn is implicated in autophagy, cell protection and virus propagation. To our knowledge, 
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this is the first time that the relation between these pathways has been established for cells 






Figure 4: A proposed work plan for the current study 
 
In this diagram we summarize the major points of interaction between the virus and the 
cellular pathways that we have investigated in our current study. 1) We looked at the global 
marker of ER stress, calreticulin (CALR) in DENV2-infected cells. 2) We then focused on the 
PERK pathway, through which ER stress is mediated during viral infection. The PERK protein 
is released from the BiP/GRP78 chaperone and it undergoes self-dimerization and 
phosphorylation. This turns off global translation by phosphorylating the eIF2α. 3) The 
transcription factor ATF4 is exempt from this inhibition and it translocates to the nucleus where 
it activates CHOP, GADD34 and other genes. We investigated the expression of ATF4, CHOP, 
and GADD34 as markers of PERK activity. 4, 5) We then studied the links between PERK 
pathway and macroautophagy. We looked at the expression and localization of LC3II (as a 
marker of formation of autophagosomes) and autolysosomal P62 degradation (as a measurement 
of autophagic flux). 6, 7) Finally, we focused on ATM kinase as an upstream regulator of 








7. MATERIALS AND METHODS 
 
7.1.  CELL CULTURES  
 
7.1.1. MADINE DARBY CANINE KIDNEY (MDCK)  Most of our experiments, especially 
those involving the virus infections, were performed on MDCK cells (ATCC#CCL34). These are 
epithelial cells isolated from the kidney of a female cocker spaniel (Canis familiaris) and have 
been widely used as a host for a wide range of viruses. We obtained this cell line as a generous 
gift from Dr. Anastasia Gregoriades of Queens College.  
• These cells were maintained in high-glucose/L-glutamine (+) Dulbecco’s Modified Eagle 
Medium (GIBCO5#12800-017), supplemented with 3.7g/L of sodium bicarbonate (Sigma6 
#S8875), 10% heat inactivated Fetal Bovine Serum (GIBCO#10438-026) and 1% Penicillin-
Streptomycin (GIBCO#15140-122).  
• On obtaining the cells, we thawed the frozen stock by carefully submerging the bottom of the 
cryovial in the 37°C water bath.  
• The thawed cells were mixed with 10mL of pre-warmed maintenance media in a Falcon® tube 
and were spun down at 1500 revolutions per minute (RPM) for 5 minutes.  
• The supernatant was discarded and the cell pellet was re-suspended in approximately 2 mL warm 
medium and plated in a new flask. The cell suspension was covered with more medium (12-
15mL/75cm2 flask; 4-5 ml/25cm2 flask).  
• The medium was removed the following day to eliminate any traces of the cryo-preservative 
Dimethyl Sulfoxide (DMSO).  
																																																								
5 Address: Gibco Laboratories, 8717 Grove Mont Cir, Gaithersburg, MD 20877 
6 Address: Sigma-Aldrich Corp. St. Louis, MO, USA 
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• The cell population was then carefully inspected and was maintained by passaging once the 
culture exceeded 80% confluence in the plate/flask. To subculture (‘passage’) the cells, the 
medium was decanted and the cells were washed with pre-warmed 1x Phosphate Buffered Saline 
(PBS).  
• The cells were then detached by adding a dissociation agent 0.25% Trypsin (made of the 2.5% 
stock, Thermo Fisher7 15090046). After the adherent cells detached, trypsin was deactivated by 
adding medium (4-5 times the volume of trypsin used).  
• Samples of the medium containing trypsin and detached cells were pooled in a Falcon tube and 
centrifuged at 3000 rpm for 5 minutes. The supernatant was then discarded and the cell pellet 
resuspended in warm medium and a fraction of the suspension was plated.  
 
We have followed this general protocol for the following cell lines unless otherwise stated 
below. 
 
7.1.2. MDCK-GFP-LC3  We collaborated with Dr. Michael Overholtzer (Memorial Sloan 
Kettering Cancer Center) to generate MDCK cells expressing GFP tagged LC3 protein. To this 
end, we used Lipofectamine to transfect the MDCK cells with retroviral plasmid carrying the 
GFP-LC3 construct. 
 
The virus-Lipofectamine complex was prepared as described below. 
																																																								




• The following were mixed and incubated at room temperature (RT) for 5 minutes: i) 0.4 µg 
Retroviral plasmid, ii) 0.2 µg VSV-G 8plasmid, iii) 0.25 µg Gag/Pol9 and iv) 100 µL Opti-MEM 
(reduced serum media/ Thermo Fisher Scientific# 31985062).  
• Simultaneously, 2.5 µL of Lipofectamine 2000 (ThermoFisher#11668027) was dissolved in 100 
µL Opti-MEM. The mixture was mixed thoroughly by inverting several times and then let sit at 
RT for 5 minutes.  
• These solutions were again mixed gently and incubated at RT for 20-30 minutes. The MDCK 
cells were washed with Opti-MEM before being fed with a cocktail (1ml) of Opti-MEM and the 
Virus-Lipofectamine mixture in the ratio of 4:1.  
• After 6 hours, the cells were covered with maintenance media. 
• The cells were collected at different times from 48 hours onwards and were tested for GFP 
signals using fluorescence microscopy.  
 
7.1.3. BABY HAMSTER KIDNEY CELLS (BHK-21) We used BHK-21 (ATCC10#CCL-
10) cells to titer and grow dengue 2 viruses.  These are fibroblast cells derived from the kidney 
of Syrian golden hamster (Mesocricetus auratus). Like MDCK, these cells are susceptible to 
virus infection and hence they are a convenient choice for plaque assay. These cells were 
maintained in the DMEM+/+ media. In some cases, they were also grown in α-MEM media 
(Mediatech#50-012-PC) supplemented with 10% FBS, 1% P-S and 2.2g/L NaHCO3.  
 
																																																								
8 It is an envelope plasmid (bacterial dsDNA) used for lentivirus production. 
9 Packaging genes used for lentivirus production – Gag is a structural precursor protein and Pol is 
a polymerase 
10 Address: American Type Culture Collection (ATCC), 10801 University Boulevard, Manassas, 




7.1.4. D1-4G2-4-15 We used this hybridoma cell line (ATCC#HB112) to generate antibodies 
against the envelope protein expressed on flavivirus. Thus, these cells are useful tools for 
detection of dengue and Zika infection by immunofluorescence. These lymphoblast-like cells 
were isolated from mouse (Mus musculus) immunized with the dengue type 2 virus antigens. 
Fusing spleen cells with P3X63Ag8 myeloma cells generated the hybridoma. These cells were 
maintained in Hybricare media (ATCC-46X) supplemented with FBS, P/S and 1.5g/L NaHCO3. 
Unlike most of the cells used, this is a suspension cell culture. After thawing the frozen stock and 
eliminating the toxic cryo-preservative, we let the cells grow for 4-5 days and release enough 
antibodies in the media. We then pooled the supernatant in a Falcon tube and centrifuged at 3000 
rpm for 5 minutes. The supernatant containing the antibodies was collected in a fresh tube and 
stored at 4° C.  The cell pellet was resuspended in warm media and was sub cultured in a ratio 
(4-5 fold). 
 
7.1.5. AEDES ALBOPICTUS (C6/36) The Aedes albopictus clone C6/36 
(ATCC#CRL1660) cells were used to grow high titers of dengue viruses. Since mosquito is a 
secondary host and a vector for arbovirus, these cells are widely used for the propagation of the 
virus. These cells were maintained in an enriched RPMI media containing 10%FBS, 1%P-S, 1% 
non-essential amino acids (Sigma#M7145), 1% sodium pyruvate (Sigma#S8636), 1% L-
Glutamine (ThermoFisher#25030081) and 3% NaHCO3 (5%). For some variants of these cells, 
L-Glutamine containing EMEM11 (ATCC#30-2003) media was used to replace RPMI. Once 
thawed in the medium, the cells were incubated at 28 or 33° C in 5% CO2. 
 
																																																								
11 Eagle’s minimum essential medium 
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7.1.6. PERK (WT, KO) MEF We obtained mouse embryonic fibroblasts (MEFs) where 
the PERK (12kinase involved in the unfolded protein response) protein has been eliminated by 
knockout of the gene. These cells were generated in the laboratory of our collaborator Dr. 
Patrizia Agostinis (KU Leuven, Belgium) and were used in our lab to examine the role of the 
PERK pathway in virus infection, cell survival and regulation of autophagy. These cells were 
either infected with the virus or transfected with plasmids expressing a viral gene. These cells 
were maintained in DMEM+/+ media. 
 
7.1.7. HEK-BLUE-2 We used these cells (InVivoGen Catalog#rep-pt1) for detection of 
mycoplasma in the supernatant of our secondary cell lines. HEK293 cells have been stably 
transfected with TLR2 and other genes involved in the Toll-like receptor pathway.  In presence 
of mycoplasma, TLR-2 is activated and several transcription factors (like NF-κβ) are turned on. 
These factors then promote the expression of an engineered secretory alkaline phosphatase (sAP) 
that can be detected by the color change of a customized medium. These cells were thawed in 
DMEM media supplemented with 10% FBS, 1%P-S and 100µg/ml Normocin (Invivogen#ant-
nr-1).  After the native cells had reached optimal (80-90%) confluence, they were detached by 
gently tapping or scraping (trypsin was not used for these cells as it has been reported to alter cell 
metabolism). Selection was carried out by maintaining and sub culturing the cells in growth 
media supplemented with the 1X HEK-Blue selection (InvivoGen#hb-sel). The selection 
contains a set of antibiotics that ensures the persistent expression of the different transgenes 
expressed in HEK. This growth medium was replaced twice a week unless we had sufficient 
																																																								




expansion to prepare frozen stocks. The mycoplasma detection was performed using the 
remaining cells. 
 
7.2. TREATMENTS In our project, mammalian cells were treated with a variety of chemicals 
mostly pharmacological regulators of ATM kinase, ER stress, and autophagy.  In case the 
treatment was to be used in conjunction with viral infection, the cells were incubated with the 
chemicals an hour before virus was added for adsorption for 2 hours. After this period, the 
chemicals were added back to the media and the cells were incubated for the desired time period.  
A list of chemicals used has been provided below. 
Table 3: A list of chemicals used for treatment of cells 
 
CHEMICAL EFFECT FINAL 
CONCN. 
ATM kinase inhibitor 
(KU55933) 
[Calbiochem#118500] 








Induces autophagy 50-100 nM 
Chloroquine Blocks fusion of autophagosome and lysosome 50 µM 





Blocks eIF2 phosphorylation by PERK 3 µM 
Tunicamycin Induced global ER stress by blocking N-







Inhibits type II Topoisomerase and induces 






7.3. ANALYSIS OF CELL DEATH (TRYPAN BLUE EXCLUSION ASSAY) 
Ø Cells treated with toxins or infected with viruses and were analyzed for survival using trypan 
blue exclusion [849, 850].  
Ø Since dead cells would be floating in the media, the supernatant was collected before the 
adherent cells were dissociated from the well by trypsin. After dissociation, the supernatant was 
used to deactivate the trypsin and the entire solution was pooled together and the cells were spun 
down at 1200 rpm for 10 minutes.  
Ø The cell pellet was suspended in a small volume of media and 10 µL of the suspension was 
mixed with an equal volume of 0.4% trypan blue solution (Thermo Fisher#15250061) and kept 
at RT for 5 minutes.  
Ø 10 µL of this solution was then added to the hemocytometer. Trypan blue is an impermeable dye 
that can penetrate only the disintegrated membrane of a dead cell. Hence, only the dead cells 
appeared blue under the microscope. 
Ø Typically, we counted the number of cells (both live and dead) in all the four quadrants of a 
hemocytometer. The total cell count and the percentage of dead cells were then calculated using 
the following formula:  
 Total number of cells = (Number of cells counted in 4 quadrants*5000*dilution factor) 





7.4. VIRUS GROWTH AND QUANTIFICATION The following was generously shared by the 
labs of Dr. Adolfo Garcia Sastre and Dr. Ana Fernandez Sesma (Mount Sinai Medical School, 
New York): Dengue 2 serotype (strain: 16681/ TH36). 
 
7.4.1. GROWTH AND PROPAGATION 
Ø Approximately 106 C6/36 or VeroE6 cells were plated in a T-75 flask one day before we 
scheduled the infection. This would give us a culture that was 70-80% confluent at the time of 
infection.  
Ø After the cells had attached, the medium was removed and the cells were washed with the 
Flavivirus Dilution Media (FDM) – 1X PBS with 0.2% Bovine Serum Albumin (BSA-Roche#10 
735 078 001), Pen-Strep and Calcium-Magnesium mix. This dilution media (1X PBS/BSA) 
facilitates the binding of the viral particles to the host cells. 
Ø The appropriate volume of virus (we used m.o.i s of 1, 0.1, 0.01) was diluted in 2 ml of FDM and 
added to the cells. The [virus was left for 1.5-2 hours at 33/37°C (C636/ VeroE6) with constant 
shaking. If a shaker was not available we manually swirled the flasks every 15 minutes. Shaking 
during the adsorption step ensures that the virus inoculum contacts as many cells as possible. 
Ø After adsorption, 10 ml growth medium (with 2% FBS, P-S optional) was added to the initial 
inoculum and the cells were left in the appropriate incubator for 6-7 days. The reduced serum 
ensures a slow rate of cell proliferation and a more efficient binding of the virus. The former also 
keeps the virus from being stressed due to over-confluence of host cells, given the fact that the 
cells are stored for almost a week. 
Ø The cells were kept under surveillance for signs of cytopathic effects (CPE) that do not usually 
develop until 6-7 days into incubation. We considered that the amount of cell death should not 
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25-30% for a culture from which we harvested virus. In case of the DEN2 16681, there should be 
no detectable signs of CPE.  
Ø The supernatant was collected from the flasks and pooled into a Falcon tube. The cells were 
washed with the medium to collect any viral particles bound to the cells. This medium was 
combined with the supernatant and the whole mix was centrifuged at 1000 rpm for 5 minutes 
(4°C). The supernatant was collected in a fresh tube and aliquots (smaller volumes) were 
prepared in sterile Eppendorf® (micro centrifuge) or cryovial tubes. 95% ethanol was added to 
dry ice kept in a container meant to store in cryovial and held for 5 minutes. The aliquots of virus 
were frozen on the dry ethanol (quick freeze) and then stored in the -80° C freezer. 
 
7.4.2. PURIFICATION/ CONCENTRATION Under specific circumstances, we had to 
maximize the yield of virus growth, e.g., when we had to grow the virus in Vero cells due to 
unavailability of C6/36 or Vero-E6 and we could foresee a low yield.  
 
Ø As in the usual harvest procedure, the supernatant was collected in a Falcon tube and combined 
with medium used to wash the cells. The solution was centrifuged at 4120 rpm for 10 minutes.  
 
Ø The supernatant was transferred to a fresh Falcon tube and kept on ice. 15 ml of the supernatant 
was added to a 100 kDA-cutoff Amicon filter tube (Fisher Scientific# UFC9-100-096) so that the 
supernatant sits on top of the filter. Each filter can be used twice. The tubes were then 




Ø The supernatant on top of the filter consists of the concentrated stock of virus. Using a P-200 
pipette, the concentrate was transferred to a fresh cryovial/micro centrifuge (re-centrifuged) and 
the flow-through was discarded.  
 
Ø These steps were repeated for another 15 ml of supernatant and the sequence was repeated until 
we had filtered the entire supernatant obtained from the cells. Aliquots containing appropriate 
volume of the concentrated stocks were then stored in the -80° C freezer. 
 
 
7.4.3. ANALYSIS OF VIRAL PROPAGATION  
 
§ Plaque assay  We followed the basic steps of traditional plaque assay method (as described here 
[851]) to quantify and determine the titer of the virus stock grown in the insect (C6/36) and 
mammalian (VeroE6) cells. When needed, minor modifications were introduced depending on 
the nature of the virus and their cytopathic effects on the cell lines used.  
 
Ø Approximately 2.5-3x105 BHK21 were plated in each well of a 12-well plate and left to attach 
overnight. While plating, the cells were dispensed at the center of the well and the plate was 
swirled gently. This was done in order to ensure that the cells formed a monolayer the following 
day at the time of infection.  
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Ø Serial dilutions were made from the viral stock that had to be titered.  The serial dilutions were 
performed in -/- media13 (without FBS, P-S). About 200-250 µl of each dilution (as well as the 
undiluted viral stock) were added to the corresponding wells containing the monolayer.  
Ø The plates were incubated at 37°C for 1.5-2 hours with occasional shaking (they were swirled 
every 15-20 minutes). The cells were then covered with an agarose overlay (made of 50% Low 
Melting Point Agarose/ Fisher # BMA 50100, 45% 2X MEM/ Invitrogen # 11935046, 5% FBS). 
The overlay was allowed to solidify inside the biosafety cabinet and incubated at 37° C for 6-7 
days. 
Ø The overlay was gently removed after adding a few drops of warm tap water. The cells were then 
incubated with 1% crystal violet solution in 30% ethanol for approximately 20 minutes at room 
temperature.  The plates were then thoroughly but gently washed with tap water and were then 
counted for plaques. 
 
7.5. QUANTITATIVE POLYMERASE CHAIN REACTION (QPCR)  
 
7.5.1. PRIMER DESIGN We designed primers for analysis of transcription of a target gene 
on the cDNA. Hence, we had to choose a pair of primers that would amplify a cDNA segment, 
which is between 150-200 bp in length. The following steps were performed in silico to design a 
pair of primers for a target gene. Occasionally, we would obtain predesigned primer sequences 
from a collaborator or a peer-reviewed research article. 
 
																																																								
13 We have indicated the media as being “-/-“ if it did not contain FBS and P-S. It is also referred 
to as “naïve” media. 
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The transcript sequence of the target gene was retrieved from the GENE database of the 
National Center for Biotechnology Information (NCBI) website. Since we designed cDNA-
specific primers, we needed the transcript sequence of the target gene and thus we selected the 
GenBank option.  
 
We used Primer3 (http://bioinfo.ut.ee/primer3/) to design the primers for qPCR. The fasta 
sequence of the transcript was imported into the Primer3 sequence window. Then conditions like 
primer size (usually 18-22 bases), melting temperature (Tm), GC content and self-
complementarity were set according to the general requirements of real time PCR, e.g., Tm 
(usually 55-60°C) difference between forward and reverse primers were restricted to a few 
degrees. The software was then instructed to pick up the best pair that met our requirements.  
Alternatively, we also used the ApE software to design cDNA-specific primers for qPCR. This 
platform enabled us to scan the entire mRNA/CDS to pick up a specific pair of primers 
amplifying a segment not longer than 200 bp.  
 
7.5.2. RNA EXTRACTION Total RNA was extracted from cells using the RNeasy mini 
kit (QIAGEN14#74104). The cells were trypsinized after the desired treatment/ time period and 
cell pellet was obtained. The pellet was either stored at -80°C or immediately used for RNA 








7.5.3. ANALYSIS AND QUANTIFICATION The RNA thus extracted was analyzed using 
the Nano Drop Lite Spectrophotometer (Thermo Scientific). Apart from the concentration of 
RNA relative to a blank solution (RNase-free water), the device also measures the absorbance of 
light at 260nm and 280nm. We could thus look at the value of A260/A280 and evaluate the purity 
of the RNA sample. A ratio of ~2 is considered a pure RNA sample. 
Ø In order to complement and verify the Nano Drop data, we analyzed our RNA samples on 
Agarose gel and looked for 28S and 18S rRNA bands.  
Ø We set up the gel by pouring a solution containing 1.5% Agarose, prepared in 1X MOPS-
formaldehyde buffer (see REAGENTS).  Once the Agarose powder was added to the buffer, the 
solution was boiled in microwave.  
Ø For visualization of RNA on the gel: After it had cooled down to 60°C, the intercalating 
reagent Ethidium Bromide (EtBr) was used at a final concentration of 0.5µg/ ml in the Agarose 
solution.  It was then poured into the casting tray. 
Ø All the solutions for this experiment were prepared in DEPC (diethylpyrocarbonate)-treated 
water (Invitrogen#46-2224). Once gel had solidified, it was covered by 1X MOPS buffer (no 
formaldehyde).  
Ø To prepare the samples, 5µg RNA was transferred to an RNase-free tube and volume was made 
up to 6µl by DEPC-treated water.  
Ø The following mix was then added to this tube: 10 µL Formamide, 4 µL Formaldehyde, 2 µL 
10X MOPS and 1 µL bromophenol blue (6X loading dye).  
Ø The solution was heated at 65°C for 10 minutes, cooled on ice and spun briefly. They were put 
back on ice and loaded quickly. Care was taken so that the samples were loaded within an hour 
of the gel solidifying, so as to preclude the dilution of formaldehyde in the gel. 
	
	 90 
Ø Once loaded, the gel was run for at least ten minutes at 5V/cm in 1X MOPS buffer. As soon as 
the samples had entered the wells, voltage was increased and the gel let to run until the dye had 
migrated about 2/3-3/4 of the total length of the gel. 
Ø After the run had finished, the gel was kept on a Gel-Doc platform and exposed to UV rays. A 
clean RNA sample would give two bands for 28S and 18S rRNA (in a roughly 2:1 density ratio). 
 
7.5.4. cDNA PREPARATION/ REAL TIME qPCR The total RNA was converted to 
complementary DNA (cDNA) to be used for quantitative PCR (qPCR). To this end, we used the 
Power SYBR Green RT to Ct 1-step kit (Applied Biosystems15#4391178) that enabled us to 
perform Reverse Transcription16 and real time PCR17 in the same tube. The manufacturer’s 
protocol was followed to carry out these reactions. Due to the high sensitivity of these reagents, 
we only used 100ng of RNA and 100 to 200nM of the primers per reaction. Triplicates were run 
for each condition. All the samples and reagents were kept on ice throughout the preparation 
process to prevent degradation. The final reaction was carried out on a MicroAmp® Fast 
Optical 48-well reaction plate (PN 4375816) in a Step One Real Time PCR (Applied 
Biosystems). The following components were provided by the manufacturer in the kit. 
Power SYBR Green RT-PCR Mix (2X) 
 SYBR Green I dye,  
 AmpliTaq Gold® DNA polymerase (ultrapure) 
 dNTPs (dATP, dCTP, dGTP, dTTP, and dUTP) 
 PCR buffer 
RT enzyme mix (125 X) 
																																																								
15 Address: 850 Lincoln Center Drive, Foster City, CA 94404 
16 A reaction to make cDNA from total RNA, that involves the reverse transcriptase enzyme 
17 Quantification of target gene transcripts using the fluorescent SYBR green dye	
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 Array Script™ UP Reverse Transcriptase 
 RNase inhibitor 
While analyzing the results on the Step One software, the Comparative CT mode was 
selected, as it is suitable for the high-throughput measurement of relative gene expression in 
multiple samples. Each reaction had an endogenous control (ß-Actin) that served as reference for 
the target genes. In most cases, unless otherwise specified, the mock-treated or mock-infected 
samples were chosen as the Reference sample.   
 
7.5.5. PRIMERS USED  
Target  Forward primer (5’-3’) Reverse primer (5’-3’) 
ß-ACTIN GTCCACCTTCCAGCAAATGT AAAGCCATGCCAATCTCATC 
ATF4 GCGTTGCTGTAACCGACAAA TCAGGAAGCTCATTTCGGTCA 
GADD34 CCAGAAACCCCTACTCATGAT CCAATTGTTCATGCTTGGTG 
NS4A CGCACTGGACAACTTAGCAG CGTGACTGTAGCCAGAAGTGTC 




7.6. ANALYSIS OF PROTEIN EXPRESSION IN MAMMALIAN CELLS 
7.6.1. EXTRACTION AND QUANTIFICATION OF PROTEINS 
Ø EXTRACTION Cells were washed with ice-cold 1x PBS after they had been treated and 
infected. The cells (in flask or plates) were placed on ice while being treated for protein 
extraction. 
• After PBS wash, the cells were treated with ice-cold Radio Immuno Precipitation (RIPA) buffer 
(see REAGENTS) and a cold plastic cell scraper was used to detach the adherent cells. 
	
	 92 
• The RIPA and the detached cells were collected in a cold centrifuge tube and incubated on a 
shaker at 4° C for 30 minutes. The lysate was centrifuged at (~13,000 rpm18) for 15-20 minutes. 
The supernatant was collected in a fresh cold centrifuge tube and stored as aliquots in -20°C. 
Ø QUANTIFICATION The proteins, thus extracted, were then quantified using the Bio-
Rad protein assay dye reagent concentrate (Bio-Rad#5000006). This solution is a based upon the 
Bradford technique for quantifying solubilized protein. 
• The dye solution was prepared by mixing 1 part of the concentrate with 4 parts of deionized 
water. 1 ml of this solution was dispensed into centrifuge tubes. The standards and the test 
samples were added to this solution. 
• Bovine Serum Albumin (BSA) was used as the standard sample. 0, 1, 5, 10, 15, 20, 25 µg/ ml of 
BSA were used as standards. A 1mg/ml stock solution of BSA was used to prepare the standards 
and the test protein samples were added to the diluted dye in a proportion of 1:1000. 
• The solutions were left at room temperature for not more than 45 minutes. Absorbance was then 
measured at 595 nm using a spectrophotometer.  
• The relative concentrations of the samples were determined using the concentrations of the BSA 




• Sodium Dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) was used to separate 
proteins in a cell on the basis of their molecular mass (in kD). The resolving gel (see 
REAGENTS section for the composition) was used to separate the proteins on basis of their 
																																																								
18 Revolutions per minute. 
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molecular mass. The anionic detergent SDS, which binds to all the proteins present in the lysates, 
rendering them heavily negatively charged, neutralized the net charge on the different amino 
acids.  
• Depending on the size of our target protein, the percentage of acrylamide was modified in the 
resolving gel and that determined the pattern of resolution of proteins and the time required to 
complete the run, e.g., a resolving gel with a higher percentage of acrylamide would take longer 
time for the maximum resolution of protein samples. Given below is a chart (from 
www.abcam.com) that was used to prepare resolving gel according to our experiment. 
• The resolving gel was poured into glass plates, separated by a spacer (1 or 1.5 mm wide). Three 
quarters of the area between the glass plates was filled with resolving gel and isobutanol was 
poured on top to prevent auto oxidation of the gel. Once the resolving gel had solidified the 
isobutanol was discarded and stacking gel (see REAGENTS section for composition) was 
poured on top of resolving gel. A plastic comb with 10/12 wells was immediately inserted into 
the stacking gel. These wells were eventually used to load the samples. 
• The following guideline (Table 4) was consulted to prepare resolving gels for target proteins of 
different sizes. 
Table 4: A guide for choosing the percentage of PAGE, according to the size of the protein  









• Samples were prepared as described in Datan et al and loaded on to the gel [10]. Typically, the 
gel was run at a low voltage (60V) while the samples were in the stacking gel and the voltage 
was increased to 100V when samples left the stacking gel. In order to track protein migration, 5 
uL of a pre-stained (GE19#RPN800E) protein marker was loaded along with the samples.  
 
• After the run was over, the gel was stained with Coomassie Brilliant Blue 
(ThermoFisher#20278) for determination of total protein content. Typically, the gel was 
submerged in the stain solution (see REAGENTS section for composition) and heated in a 
microwave (regular setting) for 10 seconds. This helps the gel to swell and this is essential for 
the stain to diffuse to the proteins. The gel was then kept in the stain at room temperature with 
constant shaking for 30 minutes. Excess stain was removed by successive washes with the 
destainer (see REAGENTS). Generally, an overnight destaining was required in most cases to 
clearly see the individual protein bands. 
 
7.6.3. WESTERN BLOTTING For Western blotting or immunoblotting gel were was 
removed from the glass plates and was kept inside a sandwich, pre-soaked in 1X transfer buffer 
(see REAGENTS), composed of two sponges with filter papers between them and next to the gel 
[10].  
§ Once the gel had been carefully positioned between the filter papers, one of the filter papers was 
removed and replaced after the wet nitrocellulose had been placed on the gel. If the target protein 
was 100kDa or less, a 0.2 µm (Bio-Rad20#1620112) pore size membrane was used; for larger 
proteins, a 0.45 µm (Bio-Rad #1620115) pore size membrane was used. 
																																																								
19 Address: Chicago, Illinois, USA 
20 Address: Alfred Nobel Drive, Hercules, California 94547 
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§ The sandwich was then placed inside a cassette and kept in enough 1X transfer buffer so that 
the entire surface of the sandwich was submerged Since negatively charged proteins would be 
transferred from the gel to the membrane, the membrane was kept facing the positive electrode.  
§ After the assembly was complete, a glass rod was rubbed along the length of the sandwich, in 
order to squeeze out any bubbles trapped between the gel and the filter papers.   
§ The electrophoresis-mediated transfer was carried out at low voltage (typically 23-35V) for 12-
16 hours.  
§ After the transfer was over, the membrane was washed with 1X TBST solution and then stained 
with Ponceau Red (see REAGENTS) for checking the efficiency of transfer. Ideally, there 
wouldn’t be any trace of the prestained marker on the gel and all the colors would have 
transferred to the membrane. Unlike Coomassie, Ponceau binds reversibly to the proteins on the 
membrane and hence can be washed off after the red bands have been visualized on the 
membrane.  
§ The membrane was then kept in a “blocking buffer”– usually 5% bovine serum albumin (BSA-
Cell Signaling technology#9998) or non-fat dry milk (Biorad#1706404XTU) in 1X TBST- at RT 
for 1-2 hours or overnight at 4° C. BSA was preferred over milk if the target was a 
phosphoprotein, as the endogenous casein of milk is highly phosphorylated and thus usually 
interferes with the signal. The milk or BSA binds to proteins and prevents the primary antibodies 
from binding to non-target proteins, but is competitively driven off by the antibodies to the target 
proteins. 
§ The blocking buffer was discarded and the membrane was washed with 1X TBST 3 times for 5 





18 hours. We usually used the dilution of the antibody specified by the manufacturer. A list of 
primary antibodies used has been appended at the end of this section. 
§ Excess primary antibody was washed off by 1X TBST (3 times/5 minutes) and secondary 
antibody was added to the membrane. The secondary antibodies used depended on the species in 
which the primaries were raised, e.g., if the primary had been raised in rabbit, an anti-rabbit 
secondary was used. Regardless of the origin of the secondary, all had a hydrogen peroxidase 
conjugate that would later on react with the ECL substrate. The membrane was incubated with 
the secondary antibody for 1-2 hours at RT. The membrane was then washed with 1X TBST (3 
times/5 minutes). 
 
§ The membrane was then developed for color detection. The Signal Fire Plus ECL reagent (Cell 
Signaling 21#12630) was used as the substrate for the HRP conjugated to the secondary 
antibodies. After the substrate was incubated for one minute, a hyper film ECL photo 
radiographic film (28906835, GE Healthcare) was placed atop the membrane inside an 
autoradiography cassette and was kept in the dark for 5-15 minutes.  
§ Detection of silver deposition (exposure) on the film was observed by successive washes with 
GBX developer/replenisher (Sigma#P7042) and GBX fixer/replenisher (Sigma#P7167). 
§ Quantification of Signals The NIH software Image J was used to perform the densitometry 
analysis of the bands obtained on an X-ray film. The film was scanned and saved (.tiff/ 600dpi). 
The file was saved in a safe location and a copy was opened on Adobe Photoshop – the file type 
was changed (.tiff to .jpeg) and the mode was changed to GRAYSCALE. The new file was 
opened on Image J and the density of each band was measured using the following commands: 
ANALYZE -> SET MEASUREMENTS -> GREY MEAN VALUE. A Region of Interest (ROI) was 
																																																								
21 Address: Global headquarters (U.S.A) – 3 Trask Lane, Danvers, MA 01923 
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selected for each row of proteins – it is the smallest area that covers the largest band in that row. 
The frame is saved and used to measure all the bands in that row as well as the background 
(simply by placing the frame outside the band) – this process is repeated for all the rows and the 
values are exported to a spreadsheet file. The inverted pixel value of each band (band/ 
background) was calculated by subtracting the values obtained from 255. The net inverted pixel 
value for each protein was then calculated by subtracting the values of background from the 
band. The ratio of the target protein expression, relative to the loading control, was then plotted 
in the form of an excel chart/ graph. 
 
7.6.4. IMMUNOFLUORESCENCE Immunofluorescence is a useful tool to monitor 
localization and expression of proteins inside the cell; we used it to study protein expression in 
infected cells. 
§ Cells were plated on coverslips and allowed to attach overnight before being treated and or 
infected. The supernatant was next discarded and cells were washed with 1X PBS (see 
REAGENTS) 2-3 times. The cells were fixed in 4% paraformaldehyde (PFA/pH 7.4) for 10-15 
minutes at room temperature. After fixation, cells were washed with 1X PBS. 
§ Since all the proteins we examined were intracellular proteins, we used 0.1-0.25% Triton-X–100 
(in 1X PBS) to permeabilize the cells. This step is necessary to ensure that the primary 
antibodies can access their target proteins. After 10 minutes of permeabilization, samples were 
washed 3 times with 1X PBS and were stored in the blocking buffer for one hour at RT. 
§ The cells were then incubated in the primary antibody (diluted in the blocking buffer) at 4° C 
overnight. As in western blotting, we initially used the dilution specified by the manufacturer but 
often adjusted it to improve visualization. 
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§ 1X PBS washed off excess primary antibodies and the appropriate secondary antibody (diluted in 
blocking buffer) was added.  
§ We used secondary antibodies that differed from the ones used for western. These antibodies had 
Alexa Fluor conjugates (488/Green, 555/Red), which would absorb and emit fluorescent signals 
that were detectable under the microscope. For this reason, samples were incubated in the 
secondary antibody solution for 1-2 hours at RT in the dark.  
§ The coverslips were then washed with 1X PBS (3 times/5 minutes each) and were treated with a 
nuclear dye like DAPI22 or Hoechst (Thermo Fisher#H3570) for 10-15 minutes in the dark. 
These nuclear stains served as counterstains. 
§ Excess stain was washed off by PBS washes and the coverslips were mounted upon slides using 
a Fluor mount medium (Sigmsa#F4680). Once the mounting medium had dried, the coverslips 
were sealed with nail polish to prevent dehydration of the cells.  
§ The slides were then analyzed for fluorescence signals using the Zeiss23 Apotome or Leica24 
confocal laser-scanning microscope. 
§ Quantification of Signals The NIH software Image J was used to quantify the intensity of 
fluorescence in the cells. The images captured under the microscope were opened on Image J and 
each cell was selected, mostly using the FREEFORM SELECTION TOOL. The fluorescence in 
each cell was measured using the commands: ANALYZE -> SET MEASUREMENTS -> check 
AREA, INTEGRATED DENSITY, And MEAN VALUE. Selecting regions outside the cells and 
running the same commands also measured the background noise. Once these values had been 
																																																								
22 A blue fluorescent stain that binds strongly to the A-T rich regions in DNA. [IUPAC ID: 2-(4-
amidinophenyl)-1H -indole-6-carboxamidine] 
23 Carl Zeiss Microscopy LLC (One Zeiss Drive, Thornwood, NY 10594, USA) 




exported to an excel spreadsheet, the Corrected Total Cell Fluorescence was calculated using the 
formula: CTCF = Integrated density – (Area of selected cell – mean fluorescence of background 
reading). The values were then plotted in a chart. 
 
7.6.5. LIST OF ANTIBODIES USED 
CATALOG NAME ISOTYPE APPLICATION 
Sigma-Aldrich 
# L7543 
LC3B Rabbit Western Blotting  
1:500–1:1000 
Immunofluorescence 

























 # 12238 

























Rabbit Western Blotting 
1:1000  





















































































Mouse MAb  























Ø 10X MOPS (1L) 
o 41g MOPS 
o 6.8g Sodium Acetate (M.W. 136.08) 
o 20mL 0.5M EDTA 
o 800mL dH2O 
§ pH adjusted to 7 with NaOH and volume adjusted to a liter  
 
Ø RESOLVING GEL (15mL) 
o 30% acrylamide/bis-acrylamide – 0.5 X ml (X = final%) 
o 1.5M Tris-HCl (pH 8.8) – 3.75mL 
o 10%SDS – 150 µL 
o TEMED – 7.5 µL 
o 10% APS – 75 µL 
§ Volume adjusted to 15mL with distilled water 
 
Ø 4% STACKING GEL (15mL) 
o 30% acrylamide/bis-acrylamide – 1.98 ml  
o 0.5M Tris-HCl (pH 6.8) – 3.78mL 
o 10%SDS – 150 µL 
o TEMED – 15 µL 
o 10% APS – 75 µL 
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§ Volume adjusted to 15mL with distilled water 
 
Ø PAGE RUNNING BUFFER 
o 25mM Tris base 
o 190mM Glycine 
o 0.1% SDS (pH expected to be around 8.3) 
 
Ø COOMASIE BRILLIANT BLUE (1L) 
o 2.5g Coomassie Brilliant Blue R-250 
o 400mL distilled water 
o 100mL Acetic Acid 
o 500mL Methanol 
 
Ø DESTAINER (1L) 
o 675mL distilled water 
o 75mL Acetic Acid 
o 250mL Methanol 
 
Ø Ponceau Red stock 
o 2% Ponceau S dissolved in 30% trichloroacetic acid and 30% sulfosalicylic acid 
o For staining proteins on the membrane, the stock was diluted 1:10 
 
Ø 10X PBS (phosphate buffer saline) 
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o 25.6 g Na2HPO4·7H2O  
o 80 g NaCl  
o 2 g KCl  
o 2 g KH2PO4 
o Volume adjusted to 1 liter with H2O.  
 
Ø 10X TBS (tris buffer saline) 
o 24.23g Trizma HCl 
o 80.06g NaCl 
o 800 ml ultrapure water 
§ pH adjusted to 7.6 using pure HCl – volume adjusted to 1L 
 
Ø Transfer Buffer 
o 48mM Tris 
o 39mM Glycine 
o 0.04% SDS (may be increased to 0.1% for larger proteins >100kD) 
o 20% Methanol (10% for larger proteins >100kD) 
 
Ø Flavivirus dilution media 
o 50 mL autoclaved 1X PBS 
o 3mL of filter-sterilized 35% BSA 
o 5mL of autoclaved 1X Calcium-magnesium mix 
o 5mL of 100x Pen-Strep mix 
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o 437 mL autoclaved distilled water 
 
Ø RIPA buffer 
o 10mM Tris (pH 7.4) 
o 150mM NaCl 
o 1% Triton X100 
o 1% deoxycholate 
o 0.1% sodium dodecyl sulfate (SDS) 
o 5mM EDTA 








8.1. INDUCTION OF ENDOPLASMIC RETICULUM STRESS, ESPECIALLY PERK 
PATHWAY, SUPPORTS INCREASED PRODUCTION OF DENGUE-2 VIRUS  
 
8.1.1. DENGUE-2 ACTIVATES CALRETICULIN IN MDCK CELLS, INVOLVING 
THE PERK PATHWAY As explained above, ER-tropic flaviviruses like Dengue-2 can 
change the conformation of the endoplasmic reticulum and thus can potentially disrupt its 
function. This disruption can serve as a major trigger for stress pathways, especially the unfolded 
protein response (UPR). We verified if such disruption holds true for Dengue-2 infected MDCK 
cells, the primary model that was used for our previous study [652]. As a positive control for this 
study, we used 3 µM tunicamycin (TM), a chemical regulator that induces ER stress by 
inhibiting protein N-glycosylation. As described in Materials and Methods, 106 MDCK cells 
were plated and allowed to attach overnight. Cells were treated with 3 µM tunicamycin or 
infected with Dengue-2 at multiplicity of infection (m. o. i.) of 5. After 24 hours of infection or 
treatment, cells were lysed; proteins were extracted and analyzed by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting. β-Actin was used as 
control for protein load and Calreticulin (CRT) was used as the marker for induction of ER 
stress.  The expression of CRT was compared among the different conditions, relative to actin 
expression (Figure 5 Cal-Actin ratio). Tunicamycin treatment increased CRT expression more 
than 3-fold (Figure 5 Cal-Actin ratio: 3.3) that of mock-treated cells (Figure 5 Cal-Actin ratio: 
defined as 1), whereas Dengue-2 infection (Figure 5 Cal-Actin ratio: 2.4) resulted in a 2.4-fold 
increase. The ratios (Cal-Actin) presented here are mean values of the ratios obtained from three 
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different western blot experiments. The picture shown here is a representative image of all three 
blots. Our finding indicates an activation of CRT by Dengue 2 to a level close to that of 
tunicamycin, suggesting activation of ER stress. 
 
Having established the induction of ER stress in infected cells, we examined the specific 
branch of ER pathways that would lead to this activation by the virus. We began by examining 
PERK pathway. To this end, we used 3 µM salubrinal (Sal), a chemical inhibitor of ER stress 
that blocks the dephosphorylation of the elongation initiation factor (eIF2α) initially 
phosphorylated by the PERK pathway [544].  We found, by the use of western blot, that Sal had 
little impact on the CRT expression of uninfected cells (Figure 5 Salubrinal: Mock = 1.1:1). 
However, Sal severely suppressed the activation of CRT caused by Dengue-2, from 2.4 to 0.5-
fold (Figure 5 Dengue-2 and Deng2 + Salubrinal, respectively). As expected, SAL addition to 
TM-treated cells partially suppressed the expression of CRT from 3.3 to 2.3-fold (Figure 5 
Tunicamycin and Tunica + Salubrinal, respectively). Since the inhibition of CRT expression 
was more specific in Dengue-2 infected cells compared to TM-treated, we conclude that 
infection causes ER stress through the PERK pathway, whereas the stress created by TM 
involves other pathways as well, or that the stress created by TM is overwhelming or nearly 
irreversible. 
 
Having established that the PERK pathway is activated by Dengue-2, we examined the activity 




8.1.2. THE DOWNSTREAM TARGETS OF PERK PATHWAY, ARE ACTIVATED BY 
INFECTION To substantiate the involvement of the PERK pathway we examined the 
transcription of its downstream substrates like Activating Transcription Factor 4 (ATF4) and 
Protein phosphatase 1 regulatory subunit 15A (GADD34). MDCK cells were infected with 
Dengue-2 (m. o. i. = 5) for 12 and 24 hours. After the desired time, total RNA was isolated and 
cDNA-specific primers were used to quantify gene expression by quantitative polymerase chain 
reaction (qPCR). All qPCR experiments were normalized against β-actin as an endogenous 
control. In this context, it must be noted that although the levels of actin varied from run to run, 
there were no significant differences among experimental groups. Each cDNA/ transcript level 
was normalized to the actin level for that specific experiment.  
 
Mock infected (Figure 6 Mock) and Dengue-2 infected (Figure 6 Dengue) MDCK cells were 
probed for β-actin expression using a cDNA-specific primer. No significant variation was 
observed between the mock and infected samples after either 12 or 24 hours of infection. The 
expression of target genes was therefore calculated relative to actin expression for each 
condition. The fold change in expression between mock and infected cells was then calculated 
using the 2-ddCt method as has been described by Li et al [852] as well as in Materials and 
Methods.  
 
There was a significant increase of ATF4 transcription in infected MDCK cells relative to 
Mock infected after 12 hours (Figure 7 DEN2, Mock); this activation disappeared with the 24 
hours post infection although the cells remained similar in morphology to that of the mock-
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infected. Thus, ATF4 activation (>40-fold change after 12 hours) is a relatively early and 
transient event during dengue infection.  
 
We also examined the transcription of GADD34 in infected MDCK cells. As described in the 
introduction, GADD34 activation is a downstream effect of PERK activation via ATF4 
translocation to the nucleus. Consistent with our findings with regard to ATF4, we see an even 
stronger upregulation of GADD34 expression in infected MDCK cells (Figure 8 Den, Mock) 
after 12 hours (>200-fold change) compared to the mock-infected cell. This difference gradually 
abated (<10-fold change) by 24 hours post infection. This supports our previous data (Figure 5 
Deng2+Salubrinal) where blocking the GADD34 activity by Sal sharply diminished the 
expression of Calreticulin [10].  
 
To avoid confusion, we have presented the ATF4 and GADD34 data, both as normalized over 
β-actin as well as datasets without any normalization (Figures 6, 7). In the former case, we have 
also added charts plotting the relative Ct values of each target gene, after subtracting the Ct 
values of Actin. These graphs also contain the fold change values that have been calculated 
relative to Actin (using the formula mentioned above). In case of the latter, we have added a 
scale for relative RNA corresponding to threshold cycle (Ct) value. This method of evaluation 
has been adopted for all the following qPCR data. 
 
8.1.3. PERK AFFECTS PRODUCTION OF VIRUS Having established the activation of 
PERK during dengue infection, we explored the relationship between the PERK pathway and 
production of virus by first examining the transcription of viral NS4A gene after inhibition of the 
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PERK pathway with Sal. Again, we used the expression of actin gene as internal control. We 
examined three different conditions: mock-infection (Figure 9 Mock), infection (Figure 9 DEN), 
and infection of cells pretreated with 3 µM Salubrinal (Figure 9 DEN-SAL). Fold change was 
then determined as described above and in Materials and Methods [852]. 
 
NS4A transcription, relative to β-Actin, increased after infection with Dengue-2 alone and 
plummeted in infected cells pretreated with Sal (<250-fold change over mock-infected) when 
compared to infected cells (>600-fold change over mock-infected). Thus, we demonstrated that 
dengue replication depends on PERK activity. As in the previous data, we have presented the 
expression of NS4A, both as normalized over β-actin as well as individual datasets that were not 
normalized (Figure 9). Fold changes have been shown in the graphs where the relative NS4A Ct 
values were plotted, after subtracting the corresponding Actin Ct values. It must be noted that 
since this was a different experiment, we had a different Actin dataset and this was considered 
while calculations were performed to obtain the NS4A fold change (Figure 9). 
 
We next verified this result by examining viral titer in infected cells. We did not use chemical 
inhibitors like Sal for this study since these agents rarely inhibit a single molecule or pathway. 
Instead, we examined the production of mature virions in infected PERK wild type (+/+) and 
PERK knockout (-/-) mouse embryonic fibroblasts, employing the traditional plaque assay (see 
Materials and Methods). In PERK -/- cells, the number of infective plaque forming units was 
reduced to 16% (~2100 pfu) of that in infected +/+ (~13500 pfu) cells after 48 hours (Figure 10). 
The PERK pathway was thus demonstrated to play an important role in viral maturation and 




8.1.4. PERK ENSURES PROTECTION OF INFECTED CELLS AGAINST TOXIC 
COMPOUNDS As reported in our previous study [652], infection increases survival of 
MDCK cells exposed to camptothecin25 (CPT). Having established that PERK pathway supports 
viral replication, we examined the relation between PERK and survival of infected cells. As in 
the previous experiments, we used Sal pretreatment (Figure 11) to block the effects of PERK 
pathway in mock (Figure 11 Salubrinal), infected (Figure 11 Dengue + Salubrinal) and CPT-
treated (Figure 11 CPT + D2 + Sal) MDCK cells; appropriate controls (Figure 11 Mock, 
Dengue, CPT + Deng) were used for each condition. Cell death was then quantified as described 
in Materials and Methods. 
 
Infected cells pretreated with Sal (Figure 11 CPT + D2 + Sal) showed a significant increase in 
cell death due to CPT-toxicity, when compared to CPT-treated infected cells (Figure 11 CPT + 
Deng). There was an upsurge in cell death from ~30% in CPT-treated infected cells, to ~85% in 
Sal /CPT-treated infected cells (Figure 11 CPT + Deng, CPT + D2 + Sal). Overall health of the 
infected cells was significantly better (Figure 11 CPT + Deng), as compared to CPT-treated 
(Figure 11 CPT) and Sal /CPT treated cells (Figure 11 CPT + Sal), thus validating our previous 
data. But it is noteworthy that regardless of infection, Sal itself (Figure 11 CPT + Sal) is 
debilitating to cells already treated with CPT, an effect that was not neutralized by infection 
(Figure 11 CPT+D2+Sal).  
 
																																																								
25 A topoisomerase type II inhibitor that induces apoptosis 
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We further substantiated the importance of the PERK pathway in protecting cells by using 
PERK knockout cells. Cell death was registered in mock (Figure 12 PERK +/+ MOCK and 
PERK -/- MOCK), infected (DEN2), CPT-treated (CPT) and CPT-treated/infected (Figure 12 
CPT DEN2) in both PERK+/+ and PERK+/+ cells. As the PERK pathway was totally abolished 
using knockout, the protective ability of DENV against CPT also decreased significantly (Figure 
12 PERK+/+ CPT DEN2, PERK-/- CPT DEN2). The infection by Dengue-2 increases the cell 
survival in PERK +/+ and this protection is abolished in PERK -/- cells but not to the same 
degree as MDCK cells treated with Sal.  
The protective effect in PERK+/+ cells, albeit significant, is not as strong as in Sal-treated 
MDCK cells. This result can probably be attributed to the non-specificity of chemical inhibition 
compared to genetic knockout, as well as variation in susceptibility towards CPT between 
MDCK (Figure 11 CPT - ~40% death) and MEF (Figure 12 PERK+/+ CPT - ~80% death) cells. 
It must be noted that in the absence of either the virus  (PERK +/+ and PERK -/-, CPT) or of 
CPT (PERK +/+ and PERK -/-, DEN2), amounts of cell death were quite uniform, thereby 
eliminating the argument that an external factor could explain the ability of the PERK pathway 
to protect infected cells [10]. 
 
8.2. PERK REGULATES AUTOPHAGOSOME FORMATION AND AUTOPHAGIC FLUX 
IN INFECTED CELLS 
 
8.2.1. RELATION BETWEEN PERK AND AUTOPHAGOSOME FORMATION IN 
INFECTED CELLS In our previous study we had established that dengue infection does not 
kill cells but rather protects them by inducing autophagy [652]. In the current study, we 
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established that dengue infection activates the ER stress related PERK pathway. Here we ask the 
next question: what is the relation between the induction of autophagy and activation of PERK 
pathway during Dengue-2 infection? 
 
We measured the rate of LC3 lipidation (LC3II formation) in PERK KO and WT MEF cells 
infected for 24 hours with Dengue-2 (Figure 13 LC3I, LC3II). WT and KO MEF cells were 
infected with Dengue-2 for 24 hours and were lysed for protein extraction. Proteins were 
analyzed using western blotting (see Materials and Methods). The membrane was then probed 
using specific antibodies for LC3I/II and ß-tubulin (loading control). After the bands were 
developed on a film, a densitometry analysis was performed using ImageJ. The ratio of LC3I, 
LC3II, and total LC3 were calculated relative to tubulin (Figure 13 table). 
 
According to our data, infection in the PERK knockout cells resulted in higher LC3II 
lipidation, compared to mock-infected PERK KO (Figure 13 PERK -/- MOCK, DEN2). The rate 
of LC3-PE conjugation (lipidation) was also higher than that of infected and mock WT cells 
(Figure 13 PERK +/+ Mock, DEN2). There was a mild increase (24%) in the LC3II/I ratio in the 
mock-infected PERK-/-, compared to the mock-infected PERK+/+. Dengue-2 infection of 
PERK+/+ cells led to a mild increase (36%) in the LC3II/LC3I ratio, compared to mock-infected 
cells (Figure 13 PERK+/+ Mock, PERK+/+ DEN2). In contrast, infected PERK -/- cells 
displayed a roughly two-fold increase (93%) in LC3 lipidation, compared to the mock-infected 
PERK -/- cells (Figure 13 PERK-/- Mock, PERK-/- DEN2). Also, there was a significant 





All these shows a high rate of autophagosome formation, which besides pointing to an 
increased rate of autophagy, could also indicate a block in the autophagy flux in infected PERK -
/- cells. To validate this hypothesis, we had to look at a more definitive marker of autophagic 
flux26, instead of just looking at the maturation of autophagosomes [10].  
 
8.2.2. PERK PATHWAY IS NECESSARY TO MAINTAIN A HIGH AUTOPHAGY 
FLUX, AND THE PERK-AUTOPHAGY AXIS PROMOTES EXPRESSION OF 
DENGUE PROTEIN To evaluate whether autophagy was increased or flux was blocked 
in our model, we monitored the lysosomal protein Sequestosome 1(P62), which undergoes 
proteasome-mediated degradation along with the autophagy cargo under conditions of a high 
turnover. We thus looked for degradation of p62 as a marker for autophagy turnover, in infected 
MDCK, PERK-WT and KO cells [853].  
 
MDCK cells were grown on cover slips, infected with dengue virus, and incubated for 48 
hours (at which time E protein was much more detectable). Cells were then fixed and treated 
with specific antibodies for immunofluorescence analysis (see Materials and Methods). Images 
were captured under a confocal microscope using the green filter to look at P62 in mock, 
infected and Sal-treated infected cells (Figure 14 Anti-p62). The red filter was used to monitor 
the levels of viral E protein (Figure 14 Anti-E). We merged the images to see how infection 
affected P62 (Figure 14 Merge).  
 
																																																								




Infected MDCK cells had less p62, compared to the mock-infected cells (Figure 14 Dengue, 
Mock), indicative of high autophagy turnover in the infected cells. To verify infection, we 
looked at E protein expression. The infected cells show high expression of the E protein 
compared to the mock-infected cells (Figure 14 Dengue, Mock). We thus established a link 
between infection and p62 degradation (autophagy turnover).  
 
To examine the role of the PERK in autophagy turnover, we pretreated infected cells with 
Salubrinal, and looked at the same markers. Sal- treated cells expressed more p62 expression and 
less E compared to the untreated infected cells (Figure 14 Dengue, Dengue/ Sal). Thus, Sal 
exerted the same effect on E protein expression as for transcription of Dengue-2 NS4A [10]. 
 
8.2.3. THE LINKS AMONG PERK ACTIVITY, AUTOPHAGY FLUX AND VIRAL 
PROTEIN EXPRESSION ARE VERIFIED USING GENETICALLY MODIFIED MEF 
CELLS The data reported above suggest that suppression of PERK activity lowers 
degradation by autophagy and consequently decreases viral translation. Since salubrinal inhibits 
eIF2α phosphatases, leading to ER stress, we examined the pathway more directly using PERK 
WT and KO cells. PERK +/+ (Figure 15) and -/- (Figure 16) cells were infected with dengue in 
the presence or absence of salubrinal. Immunofluorescence was performed as in Fig. 14. 
 
Infected PERK +/+ cells expressed significantly less p62 compared to mock-infected cells 
(Figure 15 PERK+/+ Mock, Dengue), with infection verified by expression of E-specific red 
signals. Pretreatment of infected +/+ cells with Sal (Figure 15 Dengue/Sal) mimicked the 
MDCK data: p62 did not decrease, and the E protein was much reduced (Figure 15 PERK+/+ 
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Dengue, Dengue/Sal). Statistical analysis based on measurements using ImageJ showed that p62 
was significantly lower in the infected cells, compared to mock and Sal-pretreatment (Figure 17). 
For measurement using Image J, p62-positive puncta were counted (~ 200–300 cells) for each 
condition. The images captured under the microscope were opened on Image J and each cell was 
selected, mostly using the FREEFORM SELECTION TOOL. The fluorescence in each cell was 
measured using the commands: ANALYZE -> SET MEASUREMENTS -> check AREA, 
INTEGRATED DENSITY, and MEAN VALUE. Selecting regions outside the cells and running 
the same commands also measured the background noise. Once these values had been exported 
to an excel spreadsheet, the Corrected Total Cell Fluorescence was calculated using the formula: 
CTCF = Integrated density – (Area of selected cell – mean fluorescence of background reading). 
The values were then plotted in a chart.  
 
Our analysis indicated a significant decrease in the puncta count in infected PERK+/+ cells, 
but no significant difference in infected PERK −/− cells. Thus, infected PERK +/+ showed the 
same pattern as the MDCK in the presence of SAL. In contrast, mock-infected PERK KO cells 
expressed much more baseline p62 than their WT counterparts (compare Figure 15 Mock to 
Figure 16 Mock) suggesting that autophagy in these cells is PERK-dependent. Also, infected KO 
cells expressed much less viral E protein, compared to the infected WT cells (Figure 15, Figure 
16 Dengue). The number of p62 puncta in the PERK -/- cells varied considerably but there was 
no significant difference in p62 signals between mock PERK +/+ and PERK -/-; nor among 
Mock, DEN2, and DEN2-SAL in the PERK -/- cells, reflecting the a slow rate of autophagy that 




8.3. AN EARLY ACTIVATION OF ATM KINASE IS IMPORTANT FOR AUTOPHAGY, ER 
STRESS AND CELL PROTECTION IN DENGUE INFECTION 
 
8.3.1. ATM IS ACTIVATED EARLY IN INFECTION  As described before, ATM 
kinases can potentially upregulate autophagy under conditions of high stress. To test whether 
ATM kinase is activated following infection by Dengue-2, we looked at the activity (measured 
by phosphorylation of Ser 1981 in ATM) of ATM kinase in infected MDCK cells at different 
times following infection (Figure 18) upper panel p-ATM Den). After infection, cells were lysed 
for protein extraction and analysis by western blotting (see Materials and Methods). In this 
experiment, ß-tubulin was used as a loading control and uniform protein quantity was verified 
(Figure 18 upper panel ß-tubulin).  
 
High ATM activity was recorded at the earliest stage of infection (1.5 hours post infection) 
and this activation sustained until up to 12 hpi (Figure 18 upper panel p-ATM Den) after which 
this wave subsided. To link ATM activation to autophagosome elongation, we also measured 
LC3 lipidation (formation of LC3II, 16 kDA) in the same lysates. LC3II began to increase, 
significantly compared to the mock-infected cell, after 24 hours and this activation lasted well 
into 48 hours post infection (Figure 18 upper panel LC3 Den). Thus, a pattern emerged where 
LC3 lipidation (formation of autophagosomes) closely followed ATM activity; indeed, LC3II 
started rising only after ATM had returned to its basal level [10].  
 
8.3.2. ATM IS POSITIVELY LINKED TO INDUCTION OF AUTOPHAGY IN 
INFECTED CELLS Having verified that ATM activation was a relatively early result of 
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infection, compared to autophagy, we next investigated if ATM activity was directly linked to 
autophagy. To this end, we blocked the ATM activity using the alkaloid inhibitor caffeine. Cells 
were infected and treated for 24 hours and were lysed for protein analysis by western blotting 
(see Materials and Methods). Actin was used as a loading control in this study (Figure 18 lower 
panel Actin). To measure autophagy, we looked at the expression of LC3I (18 kDa) and LC3II 
(16 kDA) (Figure 18 lower panel LC3). 
 
After 24 hours, infected cells showed high LC3II lipidation, compared to mock and caffeine-
treated cells (Figure 18 lower panel LC3 Mock, Den, Caf). This activation, which is a result of 
LC3-PE conjugation, was significantly impaired when caffeine was administered prior to 
infection as well as after the virus has been allowed to adsorb into the cells (Figure 18 lower 
panel LC3 Den, Den Caf).  This finding demonstrated that ATM activity, apart from being part 
of an early response of the infected cell, also plays a key role in induction of autophagy [10].   
 
8.3.3. ATM ACTIVATION IS IMPORTANT FOR THE VIRUS-MEDIATED 
PROTECTION AGAINST CPT As we had earlier found a correlation between autophagy 
and protection of cells against toxic agents, we proposed that ATM upregulation in infected cells 
might be involved in protection against CPT [652]. We exposed infected MDCK cells to 
KU55933/ATMi (Calbiochem#118500), a specific inhibitor of ATM kinase (Figure 19). After 24 
hours of growth in the presence of both ATMi and the virus, the toxic topoisomerase I inhibitor 
camptothecin (CPT) was added to the cell culture and incubation was continued for 24 hours. 
CPT binds to DNA and blocks cell cycle, eventually precipitating apoptosis-mediated cell death 
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[854].  Following 24 hours CPT treatment, cell death was measured using the trypan blue 
exclusion assay (see Materials and Methods).   
 
In cells treated with ATMi and/or infected with the virus, we could not record any 
significant increase in cell death, greater than that seen in mock-infected cells (Figure 19 ATMi, 
Den (-), Den ATMi). We also did not register a significant change in cytotoxicity in cells treated 
with CPT alone compared to cells treated with both CPT and ATMi (Figure 19 CPT (-), CPT 
ATMi). Thus, there appears to be no additive effect, even though both the chemicals are involved 
in the disruption of genome stability. Finally, infected cells treated with CPT alone were 
compared to those that were also exposed to ATMi. The ‘protective’ function created by the 
virus was lost when ATM kinase was knocked out by ATMi (Figure 19 Den CPT (-), Den CPT 
ATMi). Cell survival decreased significantly when a pharmacological inhibitor specifically 
blocked ATM kinase. Therefore, ATM kinase is involved in both autophagosome maturation and 
protection of infected cells from cytotoxic assaults [10]. 
 
8.3.4. ATM IS REQUIRED FOR PERK ACTIVITY IN THE EARLY STAGE OF 
INFECTION As demonstrated in previous sections; Dengue 2 activates the PERK branch of 
UPR. PERK is also implicated in the maintenance of a high autophagy flux as well as protection 
of cells in response to CPT [10]. Since the previous study also linked the activity of ATM kinase 
to autophagosome formation and cell protection, we have identified a possible common 
mechanism between ATM and PERK. In the following study, we looked at the effect of 
inhibition of ATM on activation of PERK in infected cells. We asked if the early ATM 




To this end, and also to eliminate any form of target-bias, we looked at a different 
downstream target of PERK: CCAAT-enhancer-binding protein homologous protein (CHOP). 
As described earlier, CHOP undergoes transcriptional activation as ATF4 is selectively 
translated during PERK activation. 
 
MDCK cells were infected with dengue, with or without ATMi pretreatment and 
incubation (Figure 20 Den, Den+ATMi). After 12 hours, cells were lysed and total RNA was 
extracted, followed by a 1-step reaction where CHOP expression was measured using cDNA-
specific primers in a SYBR green qPCR reaction. The cycle threshold (Ct) values were plotted 
and statistically analyzed on MS Excel. Each PCR was run in triplicate. CHOP expression was 
significantly higher in infected cells, compared to mock and ATMi-treated controls (Figure 20 
Den, ATMi, Mock). In the presence of ATMi, CHOP transcription significantly decreased in 
infected cells (Figure 20 Den+ATMi). From these data we propose a sequence in infected cells 




9. DISCUSSION Dengue virus is the most debilitating mosquito-borne virus, potentially 
capable of infecting half the global population. It poses a serious threat to infants, especially in 
heavily populated urban setups in the tropical and developing world. Like most RNA viruses, 
especially members of the Flavivirus family, dengue also hijacks and subverts a large number of 
host cellular organelles and pathways. The organelles most affected are those that provide sites 
for virus replication and resources for membranes. Thus, the endoplasmic reticulum, Golgi and 
other double membrane vesicles (autophagosomes) are potential ‘replication’ hotspots for the 
virus.  
 
The translocation of viral non-structural proteins to the ER, especially the membrane, affects 
the ER in two ways: it rearranges the membrane structure, and increases the translation “load”. 
Both these processes are implicated in the initiation of ER stress pathways, which in turn can 
elicit both pro-survival and pro-apoptotic responses.  One of the most widely studied markers of 
induction of global stress within the ER is the calcium binding protein Calreticulin (CRT). CRT 
is overexpressed under two conditions: a) presence of misfolded proteins in the ER lumen, and b) 
release of Ca2+ ions from the ER lumen. We have shown the upregulation of CRT in Dengue 2 
infection in our model, using Tunicamycin (TM)27 as a positive control for induction of stress.  
 
Once extracellular or intracellular stimuli trigger ER stress, the stress can be communicated 
through different branches of UPR, i.e., PERK, IRE1α and ATF6, as well as pro-apoptotic 
pathways like PUMA and NOXA. Since there is substantial evidence that other members (HCV) 
of the Flaviviridae, as well as Dengue itself (in different cell types), activate PERK we focused 
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on the same. To this end, we monitored the transcription rate of downstream substrates of PERK, 
such as ATF4, GADD34, and CHOP in infected cells. ATF4 is a common marker for PERK 
activity since only ATF4 is spared from the translation repression imposed by phosphorylation of 
eIF2α. ATF4 translocates to the nucleus and induces the expression of GADD34 and CHOP 
(C/EBP-homologous protein), hence these are also used as markers for tracking PERK activity. 
We have shown here that transcription ATF4, GADD34 and CHOP significantly increases, and 
at least in one instance (CHOP) this upregulation is blocked when ATM kinase is inhibited [10]. 
 
GADD34 acts as a primary checkpoint for the switch between the pro-survival and pro-
apoptotic branches of PERK and UPR. GADD34, a phosphatase, removes the PERK-imposed 
phosphate group on eIF2α, thereby rescuing the cell from the translation blackout. To assess the 
effect of a functional PERK pathway on viral infectivity, we employed a specific 
pharmacological inhibitor salubrinal, which blocks the feedback of GADD34 on a downstream 
substrate (eIF2α) of the PERK kinase; we also acknowledged the limitations of a chemical 
inhibitor and validated our studies using PERK knockout MEF cell [10, 544]. The recovery of 
the translation machinery, following GADD34-mediated dephosphorylation of eIF2α, might act 
in favor of the virus replication and maturation, since both need to harness the host translation 
machinery. This would be manifest in an increased transcription of the viral genome. The viral 
genome consists of 3 genes for structural proteins and 7 genes for non-structural proteins, all of 
which can be measured.   
 
To measure the effect of SAL-mediated GADD34 inhibition or PERK knockout, we looked 
at viral transcription. To this end, we quantified the transcription of the DENV non-structural 
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protein 4A (NS4A) in presence of SAL. Although one of the least characterized of all flavivirus 
proteins, NS4A has been reported to insert into the ER membrane and thus modify the topology 
of the organelle, thereby inducing ER stress [826]. In our model, SAL pretreatment resulted in a 
significant slowdown of NS4A transcription in infected cells. Our previous study had also 
identified NS4A as the only viral genetic component that mimicked the ability of the whole virus 
to induce mild autophagy and protect MDCK cells from the cytotoxic effects of camptothecin 
(CPT) [652, 698]. Thus, the collective results from these studies indicate a possibility of PERK-
autophagy crosstalk, with NS4A probably playing the role of a mediator.  
 
We previously demonstrated that infection by dengue-2 makes MDCK cells resistant to the 
toxic effect of a cell-killing agent like camptothecin (CPT). The same study also linked the 
protective effect to the induction of PI3K-dependent autophagy by the virus [652]. The 
possibility that autophagy and PERK might converge in an infected cell prompted us to look at 
the effects of PERK blockage in infected cells.  Infected but SAL-exposed and PERK KO cells 
both lost protection against CPT [10]. This result was the first piece of evidence that the virus 
might mediate a pro-viral and pro-survival interaction between autophagy and PERK. Apart 
from this study, we had other suggestions that these two pathways cooperated in infected cells. 
The most important step carried out by the virus inside the host cell is the proper assembly and 
processing before infective virions are released. Several organelles (ER, Golgi) are involved and 
multiple pathways (exocytosis) are regulated by the virus to ensure that the structural proteins are 
processed (Furin-mediated cleavage of pr and M) before the release. We had previously shown 
that induction of mild autophagy is required for production of infective virions [652]. To 
evaluate the role of PERK in the final stages of viral production, we quantified the plaque-
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forming ability of infected PERK WT and PERK KO cells. The current study shows that PERK 
is partially necessary for the production and release of structurally infective virions.  
 
This prompted us to explore more directly the links between PERK and autophagy. Due to 
the pivotal roles that processes like endocytosis (virus internalization) and exocytosis (viral 
release) play in the life cycle of the virus inside the host (human or other mammal) cell, 
macroautophagy (which shares some of the molecular machinery with these pathways) and other 
selective autophagy (Virophagy, Lipophagy) are also subject to viral manipulation. Since 
autophagy is intricately linked to the innate and adaptive branches of antiviral immune response, 
and often provides essential raw materials for membrane construction (release of lipid droplets 
through selective Lipophagy), dengue and similar viruses (WNV, JEV, HCV) use this 
homeostatic pathway to their own advantage in infected cells [17]. We looked at the final step 
and the functional culmination of autophagy, i.e., formation of autolysosome and the degradation 
of the cargo entrapped within the inner autophagosome membrane. We used P62 as a marker for 
“autophagic flux”; in a cell undergoing rapid degradation, this ubiquitin-linked protein is also 
destroyed. In absence of an active PERK pathway (infected KO cells), expression of the viral 
envelope (E) protein was significantly lower, accompanied by low autophagic “flux” as 
manifested by high p62. These results directly linked the following three pathways: the PERK 
pathways, autophagic flux, and viral expression. 
 
Our studies indicate that both PERK and autophagy took place and operated at a high level, 
between 12-48 hours of infection. In search of earlier events that might trigger or upregulate the 
PERK/autophagy nexus, we turned our attention to the Ataxia Telangiectasia Mutated (ATM) 
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kinase. ATM, usually active in the nucleus, is a key component of the DNA-Damage Response. 
Until recently, its involvement in cytosolic events was unclear. Studies with ATM -/- models 
have shown that this protein is involved in the activation of redox homeostasis and autophagy 
pathways, especially in tumor cells with high reactive oxygen species (ROS) and reactive 
nitrogen species (RNS) [580]. Mechanistic studies had also shown that ATM upregulates the 
initiation and nucleation of autophagy (ULK1 complex) by the activation of the AMPK-LKB1 
pathway. Thus, dengue virus could be hijacking the same pathway; we validated this argument 
further by preliminary studies (data not shown) using an ATM inhibitor (caffeine) and NS4A-
overexpressing MDCK cells. CPT remained very toxic in caffeine-treated cells, suggesting a 
possible role of ATM in DENV infection.   
 
Although DNA damage and ATM-CHK2 activation had been implicated in the infectivity of 
a wide range of viruses (Epstein-Barr, Hepatitis B, Hepatitis C, latent HIV-1, papilloma viruses, 
Herpes Simplex Virus-1, Kaposi’s Sarcoma associated herpesvirus, gamma herpesvirus), studies 
with flaviviruses were wanting. We found that blocking ATM activity by caffeine and a more 
specific inhibitor (KU55933/ATMi) resulted in a significant decrease in autophagosome 
expansion (measured by LC3II) as well as a decrease in cell protection against CPT. Having 
established a link between ATM activity and autophagy, we also tested if the former also 
affected the PERK pathway. We recorded a significant decrease in the rate of CHOP 
transcription, which is used a marker for PERK activity, in infected cells exposed to ATMi. A 
recent study, using JEV, another important flavivirus, has also demonstrated the activation of 




In sum, we have suggested a role of the UPR pathway, especially PERK, in modulating 
global translation in response to infection. Along with other UPR pathways, PERK has been 
reported to activate proteins involved in different stages of autophagy, e.g., both ATF4 and 
CHOP upregulate LC3, ATG5 and P62/SQSTM1.  Earlier studies linking PERK and autophagy 
encouraged us to investigate the impact of inhibition of PERK on virus-mediated protection of 
cells. In our model, PERK plays an important role in dengue-mediated cell protection and in this 
respect, it closely mimics autophagy.  
 
As a functional PERK pathway correlates with viral replication, we looked at the effect of 
interference with this pathway on viral maturation. A complicated aspect of viral infection that 
also depends on successful replication is the assembly and extracellular release of the mature 
virions. In DENV infection, the virus uses replication organelles (RO) like the endoplasmic 
reticulum to express the genome and produce the proteins. ER is also used as a scaffold for the 
assembly of the viral genome. The Golgi apparatus is used for processing the assembled virion 
(e.g. furin-mediated cleavage of prM) after which the infective virion is released by exocytosis. 
 
A functional PERK pathway can block global protein translation. However, the virus can 
exploit the feedback effect of GADD34 (target of Sal). Since functional translation machinery is 
necessary for the maturation of the virus, the virus may use the ER stress pathways to produce 
infective particles. In our previous study, we had linked PI3K-dependent autophagy to virus 
production [652]. In this respect, deletion of the PERK pathway has the same effect as chemical 
inhibition of autophagy. As discussed earlier, this highlights the importance of double membrane 
vesicles in the life cycle of dengue virus. However, in dengue infected MDCK cells, expression 
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of GADD34 in infected cells does not correlate with cell death. A functional PERK pathway 
possibly modulates replication of the dengue genome by regulation of the host global translation. 
The ability of Sal to block the activity of a pro-apoptotic GADD34 protein might also explain the 
increased protection that was recorded in cells overexpressing NS4A or infected with the whole 
virus [652]. The ability of the virus to protect cells from CPT has thus been linked to the 
activities of both PERK and autophagy. 
 
Finally, we have also shown the involvement of the DNA damage response (DDR) protein 
ATM in mediating PERK and autophagy-dependent cell protection in infected cells. There is a 
possibility that ATM might operate through the upregulation of AMPK-LKB1, as has been 
shown in a recent study that looked at DENV-mediated Lipophagy [761]. However, yet another 
recent study has shown that pharmacological activation of the AMPK protein reduces the 
infectivity of three flaviviruses, DENV, WNV and ZIKV, highlighting an anti-viral aspect of this 
protein that is conserved among several flaviviruses [791]. Thus, more mechanistic studies 
should be conducted on the possible relationship between DDR, ER stress (UPR/PERK) and the 
pro-survival homeostatic processes (autophagy) in DENV infection.  
In this study, we have also investigated the timeline of dengue infection. Our results indicate 
that ATM activation is probably one of the earliest responses mounted by the host cell, and this 
activation stimulates the activation of three interconnected pathways that we have described: 
PERK pathway, autophagy and cell protection. The current study shows that ATM is essential 
and precedes all three. What would be an interesting follow up is to look at the mutual crosstalk 
between each of these pathways. Such a study would enable us to identify a potential metabolic 












Fig 2. Dengue-2, induces ER stress like tunicamycin. Dengue can be 









































Cal/Actin ratio: 1            2.4          3.3          1.1         0.5         2.3
Figure 2: A) Global ER Stress was measured by the amount of calreticulin produced in 
cell. Dengue caused an increase in production of Calreticulin like Tunicamycin while 
Salubrinal inhibited the production of Calreticulin even in the presence of virus. B) Actin 








Figure 5: DENV infection, like tunicamycin, induces expression of calreticulin, which is 
blocked by an inhibitor of PERK pathway [10]. 
MDCK cells were infected with DENV and treated with tunicamycin and/or salubrinal.  
After 24 hours, cells were lysed and total protein was extracted. The proteins were then 
quantified and run on an SDS-PAGE gel. The separated proteins were transferred to a 
nitrocellulose membrane and were probed for calreticulin using specific antibodies. Infection 
induced activation of calreticulin. Cotreatment with salubrinal, however, arrests this activation, 
and calreticulin is sharply reduced, even dropping lower than mock-infection. Salubrinal also 
suppressed the activation by tunicamycin, though not as effectively. Actin was used as a loading 
control. The ratios (Cal-Actin) presented here are mean values of the ratios obtained from three 
different western blot experiments. The picture shown here is a representative image of all three 
blots.  
[This experiment was performed in collaboration with Golnoush Golshan and Sasha Harbajan, 





                                     
 





































ACTIN EXPRESSION: 24H 
P-value = .146 
P-value = .21 
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Figure 6: Verification of controls [10]. 
 
MDCK cells were infected with DENV for 12 and 24 hours. Total RNA was extracted 
using a kit and the transcription rate of an endogenous control β-actin (a housekeeping gene) was 
measured using cDNA-specific primers (SYBR green qPCR). No significant changes (n.s.) were 
recorded in mock- or DENV-infected MDCK cells after either 24 or 48 hour. In the lowest panel, 
data from both the time points have been shown together. We have also included an axis (to the 
right of the chart) showing the relative RNA present based on the Ct values. According to 
convention, a unit change in Ct represents a two-fold change in transcription and this pattern 
continues in an exponential fashion, e.g. 4-fold change in transcription for 2 unit changes in Ct, 











   
                                  
     
 
















































Relative dCt of ATF4 over Actin (24 hpi)  
P-value = .00148 
Fold change (DENV2/MOCK) = 43.31 
P-value = 0.552 
Fold change (DENV2/MOCK) = 0.181 
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Figure 7: Transcriptional activation of ATF4 [10]. 
 
 MDCK was infected with DENV for 12 or 24 hours and was tested for actively 
transcribing ATF4. Total RNA was extracted using a kit and the transcription rate of ATF4 was 
measured using cDNA-specific primers (SYBR green qPCR). All qPCR experiments were 
calculated relative to the loading control β Actin (FIG.5). In the upper and the middle panels, we 
have presented the charts showing the actual Ct values of ATF4 gene, as well as the relative Ct 
values over Actin (δCtATF4 – δCtACTIN). The fold change (relative to actin) of ATF4 has been 
provided in the charts showing the latter. Significant activation (>40-fold change relative to 
actin) was recorded after 12 hours but not after 24 hours of infection. Thus, ATF4 activation is 
an early event in infection that gradually comes down to basal level after 24 hours of infection. 
In the lowermost panel we have presented the 12-hour data, without normalizing the ATF4 Ct 
values relative to the Actin Ct values. As in the previous figure, we have added a scale for 
relative RNA expression corresponding to threshold cycle (Ct) value. This method of evaluation 
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Relative dCt of GADD34 over Actin (24 hpi)  
P-value = .015 
Fold change (DENV2/MOCK) = 234.5 
 
Fold change = 7 
Fold change (DENV2/MOCK) = 7 
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Figure 8: ATF4 activity is enhanced in infection [10]. 
 
MDCK was infected with DENV for 12 or 24 hours and tested for GADD34 
transcription, which has been used as a marker of ATF4 activation. Total RNA was extracted 
using a kit and GADD34 transcription was measured using cDNA-specific primers (SYBR green 
qPCR). In the upper and the middle panels, we have presented the charts showing the actual Ct 
values of the GADD34 gene, as well as the relative Ct values over Actin (δCtGADD34 – δCtACTIN). 
The fold change (relative to actin) of GADD34 has been provided in the charts showing the 
latter. Expression of GADD34 increased significantly (>200-fold change) after 12 hours of 
infection and the increase persisted though diminishing until 24 hours (<10-fold change). It is 
noteworthy that the downstream effect of ATF4 persists longer than ATF4 transcription. The 
fold change relative to actin has been calculated as indicated in the figure. As in the previous 
diagram, In the lower panel we have presented the same data, without normalizing the Ct values 
relative to Actin. Here, as in the previous diagram, we have added a scale for relative RNA 
corresponding to threshold cycle (Ct) value. This figure shows the internal variation in GADD34 






       
 
      
 
 










Mock DEN DEN-SAL 
ACTIN  EXPRESSION: 24HPI 
















































Relative dCt of NS4A over Actin (24 hpi)  




Fold change (DENV2/MOCK) = 632 Fold change (DENV2+SAL/MOCK) = 249 
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Figure 9: Regulation of PERK pathway is conducive to viral replication [10]. 
 
MDCK was infected with DENV, with and without salubrinal, for 24 hours. Total RNA 
was extracted using a kit and NS4A transcription was measured using cDNA-specific primers 
(SYBR green qPCR). For this experiment, a different set of Actin Ct values was used. In the 
upper and the two middle panels, we have presented the charts showing the actual Ct values of 
the loading control (Actin) and the viral gene (NS4A), as well as the relative Ct values of NS4A 
over Actin (δCtNS4A – δCtACTIN). The fold change (relative to actin) has been provided in the 
charts showing the relative Ct graphs. After 24 hours, Salubrinal suppressed the transcription of 
dengue NS4A gene by >50% in infected MDCK cells. Treatment with SAL reduced the fold 
change in NS4A expression from >600 to ~250 fold in infected cells, compared to mock-
infection. As in the previous results, fold change was calculated relative to actin expression, 
which SAL/Sal did not significantly affect. In the lower panel we have presented the same data, 
without normalizing the NS4A Ct values relative to Actin [10]. A scale for relative RNA 
corresponding to threshold cycle (Ct) value has been added to the graph in the lowest panel. This 
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Figure 10: PERK pathway is partially responsible for maturation and release of infective 
virions [10]. 
 
 PERK +/+ and -/- cells were infected with DENV for 48 hours. Supernatants were then 
isolated from each cell line and were tested for their ability to form visible plaques on Baby 
Hamster Kidney (BHK) cells. KO cells produced only 16% (inverse log values shown in the 
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Figure 11: PERK regulation is important for DENV-mediated protection [10]. 
 
 MDCK cells were infected with DENV and treated with salubrinal (Sal) and/ or 
camptothecin (CPT). After 24 hours of infection/ treatment, cell death was measured by Trypan 
Blue exclusion assay. Salubrinal abrogated the protective effect of DENV infection in the 
MDCK cells. A significant increase in cell death was recorded in infected MDCK cells that were 
pretreated with salubrinal, indicating that blocking PERK pathway abrogates the cytoprotective 
effect of DENV2 against CPT. 
[In this figure and in others, the following convention has been used for p-value/T-test: 
















































































Figure 12: PERK knockout modestly reduces protection from CPT in infected cells [10]. 
 
 The effect of Salubrinal on CPT-treated cells was verified in PERK-knockout MEF cells. 
Infected KO cells showed lower resistance against CPT-mediated cytotoxicity, compared to 
infected WT cells. It should be noted, however, that in absence of the virus both WT and KO 
cells responded in a similar fashion to CPT. Hence, the resistance observed in infected WT cells 





















 LC3II/LC3I Total LC3/ Tubulin 
PERK +/+ MOCK 0.69 1.34 
PERK +/+ DENV2 0.95 1.28 
PERK -/- MOCK 0.86 0.54 
PERK -/- DENV2 1.66 1.18 
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Figure 13: PERK might be involved in autophagosome formation in infected cells [10]. 
 
PERK WT and KO MEF cells were infected with DENV2 for 24 hours. Proteins isolated 
from the cells were then probed for LC3I/II and tubulin using immunoblotting. NIH software 
Image J was used for densitometry analysis of the bands. The fold change in LC3 II over LC3I 
was used as quantification for autophagosome formation. In infected cells, the ratio of LC3 
lipidation/ LC3-PE conjugation (measured as LC3II: I) was normalized to that of MOCK cells. 
Infection in the PERK knockout cells resulted in higher LC3II lipidation, compared to mock-
infected PERK KO. The rate of (lipidation) was also higher than that of infected and mock WT 
cells. There was a mild increase (24%) in the LC3II/I ratio in the mock-infected PERK-/-, 
compared to the mock-infected PERK+/+. Dengue-2 infection of PERK+/+ cells led to a mild 
increase (36%) in the LC3II/LC3I ratio, compared to mock-infected cells. In contrast, infected 
PERK -/- cells displayed a roughly two-fold increase (93%) in LC3 lipidation, compared to the 
mock-infected PERK -/- cells. Also, there was a significant increase (74%) in the LC3II/I ratio in 
infected PERK-/- cells compared to infected PERK+/+ cells. The values of densitometry analysis 


































Figure 14: Blocking PERK pathway in MDCK cells negatively affects net autophagy 
turnover as well as expression of viral protein. 
 
 MDCK cells were grown overnight on coverslips, before being infected with DENV and/ 
or treated with salubrinal. After 48 hours, the cells were fixed with 4% paraformaldehyde and 
were permeabilized with Triton X-100. They were then probed for viral E protein (Red 
secondary/ TRITC) and the autophagy marker p62 (Green secondary/ FITC). Mock cells showed 
no E protein signal. They had more p62 expression compared to infected cells, thus indicating a 
lower autophagy flux compared to the latter. In presence of salubrinal, levels of E protein 
decreased and p62 levels were restored to basal level. Thus, blocking the PERK pathway had a 
deleterious effect on autophagy flux as well as viral protein expression. Salubrinal-treated cells 





   
   
   
Figure 15 
PERK +/+ 

















Figure 15: PERK WT cells show reduction in autophagy turnover as well as E protein 
translation when pretreated with Salubrinal [10]. 
 
 PERK WT cells were infected with dengue for 48 hours and were probed for p62 (green) 
and E (red) proteins. When cells were pretreated with salubrinal, p62 increased and E protein 
translation decreased. Thus, MEF cells show the same results as in MDCK, i.e., impairment of 





   














Figure 16: PERK KO cells show weaker E protein expression when compared to infected 
WT cells [10]. 
 
 PERK KO cells, even in absence of virus, had a much slower rate of P62 degradation 
compared to mock, which did not change significantly when the cells were infected with virus 
(quantification presented in Fig.13). In contrast, in WT cells p62 fell significantly when the cells 
were infected (Fig.11), an effect that was mostly blocked by the prior addition of salubrinal. KO 








































Figure 17: Statistical analysis reveals a significant decrease in P62 in infected PERK WT 
cells [10]. 
 
Image J was used to quantify the green p62 signals in the fluorescence images shown in 
Figures 11 and 12.  The images captured under the microscope were opened on Image J and each 
cell was selected, mostly using the FREEFORM SELECTION TOOL. The fluorescence in each 
cell was measured using the commands: ANALYZE -> SET MEASUREMENTS -> check AREA, 
INTEGRATED DENSITY, and MEAN VALUE. Selecting regions outside the cells and running 
the same commands also measured the background noise. Once these values had been exported 
to an excel spreadsheet, the Corrected Total Cell Fluorescence was calculated using the formula: 
CTCF = Integrated density – (Area of selected cell – mean fluorescence of background reading). 
The values were then plotted in a chart. Here we demonstrate significant p62 degradation in 
infected cells, as compared to control (MOCK) and salubrinal pretreatment (D/SAL). In contrast, 










Figure 18: An early ATM activation is required for induction of autophagy in DENV2 
infection [10]. 
 
 MDCK cells were infected with Dengue virus and probed for active ATM (p-
ATM_Ser1981) at different times (upper panel). ATM activation starts quite early in infection, 
reaching its apogee between 2 hpi to 12 hpi, clearly preceding the LC3 lipidation, which 
increases most dramatically after 24 hpi. Pretreatment of infected MDCK cells with 20 µM 
Caffeine significantly lowered LC3 lipidation after 24 hours (lower panel).  










Figure 19: ATM activation is essential for dengue-mediated cell protection against CPT 
[10]. 
 
 MDCK cells were infected with dengue, and/or pretreated with a specific ATM inhibitor, 
before being treated with CPT. Cell death was quantified using trypan blue exclusion method 
and was statistically analyzed using MS Excel. Similar to our previous findings, CPT 
cytotoxicity was markedly lower in infected cells. This protection was however eliminated when 
infected cells were pretreated and incubated with 5µM ATM inhibitor (KU55933). There was no 
significant difference in cell death between ATMi-treated mock-infected and dengue-infected 
cells, thus eliminating any chance of cell death due to ATMi treatment. [In this and subsequent 























Figure 20: ATM activation in infection positively impacts activity of PERK in MDCK cells 
[10]. 
 
 MDCK cells were infected with DENV and/or treated with ATMi (specific inhibitor of 
ATM). After 12 hours total RNA was extracted using a kit and the transcription rate of CHOP 
was measured using cDNA-specific primers (SYBR green qPCR).  Infected MDCK cells that 
were pretreated and incubated with KU55933 showed a significant drop in CHOP transcription 
compared to DENV-infected, mock and KU55933 -treated cells. We have also included an axis 




10. CHAPTER ON SUPPLEMENTARY DATA: “THE EFFECT OF ER STRESS, 
APOPTOSIS AND AUTOPHAGY ON THE EXPRESSION OF ZIKA VIRUS” 
 
10.1. INTRODUCTION 
Flaviviruses are seriously underestimated as a threat to humans. Zika, the latest flavivirus to 
concern many governments, comes from the same family (Flaviviridae) and genus (Flavivirus) 
as other human viruses like Dengue, West Nile and Japanese encephalitis. With Zika now a 
worldwide threat, research on the mechanisms of infection is imperative. Though Zika was 
identified almost 70 years ago, it attracted attention only when, in 2007, it caused an epidemic in 
the Yap Islands (Micronesia) [856, 857]. Almost a decade later, it was associated with 
debilitating diseases like Guillain–Barré syndrome and acute disseminated encephalomyelitis 
(ADEM) in adults, and microcephaly in infants, with now over 8,000 of the latter in Brazil [858]. 
The virus can be passed in both directions during intercourse and is readily passed from mother 
to fetus [859]. The virus has been found in amniotic fluid and in cerebrospinal fluid of micro 
cephalic infants [860-863]. It can persist for a few months in semen and vaginal fluids [864, 
865]. There are now over 15,000 infections in Puerto Rico, potentially creating several hundred 
cases of microcephaly (though voluntary decrease in birthrates may be a limiting factor. It is now 
established in Florida [866, 867]. Though a vaccine is likely in the near future, we nevertheless 
need to understand how its biology makes it so destructive [868, 869]. 
10.1.1. Apoptosis in ZIKV infection ZIKV is a neurotropic virus that has been associated 
with neurodegeneration both in vitro and in vivo. It has however been suggested that the virus 
exerts differential cytotoxicity in different regions of the fetus brain. In a 20-week old fetus, 
intermediate progenitor cells (IPC) and immature neurons were the most susceptible to infection, 
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while neural progenitor cells (NPC) and mature neurons had a much lower level of infection. 
Interestingly, apoptosis did not always correlate with infectivity in cells of neuronal lineage, 
giving rise to speculation that a paracrine mechanism is involved in ZIKV-mediated apoptosis 
[870]. The ZIKV strain responsible for the 2015 Brazil epidemic induces apoptotic cell death and 
causes mitotic errors dysfunction in human neural progenitor cells (NPC). Apart from the 
activation of caspases, the infected NPC also showed formation of autophagic vacuoles and 
increase in LC3 lipidation, thus pointing to the possibility of crosstalk between the different 
branches of programmed cell death [871]. Alternate forms of cell death have also been observed 
in infected cells. In human epithelial cells (HeLa), primary fibroblasts and astrocytes, ZIKV 
infection induced formation of cytoplasmic vacuoles that were derived from ER membranes. 
Further analysis of these vacuoles revealed that these structures were responsible for a caspase-
independent form of cell death, and it was believed to be very similar to paraptosis. Formation of 
vacuoles and cell death were particularly rampant in cells that lacked a functional Interferon 
Induced Transmembrane Protein (IFITM) 3, an important antiviral factor [872].  
 
High throughput systems virology studies have shown the close association of ZIKV with the 
components of the p53-dependent apoptosis pathway, including TP53 and MDM2, in infected 
human primary glioblastoma cells (U87) and female BALB/C mice [873]. Using synthetic 
mimics, these authors demonstrated a direct interaction between ZIKV capsid protein (ZCP) and 
MDM2, the interaction likely being important for induction of apoptotic cell death. Thus, like 
DENV capsid protein, ZCP is also instrumental in the establishment of pathogenicity through the 
induction of apoptotic cell death. Another important structural protein, Envelope protein (Env), 
has also been implicated in the induction of intrinsic apoptosis in neuroendocrine (PC12) cells. 
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Besides the activation of Bax- and Caspase-dependent intrinsic apoptosis response, lentivirus-
mediated expression of the truncated Env also led to mitotic catastrophe in the form of G2/M cell 
cycle arrest. Like the previous study (involving ZCP), here too TP53 plays an important role in 
Env-mediated apoptosis and cell cycle arrest in PC12 cells [874]. Thus TP53 lies at an important 
junction of different pathways that are elicited by viral proteins.  
 
10.1.2. Autophagy in ZIKV infection Autophagy plays an important role in ZIKV 
infectivity and pathogenicity, as has been demonstrated by both in vivo and in vitro studies. Like 
other Flaviviruses, the relation between autophagy and infectivity is not straightforward and 
depends strictly on the cell type infected. ZIKV hijacks multiple forms of autophagy in various 
cell lines, and pharmacological inhibition of autophagy reduces the viral load as well as the 
pathogenic effects of infection [875]. 
ZIKV induces autophagy in human trophoblasts, and ATG16L1 was implicated in the 
pathogenicity as well as vertical transmission of ZIKV to the embryo. Pharmacological 
inhibition of autophagy by 3-MA, Bafilomycin, hydroxy-chloroquine was effective in limiting 
the presence of ZIKV in the placenta. The same observation was recorded when ATG16L1 was 
knocked out in these cells. In a separate study, chloroquine, an endocytosis-blocking agent, 
blocked early stages of ZIKV replication in Vero cells, human brain microvascular endothelial 
(hBMEC) cells, human neural stem cells and mouse neurospheres. Since endocytic proteins are 
involved in the fusion between autophagosome and lysosome, and chloroquine and its 
derivatives are commonly used to block the final step of autophagy, this finding further validates 
the engagement of autophagy in ZIKV infection and transmission. Treatment with chloroquine 
and Wortmannin also significantly reduced ZIKV replication/infection in human umbilical vein 
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endothelial cells (HUVEC); however, induction of autophagy by rapamycin had no significant 
effect on ZIKV production. ZIKV infected HUVEC manifest high autophagy flux as well as 
autophagosome formation, as measured by p62 degradation and LC3 lipidation, respectively. 
Beclin 1 -/- cells were shown to harbor fewer infective ZIKV compared to wild type cells [876-
878].  
 
Autophagy could also be manipulated to prevent the passage of the ZIKV from placenta to the 
fetus. A non-reducing disaccharide, Trehalose, is a possible antiviral agent that has the potential 
to block the vertical transmission of ZIKV in the early stages of infection. Trehalose induces 
autophagy through an mTORC-independent pathway and can facilitate the clearance of ZIKV 
through autophagolysosomal degradation of the virus in the placenta. It also holds the potential 
of activating the immune response in infected placental cells. Trehalose is harmless compared to 
pharmacological inhibitors and is usually consumed as sugar additives in foods. Thus, it might be 
an ideal candidate for an anti-ZIKV drug because of its low side effects. However, stringent tests 
are required to test the feasibility of this sugar as an antiviral agent [603]. 
 
Although the involvement of autophagy in ZIKV has been recorded only very recently, a 
significant body of work has been dedicated towards deciphering the molecular mechanism 
responsible for ZIKV-induced autophagy. In human fetal neural stem cells (fNSCs) ZIKV-
induced autophagy is important in impaired neurogenesis and formation of neurospheres.  Not 
surprisingly, the AKT-mTOR pathway, which is essential for brain formation apart from being a 
negative regulator of autophagy, was inhibited by the ZIKV in fNSCs. Among all the viral 
proteins, only NS4A and NS4B were demonstrated to be responsible for this inhibition of 
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autophagy. Similarly, we have previously linked DENV NS4A to induction of autophagy and 
cell survival [879]. This was not the only study to point out the involvement of autophagy in 
ZIKV and DENV pathogenesis: Lennemann and Coyne showed that both of these viruses were 
capable of hijacking the autophagolysosomal degradation of ER membranes, a specific 
autophagy known as Reticulophagy. The ER-localized reticulophagy receptor FAM134B was 
identified as a restriction factor acting against both the viruses. As a countermeasure, these 
viruses employ their NS3 protease to cleave FAM134B thereby disrupting the reticulophagy 
process in infected cells. This might be important since it provides more double membrane 
vesicles for viral replication in these cells [752]. 
 
10.1.3. Stress in ZIKV infection As a member of the Flavivirus family, ZIKV also uses the 
endoplasmic reticulum as a replication organelle inside the host cell. Although fewer studies 
have been published about the role of ZIKV in ER stress, compared to other Flavivirus, ZIKV 
does manipulate the stress pathways.  In infected human fetuses, neural stem cells and mouse 
embryos ER stress and UPR are involved in ZIKV-induced pathophysiology including 
microcephaly. Treatment with a specific PERK inhibitor (GSK2656157) alleviates the 
neurogenic deformities induced by ZIKV in mouse embryos, thus pointing to the direct 
involvement of PERK in ZIKV pathogenicity. In this regard, we observe close parallels between 
ZIKV and other flavivirus like DENV [880].  
 
The assembly of Stress Granules (SG), aggregates of stalled translation preinitiation 
complexes, is an important component of host antiviral response and is modulated by several 
Flaviviruses. ZIKV also modulates SG formation in an eIF2α-dependent fashion in Vero and 
	
	 165 
human osteosarcoma-derived U2OS cells. ZIKV blocks eIF2α phosphorylation-dependent SG 
formation but not the eIF2α-independent branch. GADD34 is upregulated in ZIKV infected 
cells, thus raising the possibility that the virus alters translation. An inhibitor (Sal) of GADD34-
mediated dephosphorylation of eIF2α decreases ZIKV replication. Since both these data match 
our observations in DENV-infected MDCK and MEF cells, it is likely that these two viruses 
have a similar pattern of ER stress modulation [881].  
 
In Vero, A549 and HEK293T cells, ZIKV hijacks the SG pathway, especially the G3BP1, 
TIAR, and Caprin-1, to facilitate its own replication. The viral components behind the reduction 
of SG formation in infected cells were also identified in the same study - overexpression of 
NS2B, NS3, NS4A and Capsid proteins inhibited SG formation [882]. These studies clearly 
indicate that ZIKV depends heavily upon its ability to block global translation, usually mediated 
by eIF2α phosphorylation. It also blocks one of the major pathways of host antiviral response - 
formation of stress granules. Thus, ER stress and UPR in particular can be harnessed for putative 
antiviral targets to prevent ZIKV infection. 
 
10.2. MATERIALS AND METHODS 
10.2.1. Cell Culture 
1. SEPT4 (WT, KO) MEF We obtained knockout MEFs for the pro-apoptotic ARTS (SEPT4) 
protein from our collaborator Dr. Sarit Larisch (University of Haifa, Israel). These cells were 
infected with the virus as well and provided us with information about the role of mitochondria 
and apoptosis in infection. These cells were grown in DMEM+/+ media, containing 55µM β-
mercaptoethanol (GIBCO#21985), a reducing agent useful for scavenging oxygen radicals.  
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2. P110 β (WT, KO) MEF We collaborated with Dr. Wei-Xing Zong (Rutgers University/ 
Stony Brook University) and obtained MEFs deficient in one of the major catalytic subunits of 
the VPS34 protein (p110 β). Since this protein is important to the induction of autophagy, we 
infected these cell lines to evaluate the viral production when this pathway is blocked. These 
cells were grown in DMEM+/+ media. 
3. A549 This epithelial cell line (ATCC#CRM CCL 185), originally isolated from the human 
lungs was used for infection with influenza, dengue and Zika viruses. These cells are also 
suitable for lipofectamine-based transfection. We also used the line to look at the effects of 
overexpression of viral protein. These cells were maintained in DMEM+/+ media. 
4. PC12 The pheochromocytoma cell line (ATCC CRL#1721) was maintained in Ham’s F12K 
medium containing 1.5 g/L L-glutamine, 10% horse serum, 2.5% fetal bovine serum and 1% 
Pen-Strep. The cells were incubated in 5% CO2 at 37ºC. 
5. VERO, MDCK, PERK+/+ and -/- MEF cells were grown and maintained as described above. 
 
10.2.2. Quantification of Cell Death Cell death was quantified using Trypan Blue 
Exclusion Assay, as has been described in the preceding sections.  
 
10.2.3. Treatment Pharmacological agents were used to induce or block specific signaling 
pathways. Cells were pretreated with these chemicals for 2 hours prior to infection, and were 
added back after the viral adsorption. These treatments were useful to investigate the links 
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10.2.4. Growing Virus We obtained Zika MR766 (ATCC#VR84) as a generous gift from 
the lab of Dr. Adolfo Garcia Sastre (Mount Sinai Medical School, New York). We used the 
general protocol followed by the Sastre lab (Mount Sinai); however, we improvised the manual 
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according to the conditions and requirements in our lab. The protocol for growing and purifying 
Zika was almost same as that used for DENV2 (as described earlier). However, Zika causes 
cytopathic effect (CPE) much earlier than the latter; we started harvesting the virus within 2-3 
days of infection. After the cells has been stored as aliquots in the -80° C, they were titered on 
VERO cells. 
 
Titering Zika virus The protocol for titering Dengue was employed for the 
quantification of Zika as well, with certain modifications. Instead of one week, the plate 
containing the overlay was taken out after 3-4 days and was stained with Crystal Violet to 
measure plaque formation.  Apart from this classical approach, a different method was also used; 
this is described below. 
 
Instead of performing the serial dilution in naïve (-/-) media, without FBS/P-S28, we diluted 
the Zika stocks in 2.5% α-MEM. Also, the Agarose overlay was replaced by 1% 
carboxymethylcellulose (CMC) and 2.5% α-MEM. After 3-4 days the plates were stained with 
Crystal Violet for detection of plaques. Plaques were counted and the titer of the virus was 
expressed as plaque forming units (P.F.U)/ ml. 
 
10.2.5. RNA extraction/ qPCR RNA was extracted from cells as described above. The 
extracted RNA was then quantified and used for quantitative Polymerase Chain Reaction (qPCR) 
as described above. cDNA-specific primers were used to measure the transcription of the ZIKV 
NS1 gene in infected cells. Tubulin was used as a loading control. The sequence of primers used 
in this experiments have been listed in the table below. 
																																																								
28 FBS: Fetal Bovine Serum, P-S: Penicillin/ Streptomycin 
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Gene Sequence (5’-3’) 
Tubulin FWD AGG ATT CGC AAG CTG GCT G  
Tubulin REV TAA TCC ACA GAG AGC CGC TCC 
ZIKV NS1 FWD TTT GTT AGG GCG GCA AAG AC 
ZIKV NS1 REV ACG GCT GGG TCA CAT TCT AA  
 
10.2.6. Immunofluorescence We looked at the expression of ZIKV Env protein in 




10.3.1. ZIKV can efficiently replicate in different cell lines ZIKV and DENV both are in 
the genus Flavivirus. However, they possess different patterns of infectivity in cell lines. We 
therefore evaluated expression of virus protein in different mammalian cell lines. We used 
antibodies for ZIKV E protein (described above) to verify by immunofluorescence infection and 
quantify virus protein expression. We infected three different mammalian cell lines – a human 
lung cell (A549), a green monkey kidney cell (VERO), and canine kidney cell (MDCK) – with 
ZIKV (moi-1) for 48 hours. After the infection period was over, we fixed the cells and stained 
them with mouse anti-E primary, followed by a green (FITC) anti-mouse secondary antibody 
raised in goat. Using DAPI, we performed nuclear staining.  The cover slips were mounted on 




We observed strong infection in all tested cell lines: A549 (Fig. 1A), VERO (Fig. 1B), and, 
MDCK (Fig. 1C). Our images show that almost 100% of the cells are infected. We verified the 
perinuclear expression of the Env protein, by presenting the merge between DAPI and FITC (Fig 
1B).  
 
10.3.2. ZIKV does not kill MDCK cells, however, it doesn’t protect them from the toxic 
effects of CPT Having established that ZIKV replicates well in mammalian cells (after 48 
hours), we investigated the effect of infection on cell survival. Since most of our DENV studies 
had been conducted using MDCK, we adopted the same approach for studying ZIKV. 48 hours 
after infection, we measured cell death using Trypan Blue Exclusion assay (as described above). 
We did not observe any significant change in cell survival, compared to mock-infected cells 
(Fig. 2). Thus, infectivity (Fig. 1C) does not correlate with death of MDCK cells. In this regard, 
ZIKV was strikingly similar to DENV.  
 
We next looked at the cytoprotective effects of ZIKV against toxins. After 24 hours of 
infection, infected cells were exposed to the toxin Camptothecin (CPT), and were left at 37º C 
for another 24 hours. As a control, we used MDCK cells exposed to CPT alone. Unlike DENV2, 
which showed significant cytoprotective effect against CPT [652], the current study shows that 
ZIKV does not protect cells against the toxic effects of CPT. Hence, DENV2 and ZIKV probably 
have different mechanisms of manipulating the cell death pathways.   
 
10.3.3. ZIKV alone does not kill A549 cells; however, it kills cells in presence of 
Camptothecin Since most Flavivirus, including DENV and ZIKV, are known to be 
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differentially lethal to different types of cells, we looked at cell survival in other cell types. To 
this end, we used a human lung epithelial cell line – A549 – that has been widely used as a 
transfection and infection host. We treated these cells in a same way as MDCK (Fig. 2) and 
quantified cell death using Trypan Blue Exclusion Assay.  
 
Like MDCK, cell survival was not altered significantly after 48 hours of infection (Fig. 3), 
which was earlier shown to have established a strong infection (Fig. 1A). Also, CPT at this 
concentration (75µM) was much less toxic to these cells. However, the virus synergized with 
CPT in killing the cells, as the number of dead cells far exceeded that of CPT treatment and 
ZIKV infection alone (Fig. 3). ZIKV apparently affects cell death pathways differently in 
MDCK and A549 cells. 
 
10.3.4. ZIKV is cytotoxic for VERO cells, and its effect becomes even more severe in 
presence of Camptothecin Since VERO is used as a primary host for growing ZIKV, it is 
important to study the effect of infection on the survival of these cells. VERO cells were treated 
the same manner as MDCK and A549, and cell death was quantified as described above. Unlike 
MDCK and A549, we observed a significant increase in VERO cell death after 48 hours of 
ZIKV infection (Fig. 4). Furthermore, the presence of CPT in infected cells produced a 
synergism in which cell death substantially and significantly exceeded the summed effects of the 
virus and the toxin (Fig. 4). Thus, ZIKV exerts very different effect on the survival of MDCK, 




10.3.5. Dengue virus might have protective effect against ZIKA  Although ZIKA did 
not significantly kill MDCK cells within 48 hours, it potentially was slower acting. We therefore 
increased the span of infection to 120 hours (5 days), after which cell death was calculated using 
trypan blue exclusion assay. By this time, viability of infected cells was approximately 45% of 
that of control cells (Fig. 5). Therefore, ZIKV is cytotoxic, though more slowly than to other 
cells.  
Since DENV can protect MDCK cells from CPT and IAV, we tested whether it could 
protect them from long term ZIKV infection. To this end, we infected cells with ZIKV and after 
48 hours, added DENV and left the cells for a further 72 hours. Thus, we had cells infected with 
ZIKV for 120 hours, and a co-infection of ZIKV/DENV for the last 72 hours. The presence of 
DENV dramatically reduced death in MDCK cells (Fig. 5).  
 
Thus, DENV protected MDCK cells from the toxicity of prolonged ZIKV exposure. In 
this regard, it has the same effect as that in IAV29-infected MDCK cells, as had been reported in 
our earlier study [652]. 
 
10.3.6. ZIKV infection does not affect the survival of PC12 cells The pheochromocytoma 
PC12 cell line has been frequently used a model for studying neurodegenerative disorders. Since 
ZIKV causes microcephaly, investigated the effect of infection on the survival of the neuron-like 
PC12 cells. We infected these cells for 48 and 72 hours and evaluated cell death (Fig. 6). There 
was no significant effect of infection on the survival pattern of these cells. 
 
																																																								
29 Influenza A virus 
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10.3.7. A functional PERK pathway is important for ZIKV transcription and translation
 We had already established the importance of PERK pathway in the life cycle of DENV2 
[10]. Since ZIKV is closely related to DENV, we verified the role of PERK in ZIKV infection. 
To that end, we infected PERK WT and KO MEF cells with ZIKV for 48 hours. Cells were lysed 
and RNA was extracted using the Qiagen kit, as described above.  
 
We used the Power SYBR Green RT to Ct 1-step kit (Applied Bio systems30#4391178) to 
measure the relative expression of the ZIKV NS1 gene, compared to a loading control tubulin. 
There was no significant internal variation between tubulin expression in mock and infected WT 
and KO cells (Fig. 7). We recorded a 5-fold decrease in NS1 expression in infected PERK -/- 
cells, compared to infected PERK +/+ (Fig. 7). The relative fold change in NS1 transcription was 
calculated using the formula described above. We registered a 5-fold decrease in NS1 
transcription in the absence of a functional PERK pathway (Fig. 7 table). 
 
In order to further validate the compromised ZIKV transcription, we looked at viral translation 
in infected PERK WT and KO cells. These cells were infected with ZIKV for 48 hours and were 
probed for the Env protein expression using specific antibodies (mouse anti- E primary/ anti-Red 
secondary) in an immunofluorescence study. In our study, we demonstrate a significant reduction 
in E protein expression in infected PERK KO cells, as compared to infected WT cells (Fig. 8). 




30 Address: 850 Lincoln Center Drive, Foster City, CA 94404 
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10.3.8. Different pathways are activated in PERK +/+ and PERK -/- following ZIKV 
infection Having established the importance of a functional PERK pathway in ZIKV 
transcription/translation, we looked at related pathways that we had earlier shown to be activated 
during DENV2 infection – ATM and autophagy [10]. To this end, we pretreated PERK +/+ and -
/- cells with the following before infecting them with ZIKV: 3µM tunicamycin (inducer of ER 
stress), 3µM salubrinal (inhibitor of PERK pathway), 5µM KU55933 (inhibitor of ATM 
kinase), 250nM Torin1 (inducer of autophagy) and 50µM Chloroquine (inhibitor of 
autolysosome formation). After 24 hours of infection, we lysed the cells and extracted RNA. 
RNA was then used as a template for a qPCR reaction where we used cDNA specific primers to 
quantify NS1 expression, compared to tubulin. 
 
In PERK +/+ cells, induction of ER stress/protein misfolding by tunicamycin increased NS1 
expression by more than 10-fold relative to ZIKV infection alone (Fig. 9). Since ER stress is a 
byproduct of infection and replication, apparently ER stress alone improves viral replication or 
translation. Blocking GADD34-activity (PERK pathway) using salubrinal caused a smaller albeit 
significant upregulation (4-fold) in NS1 transcription (Fig. 9). In this regard, ZIKV is 
diametrically opposite to DENV2; our earlier study shows salubrinal reducing transcription of 
DENV2 NS4A [10]. Since salubrinal blocks the feedback step in PERK pathway, it maintains 
the global translation arrest initiated by PERK-induced eIF2α. While this is detrimental for both 
the host and the virus, it might offer an alternate scheme of selective transcription of viral genes. 
As has been described in the background section, salubrinal has also been reported to reduce 
viral transcription in other cell types; hence it is important to take into account the type of cells 
being infected. None of the other pathways studied here, i.e., ATM, autophagy, had any effect on 
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viral transcription in PERK +/+ cells eIF2α (Fig. 9). Blocking or activating these pathways did 
not alter expression of NS1. Thus, unlike our previous study evaluating how DENV functions 
[10], ZIKV uses very limited crosstalk between PERK and these pathways. However, more 
studies are required to reach a definite conclusion.   
 
In contrast, neither tunicamycin nor salubrinal had any effect on NS1 transcription in infected 
PERK-/- cells (Fig. 10). This points to the possibility that most of the ER stress induced by 
tunicamycin was mediated mostly through the PERK pathway in ZIKV infected WT cells (Fig. 
9). Thus, in absence of this pathway, tunicamycin could not upregulate viral transcription in 
PERK-/- cells (Fig. 10). On the other hand, NS1 transcription was upregulated when the fusion 
of autophagosome and lysosome was blocked by chloroquine (Fig. 10). Thus, blocking 
autophagic degradation in PERK -/- cells increased ZIKV transcription. While this does not 
indicate any direct correlation between PERK and autophagy, it nevertheless points to an indirect 
link – weakening the PERK pathway and autophagy together increases viral transcription. It is 
important to look at the synergistic effects of these pathways in ZIKV infection. It is even more 
crucial, because, although autophagy contributes to ZIKV pathogenicity in several cell lines, 
recent studies have suggested that it might be instrumental in the degradation of viral particles 
especially before they transmit to the fetus from the placenta [603]. 
 
Finally, we further established the importance of PERK in ZIKV infectivity by comparing the 
change of NS1 expression between infected and mock cells from each (WT, KO) background. 
While infection induced a 839-fold increase of NS1 expression in WT cells, in infected KO cells 
the increase was reduced to 267-fold, a 68% decrease. 
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10.3.9. An important component in the initiation step of autophagy - class IA P13K p110β 
catalytic subunit - plays an important role in ZIKV protein expression Having established 
the role of PERK in ZIKV infection, we turned our focus to proteins involved in autophagy. 
Since many studies measured the effect of ZIKV on mTOR-dependent autophagy, we looked at a 
non-mTOR branch. We examined the p110β catalytic subunit of the class IA P13K, which 
interacts with the Vps34-Vps15-Beclin1-ATG14L complex during the nucleation and expansion 
stages of autophagy. 
 
We obtained p110β WT and KO MEFs from our collaborator (Dr. Wei-Xing Zong). We 
infected these cells with ZIKV and looked at viral E protein expression after 24, 48, and 72 
hours. In a fashion similar to our earlier studies, we used specific antibodies for the ZIKV E 
protein (green FITC channel) in an immunofluorescence experiment. DAPI was used for nuclear 
staining. Protein expression was severely compromised in absence of a functional p110β 
catalytic subunit (Fig. 11). There was a significant drop-off in E signals in absence of the 
catalytic subunit, an event that was consistent through 24 to 72 hours post infection. The early 
steps of autophagy are thus important for ZIKV protein expression. However, as we have also 
shown that autophagy is inhibitory in a PERK -/- background, it will be a worthy endeavor to 
look at the effects of PERK inhibitor on infected p110β WT and KO cells. 
 
10.3.10. A pro-apoptotic protein SEPT4/ARTS possibly takes an active role in blocking 
ZIKV replication/ translation A unique member of the Septin family, Apoptosis related 
protein in TGF-β  pathway (ARTS) or Septin 4 (SEPT4) is a pro-apoptotic protein that 
translocates from the mitochondria to the cytosol and blocks the X-linked inhibitor of apoptosis 
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(XIAP) protein. As is evident from the name, this protein induces apoptosis in response to TGF-
β  activation. Structural studies have shown that ARTS binds to the BIR3 domain in XIAP, at a 
site different from other IAP-antagonist proteins like SMAC/Diablo. Since most studies 
concerning the role of apoptosis in ZIKV have focused mainly on the TP53 and BAX/BAK, we 
examined this less-studied apoptotic protein in relation to ZIKV infection.  
 
We infected SEPT4 WT and KO MEF cells for 48 and 72 hours, then fixed and stained with 
antibodies specific for the ZIKV E protein, followed by staining with anti-FITC (green) 
secondary antibodies. The number of cells showing E (green) signals was quantified and 
expressed as percentage of cells infected. After both times, we observed a significant, almost 4-
fold, increase in viral E protein in infected SEPT4 KO cells, compared to SEPT4 WT cells 
(Figure 12). The genetic deletion of SEPT 4 thus positively affects viral replication and 
translation.  
 
Since most studies had shown that apoptosis was important for the pathogenicity of ZIKV, we 
were then interested to see the effect of infection on the viability of these cells. 
 
10.3.11. In absence of SEPT4/ARTS, infection increases cell death SEPT WT and KO 
cells were infected with ZIKV for 24, 48 and 72 hours. After each time, cell death was measured 
using the Trypan Blue exclusion assay. In case of the WT cells, there were more dead cells in the 
cultures by 48 h but by 72 h the viability of the infected cells was similar to that of the control 
(Figure 13). In case of the KO cells, infection led to more cell death compared to the WT cells, 
and this reached its peak after 72 hours of infection (Figure 13). Overall, this was an interesting 
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data because we registered higher cell death when a pro-apoptotic gene had been knocked out. 
The higher cell death in KO cells correlate with increased viral replication (as seen in Figure 
12), compared to infected WT cells. In conclusion, ZIKV potentially induces a non-SEPT4 
branch of apoptosis in KO cells, which in turn facilitates viral replication. It is also possible that 
SEPT4 might affect antiviral signaling, and in this regard it will be interesting to test the effect of 
SEPT4 on interferon signaling. 
 
10.4. DISCUSSION ZIKV is an emerging flavivirus that is potentially pandemic. 
Although it belongs to the Flavivirus genera, it is unique in that it can be vertically transmitted, 
i.e., placenta to fetus. This makes it different from other neurotropic members of these genera 
like WNV and JEV.  In the current study, we investigated the role of ZIKV infection on the 
survival of different mammalian cell lines, and we have tested the roles of PERK pathway, 
autophagy and apoptosis in ZIKV infectivity. 
 
Our studies reveal a differential response to infection in A549, MDCK and VERO cells. 
The fact that VERO has been widely used to grow ZIKV, and it also dies very soon once 
infected, suggests that this virus derives a lot of its pathogenicity from cell death. This is in stark 
contrast with DENV, which has been reported to protect cells [652]. In our study, preliminary 
data suggested that DENV2 protects MDCK cells from ZIKV cytotoxicity. Unlike DENV2, 
ZIKV did not protect any of these cell lines from CPT toxicity. In case of VERO and A549, it 
synergized with CPT, thereby aggravating the cytotoxicity of CPT. In this regard, ZIKV induces 
apoptotic cell death in the presence of CPT. However, a detailed study needs to be undertaken 




Our study also draws close parallel between ZIKV and DENV2, since in MEF cells both 
these viruses need an effective PERK pathway and autophagy to carry out gene and protein 
expression. However, as we performed more molecular analyses, it became clear that subtle 
differences underlie this apparent similarity. Although autophagy is important for the life cycle 
of both ZIKV and DENV, blocking the final step of autophagy in PERK -/- cells is favorable for 
ZIKV transcription. To add to the complexity, blocking autophagy had no significant effect on 
ZIKV transcription in infected WT cells.  There may be some synergistic relation between PERK 
and autophagy that is visible only when both these pathways are incapacitated. Salubrinal affects 
ZIKV infected PERK +/+ cells, differently compared to DENV infected PERK +/+. While in the 
latter case, salubrinal was reported to slow ZIKV E protein expression [10], in the former 
instance we observe an increase in ZIKV NS1 transcription. This data points to a possible 
difference in the mechanisms by which these viruses manipulate global translation in a host cell. 
While GADD34-mediated dephosphorylation of eIF2α presents DENV2 with a possibility of 
harnessing the benefits of global host translation, blocking GADD34-mediated 
dephosphorylation (by salubrinal) might prove effective for ZIKV replication and infectivity. 
This might also explain one of the basic differences between these two related viruses - ZIKV- 
infected cells might be dying faster because of limited access to the translation machinery, 
compared to DENV. 
 
While we presented data that shows that the initial steps of autophagy are important for 
ZIKV infectivity, we also show that a pro-apoptotic SEPT4/ARTS protein is capable of blocking 
ZIKV protein expression. We also verified that the low protein expression in SEPT4+/+ cells is 
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not a consequence of cell death; infected SEPT4-/- (which show higher E protein expression) die 
in greater number than the former. While this validates the role of cell death in ZIKV infectivity, 
it also opens the possibility that the SEPT4 branch of apoptosis is important in blocking ZIKV 
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Figure 1: ZIKV can effectively infect and replicate in three different cell lines 
ZIKV MR766 can efficiently replicate and produce infective virions in three different cell 
lines: A549 (Fig. A), VERO (Fig. B), and MDCK (Fig. C). The cells were infected for 48 hours 
and were then fixed with 4% PFA. After permeabilization with Triton X 100, the cells were 
incubated in a blocking solution to prevent nonspecific binding. They were then probed for the 
ZIKV E protein, using mouse anti-E and FITC-labeled anti-mouse secondary antibody. The 
infected cells all show strong FITC signals, thus illustrating the high infectivity established by 
































Figure 2: ZIKV does not protect MDCK cells from the toxicity of CPT 
In this experiment, MDCK cells were infected for 24 hours and were then exposed to 
CPT and incubated for another 24 hours. Trypan Blue exclusion assay was used to quantify 
percentage cell death. In the absence of CPT, ZIKV does not kill MDCK cells after 48 hours of 
infection. In this regard, it is similar to DENV2 infection. However, unlike DENV2, ZIKV does 
not protect MDCK cells against CPT, as measured after 24 hours of CPT treatment and 48 hours 





























p value = 0.78 
p value = 0.0003 




Figure 3: ZIKV synergizes with camptothecin to kill A549 cells  
 In A549 cells, ZIKV does not show any cytotoxic effect after 24 hours. However, when 
CPT is added to the cell culture after 24 hours of infection, the virus shows significant cytotoxic 
effect. Thus, after 48 hours of infection and 24 hours of CPT treatment, the virus possibly 
establishes a synergistic cytotoxicity along with CPT.  
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Figure 4: ZIKV is cytotoxic for VERO cells and synergizes in toxicity with camptothecin 
Vero cells were infected with the ZIKV for 24h. The virus was significantly toxic 
compared to mock inflection. When infected cells were exposed to CPT, the combination as 
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Figure 5: Dengue virus can protect MDCK cells against ZIKV 
MDCK cells were infected with ZIKV for 120 h, resulting in ~ 45% higher mortality than 
controls (in which the viability ranged from 5 to 10%). The experimental cells were exposed to 
ZIKV for 48 hours. DENV was then added and the cells were left for the next 72 hours. Only 
10% of the cells died in the latter instance. Thus, DENV protects MDCK cells from the 






                                                          

























Figure 6: Infection does not affect survival of PC-12 cells, even after 48 and 72 hours 
 Since neuronal cells form some of the major targets of ZIKV infection, we infected PC12 
cells. These cells are derived from the adrenal gland of rats, and are frequently used as models to 
study pheochromocytoma and can be differentiated into neuron-like cells. In our experiments, 
there was no significant effect of ZIKV infection on the survival rate of these cells in their 
undifferentiated state.   
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EXPERIMENTAL/ CONTROL NS1 FOLD CHANGE (based on dCT) 
PERK WT ZIKV/ PERK WT MOCK 4935 
PERK KO ZIKV/ PERK KO MOCK 1121 





Figure 7: A functional PERK pathway is important for ZIKV NS1 expression 
 PERK WT and KO cells were infected with ZIKV for 48 hours and then cells were lysed 
and RNA was extracted using the Qiagen kit. The RNA was then used as a template for a 1-step 
reaction where the RNA was converted to cDNA and the cDNA was used probed with specific 
primers for Tubulin (loading control) and ZIKV NS1 (target gene). The relative fold change in 
NS1 transcription (table) has been calculated using the formula described above. There was no 
significant variation between the tubulin expression of mock and infected WT and KO cells. We 
observed a similar link between PERK and ZIKV infectivity as we had shown in case of DENV 
infection. Our data shows a 5-fold decrease in NS1 transcription in infected PERK KO cells, 
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Figure 8: A functional PERK pathway is important for ZIKV E protein expression 
 PERK WT (A) and KO (B) cells were infected with ZIKV for 48 hours and were probed 
for E protein expression (anti-Red secondary antibody) using immunofluorescence. E protein 
signals are substantially reduced in infected PERK KO cells compared to wild type. We thus 
expand our previous data for DENV and demonstrated an active link between PERK pathway 
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EXPERIMENTAL/ CONTROL NS1 FOLD CHANGE (based on dCT) 
PERK WT ZIKV/ PERK WT MOCK 839 
PERK WT ZIKV w. TUNICA/ PERK WT ZIKV 11 
PERK WT ZIKV w. SALUB/ PERK WT ZIKV 4 
PERK WT ZIKV w. ATMi/ PERK WT ZIKV 0.4 
PERK WT ZIKV w. TORIN1/ PERK WT ZIKV 0.5 
PERK WT ZIKV w. CQ/ PERK WT ZIKV 0.8 
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Figure 9: In PERK+/+ MEF cells, induction of protein misfolding and to some extent, 
blocking PERK-imposed translation arrest, increases the transcription of the ZIKV NS1 
gene, however neither ATM pathway nor autophagy seems to have any significant effect on 
the rate of transcription 
 PERK +/+ MEF cells were pretreated for 2 hours with the following, before being 
infected with ZIKV: 3µM tunicamycin (inducer of ER stress), 3µM salubrinal (inhibitor of 
PERK pathway), 5µM KU55933 (inhibitor of ATM kinase), 250nM Torin1 (inducer of 
autophagy) and 50µM Chloroquine (inhibitor of autolysosome formation). After 24 hours of 
infection, RNA was extracted and quantified. Power SYBR Green RT to Ct 1-step kit 
(Applied Bio systems31#4391178) was used to measure the relative transcription of the ZIKV 
NS1 gene, compared to a loading control Tubulin. In case of tunicamycin and salubrinal 
pretreatment, we observed 11- and 4-fold increase in NS1 expression, respectively. However, 
none of the chemicals blocking ATM pathway or autophagy had any significant effect on viral 
transcription; the same holds true also for inducers of autophagy.   
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EXPERIMENTAL/ CONTROL NS1 FOLD CHANGE (based on dCT) 
PERK KO ZIKV/ PERK KO MOCK 267 
PERK KO ZIKV w. TUNICA/ PERK KO ZIKV 0.7 
PERK KO ZIKV w. SALUB/ PERK KO ZIKV  0.8 
PERK KO ZIKV w. ATMi/ PERK KO ZIKV 0.74 
PERK KO ZIKV w. TORIN1/ PERK KO ZIKV 1 
PERK KO ZIKV w. CQ/ PERK KO ZIKV 5 
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Figure 10: In PERK -/- MEF cells, blocking the formation of autolysosomes increases 
expression of ZIKV NS1  
 PERK-/- MEF cells were pretreated and infected in the same manner as PERK +/+ cells. 
The same procedure was used to extract RNA and measure the transcription of ZIKV NS1 and 
Tubulin. In absence of a functional PERK pathway, neither tunicamycin nor salubrinal had any 
significant effect on viral transcription. On the other hand, blocking the endocytosis-mediated 













Figure 11: An important component in the initiation step of autophagy - class IA P13K 
p110β  catalytic subunit - is important to expression of  ZIKV E protein 
We obtained p110β WT and KO MEFs from our collaborator (Dr. Wei-Xing Zong, Stony 
Brook University). We infected the WT and KO cells with ZIKV and looked at viral protein 
production at 24-72 hours using specific antibodies for the ZIKV E protein (green FITC 
channel). Protein expression was severely compromised in absence of a functional catalytic 
subunit (p110β). DAPI staining was used to look at the cell survival, which did not vary much 
between WT and KO cells. Thus, a decrease in viral expression was a result of decreased cell 
viability in the KO cells, as assessed by numbers of cells in the plates. However, as determined 
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p-value: 0.008 






   
   
   







   
   
   












































   
   
   
   






   
   
   
   
 




Figure 12: A pro-apoptotic protein SEPT4/ARTS blocks ZIKV replication/translation  
 We acquired SEPT4 WT and KO MEF cells from our collaborator Dr. Sarit Larisch 
(Israel). These cells were infected with ZIKV for 48 and 72 hours, after which they were fixed 
and stained with antibodies specific for the ZIKV E protein. This was followed by staining with 
anti-FITC (green) secondary antibodies. The number of cells showing E (green) signals was 
quantified and expressed as percentage of cells infected. After both the times, we register a 
significant increase in viral E protein expression in infected SEPT4 KO cells relative to wild 
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Figure 13: In absence of SEPT4/ARTS, ZIKV infection increases cell death 
 SEPT WT and KO cells were infected with ZIKV for 24, 48 and 72 hours. After each 
time point, cell death was measured using the Trypan Blue exclusion assay. In case of the WT 
cells, we observe a slight increase in cell death after 48 hours only, which is rescued after 72 
hours. In case of the KO cells, we register a higher level of cell death compared to the WT cells, 
and it reaches its peak after 72 hours of infection. The higher level of cell death in KO cells 
might have a correlation with increased viral replication (Figure 12), compared to infected WT 
cells. Thus, ZIKV might be inducing a non-SEPT4 branch of apoptosis in KO cells, which in 






11. LIST OF ABBREVIATIONS 
4EBP1 Eukaryotic Initiation Factor 4E-Binding Protein 1 
ACD                Accidental Cell Death 
ADE  Antibody Dependent Enhancement 
ADEM Acute Disseminated Encephalomyelitis 
AG129 Dengue Virus Mouse Model 
AIDS  Acquired Immunodeficiency Disease Syndrome 
AIF  Apoptosis Inducing Factor 
AKT  Protein Kinase B (Serine/Threonine-Specific Protein Kinase) 
AMBRA1 Activating Molecule in BECN1-Regulated Autophagy Protein 1 
AMPK Catalytic Subunit Of AMP-Activated Protein Kinase 
APAF  Apoptotic Peptidase Activating Factor 
Apo2L Apo2 Ligand/ Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand  
APS  Ammonium Persulfate 
ATCC  American Type Culture Collection 
ATF4  Activating Transcription Factor 4 
ATF6  Activating Transcription Factor 6 
ATG  Autophagy Related Gene 
ATM  Ataxia Telangiectasia Mutated Kinase 
ATP  Adenosine Triphosphate 
ATR  ATM And Rad53 Related (ATR) Kinase 
BAD  Bcl2-Associated Agonist of Cell Death 
BAK  Bcl-2 Apoptosis Killer 
BALB/C An Albino, Laboratory-Bred Strain Of House Mouse 
BAX  Bcl-2 associated X 
BCL-2  B-Cell Lymphoma 2 
BECN1 Beclin-1 
BH  Bcl-2 Homology 
BHK  Baby Hamster Kidney 
BID  BH3-Interacting Domain Death Agonist 
BIM  Bcl-2-Like Protein 11 
BiP  Binding Immunoglobulin Protein 
BOK  Bcl-2-Related Ovarian Killer Protein 
BSA  Bovine Serum Albumin 
C  Capsid Protein 
CALR  Calreticulin 
CaMKII Calcium/Calmodulin-Dependent Protein Kinase Type II Alpha Chain 
CARD  Caspase Recruitment Domain 
CARM1 Coactivator-Associated Arginine Methyltransferase 1 
CASP  Cysteine-Dependent Aspartate-Directed Proteases 
CBV3  Coxsackievirus B3 
CCL5  C-C Motif Chemokine 5 
CD95  Cluster of Differentiation 95 
Cdc48  Cell Division Control Protein 48 
cDNA  Complementary DNA 
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CDS  Coding Sequence  
cGAS  Cyclic GMP-AMP Synthase 
CHK  Cell Cycle Checkpoint Kinase 
CHME Cellosaurus Cell Line (Immortalized Human Microglia Cell Line) 
CHO  Chinese Hamster Ovary 
CHOP  DNA Damage-Inducible Transcript 3 Protein (C/EBP-Homologous Protein) 
CMA  Chaperone-Mediated Autophagy 
CNS  Central Nervous System 
CPE  Cytopathic Effect 
CPT  Camptothecin 
CREB  cAMP Responsive Element Binding Protein 
CRT  Calreticulin 
CTCF  CCCTC-Binding Factor 
CTS  Cathepsin 
CXCL10 C-X-C Motif Chemokine 10 
CXCR3 C-X-C Chemokine Receptor Type 3 
CYCS  Cytochrome C 
CYPD  Cyclophilin D 
DAMP Danger Associated Molecular Pattern 
DAPI  4′,6-Diamidino-2-Phenylindole (Nuclear Stain) 
DAPK1 Death Associated Protein Kinase 1 
dATP  Deoxyadenosine Triphosphate 
Daxx  Death-associated protein 6 
DC-SIGN Dendritic Cell-Specific Intercellular Adhesion Molecule-3-Grabbing Non-Integrin 
DCC  Netrin Receptor 
dCTP  Deoxycytidine Triphosphate 
DDR  DNA Damage Response 
DENV  Dengue Virus 
DEPC  Diethylpyrocarbonate 
DF  Dengue Fever 
dGTP  Deoxyguanosine Triphosphate 
DHF  Dengue Hemorrhagic Fever 
DIABLO Direct IAP Binding Mitochondrial Protein with Low Pi 
DISC  Death Inducing Signaling Complex 
dLN  Drained Lymph Nodes 
DMEM Dulbecco`s Modified Eagle Media 
DMSO Dimethyl Sulfoxide 
DMV  Double Membrane Vesicles  
DNA  Deoxyribonucleic Acid 
dNTP  Deoxyribonucleotide Triphosphate 
DR3  Tumor Necrosis Factor Receptor Superfamily Member 25 
DRP  DAPk-related protein kinase 
DSB  Double-Strand Break 
DSS  Dengue Shock Syndrome 
dTTP  Deoxythymidine Triphosphate 
dUTP  Deoxyuridine Triphosphate 
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E  Envelope Protein 
EA. hy296 Human Somatic Cell Hybrid 
EBV  Epstein Barr Virus 
ECL  Enhanced Chemiluminescence 
EDTA  Ethylenediaminetetraacetic acid 
EE  Early Endosomes 
EGFR  Epidermal Growth Factor Receptor 
EIF2AK3 Eukaryotic Translation Initiation Factor 2-Alpha Kinase 3 
eIF2α  Eukaryotic Translation Initiation Factor 2 Subunit 1 
ELANE Neutrophil Elastase 
EMEM Eagle’s Minimal Essential Medium 
ER  Endoplasmic Reticulum 
ERAD  Endoplasmic Reticulum Associated Degradation 
ERICA ER-Stress Induced Chaperone Mediated Autophagy 
ERK2  Mitogen-Activated Protein Kinase 1 
ERN1  Serine/Threonine-Protein Kinase/Endoribonuclease IRE1 
Ero1  ERO1-Like Protein Alpha 
ESCRT Endosomal-Sorting Complex Required For Transport 
EtBr  Ethidium Bromide 
EV71  Enterovirus 71 
FADD  FAS-associated Death Domain 
FAM134B Family With Sequence Similarity 134 Member B/ Reticulophagy Regulator 1 
FBS  Fetal Bovine Serum 
FDM  Flavivirus Dilution Media 
FGA/89 Dengue Virus Type 1 Strain 
FGA/NA Dengue Virus Type 1 Strain 
FLIP  FLICE (FADD-Like IL-1β-Converting Enzyme)-Inhibitory Protein 
G3BP1            G3BP Stress Granule Assembly Factor 1 
GA                  Gallic Acid    
GADD34 Protein Phosphatase 1 Regulatory Subunit 15A 
Gag/Pol Gag Is A Lentiviral Structural Precursor Protein and Pol Is A Polymerase 
GE  General Electric 
GFAP  Glial Fibrillary Acidic Protein 
GFP  Green Fluorescent Protein 
GRP78 Endoplasmic Reticulum Chaperone (BiP) 
GTA  Genotoxic Stress Targeted Autophagy 
H2AX  Histone H2ax 
HBN  CNS-derived human cell types 
HBV  Hepatitis B Virus 
HCMV Human Cytomegalovirus 
HCV  Hepatitis C Virus 
HDAC6 Histone Deacetylase 6 
HDM2 E3 Ubiquitin-Protein Ligase Mdm2 
HEK  Human Embryonic Kidney 
HeLa  Henrietta Lacks 
HIV  Human Immunodeficiency Virus 
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HMC  Human Mast Cells 
HMCV Human Cytomegalovirus 
HMGB High Mobility Group Box 
hnRNPC Heterogeneous Nucleus Ribonucleoprotein 
HPR  Fenretinide 
HPV  Human Papillomavirus 
HR-HPV High-Risk Human Papillomavirus 
HRK  Serine/Threonine-Protein Kinase Haspin Homolog Hrk1 
HRPE             CNS-Derived Human Cell Type 
HSP  Heat Shock Protein 
HSV  Herpes Simplex Virus 
HT29  Human Colon Adenocarcinoma Cell Line 
HTRA2 Serine Protease HTRA2, Mitochondrial 
IAV  Influenza A Virus 
IFN  Interferon 
IFNAR Interferon Alpha/Beta Receptor 1 
IL  Interleukin 
IMM  Inner Mitochondrial Membrane 
IP3  Inositol 1,4,5-Trisphosphate Receptor Type 1 
IRE1  Inositol Requiring Enzyme 1 
IRF  Interferon Regulatory Factor 2-Binding Protein  
ISR  Integrated Stress Response  
JAK  Tyrosine-Protein Kinase 
JEV  Japanese Encephalitis Virus 
JNK  Mitogen-Activated Protein Kinase 8 
K562  Human Immortalized Myelogenous Leukemia Cell Line 
KCl  Potassium Chloride 
kD/ kDA Kilo Daltons 
KH2PO4 Monopotassium Phosphate 
KSAV  Kaposi’s Sarcoma Associated Herpesvirus  
KU55933 Specific Inhibitor of ATM Kinase 
KU812 Human Mast Cells 
L-SIGN C-Type Lectin Domain Family 4 Member M 
LAMP Lysosome-Associated Membrane Glycoprotein 
LAP  LC3-associated phagocytosis 
LDH  Lactate Dehydrogenase 
LE  Late Endosome 
LKB1  Liver Kinase B1 
LMP  Lysosomal Membrane Permeabilization 
LUBAC1 Linear Ubiquitin Chain Assembly Complex 
M  Membrane Protein 
MAC-ELISA IgM Antibody Capture Enzyme-Linked Immunosorbent Assay 
MAP1LC3B Microtubule-Associated Protein 1 Light Chain 3 Beta 
MAPK2 Mitogen-Activated Protein Kinase 
MCF  Michigan Cancer Foundation-7 
MCP  Monocyte chemotactic protein 
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MDCK Madine Darby Canine Kidney 
mdDC  Monocyte-Derived Human Dendritic Cells 
MDM2 Mouse Double Minute 2 Homolog/ E3 Ubiquitin Protein Ligase 
MEC  Pulmonary Microvascular Endothelial Cells 
MEF  Mouse Embryonic Fibroblast 
MEM  Minimal Essential Media 
MHC  Major Histocompatibility Complex 
MIF  Macrophage Migration Inhibitory Factor 
miR  Micro RNA 
MLKL Mixed Lineage Kinase Domain-Like Pseudo Kinase 
MOMP Mitochondrial Outer Membrane Permeabilization 
MOPS  3-(N-Morpholino) Propane Sulfonic Acid 
MPT  Mitochondrial Permeability Transition 
MRF  Microglial Response Factor 
mRNA Messenger RNA 
mTORC Mammalian Target of Rapamycin 
N-2  Mouse Neuroblastoma Cell Line 
N18  Mouse Neuroblastoma X Rat Glioma Hybrid 
Na2HPO4 Disodium Phosphate 
NaCl  Sodium Chloride 
NADPH Nicotinamide Adenine Dinucleotide Phosphate 
NaOH  Sodium Hydroxide 
NCBI  National Center for Biotechnology Information 
NCCD  Nomenclature Committee on Cell Death 
NDP52 Calcium-Binding and Coiled-Coil Domain-Containing Protein 2 
NET  Neutrophil Extrusion Traps 
NFκB  Nuclear Factor NF-Kappa-B 
NGC  DENV Type 2, Strain New Guinea C 
NIH  National Institutes of Health 
NO  Nitric Oxide 
NOX2  Cytochrome B-245 Heavy Chain 
NOXA Phorbol-12-Myristate-13-Acetate-Induced Protein 1 
NS  Non-Structural 
NTRK3 Neurotrophin-3 Growth Factor Receptor 
OMM  Outer Mitochondrial Membrane 
OPTN  Optineurin 
P-S  Phosphatidylserine 
p70S6K p70 ribosome S6 kinase 
PAGE  Polyacrylamide Gel Electrophoresis 
PAMP  Pathogen-Associated Molecular Pattern 
PANX1 Pannexin-1 (Structural Component of The Gap Junctions) 
PARK2 E3 Ubiquitin-Protein Ligase Parkin 
PARP  Poly [ADP-Ribose] Polymerase 
PAS  Pre-Autophagosome Membrane 
PBMC Peripheral Blood Mononuclear Cells 
PBS  Phosphate Buffer Saline 
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pCAGGS Mammalian Expression Vector with CMV IE Promoter 
PCD  Programmed Cell Death 
pEGFP Mammalian Expression Vector (coding for enhanced GFP) 
PERK  Protein Kinase R Like Endoplasmic Reticulum Kinase 
PEX  Pexophagy 
PFA  Paraformaldehyde 
PHLPP1 PH Domain Leucine-Rich Repeat-Containing Protein Phosphatase 1 
PI3K  Phosphatidylinositol-3-Kinase 
PI3P  Phosphatidyl-3-Inositol Phosphate 
PIKK  Phosphatidyl-3-Inositol Phosphate Like Kinase 
PIN1  Peptidyl-Prolyl Cis-Trans Isomerase Nima-Interacting 1 
PP2A  Serine/Threonine-Protein Phosphatase 2A  
PPAR  Peroxisome Proliferator-Activated Receptor 
PRR  Transcription Factor Prr1 
PTCH1 Protein Patched Homolog 1 
PTEN Phosphatidylinositol 3,4,5-Trisphosphate 3-Phosphatase and Dual-Specificity 
Protein Phosphatase 
PTPC  Permeabilization Transition Pore Complex 
PUMA Bcl-2-Binding Component 3 
PV  Poliovirus 
qPCR  Quantitative Polymerase Chain Reaction 
RAB7A Ras-Related Protein Rab-7a 
RAF1  RAF Proto-Oncogene Serine/Threonine-Protein Kinase 
RANTES C-C Motif Chemokine 5 
RC  Replication Complex 
RCD  Regulated Cell Death 
RdRp  RNA-Dependent RNA Polymerase 
RER  Rough Endoplasmic Reticulum 
RHEB  GTPase Ras Homolog Enriched in Brain 
RHIM  Respective Homotypic Interaction Motif 
RIDD  IRE1-Dependent Decay Pathway 
RIG  Retinoic Acid Inducible Gene 
RIPA  Radio Immuno Precipitation 
RIPK1 Receptor Interacting Serine Threonine Protein Kinase 1 
RNA  Ribonucleic Acid 
RNase  Ribonuclease 
RNS  Reactive Nitrogen Species 
ROCK Rho-Associated Protein Kinase 
ROI  Region of Interest 
ROS  Reactive Oxygen Species 
RPM  Revolutions Per Minute 
RPMI  Roswell Park Memorial Institute  
rRNA  Ribosomal RNA 
RT  Reverse Transcriptase 
RTN3  ER Membrane Protein Reticulon 3 
RUBICON Run Domain Beclin-1-Interacting and Cysteine-Rich Domain-Containing Protein 
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Sal  Salubrinal 
sAP  Secretory Alkaline Phosphatase 
SDS  Sodium Dodecyl Sulfate 
SET  N-Lysine Methyltransferase KMT5A 
SIRT1  NAD-Dependent Protein Deacetylase Sirtuin-1 
SK-N-MC Human Neuroblastoma Cells 
SMAC Secondary Mitochondrial Activator of Caspase 
SMPK  C-GMP Dependent Protein Kinase 
SMURF1 E3 Ubiquitin-Protein Ligase SMURF1 
SNARE SNAP (Soluble NSF (N-Ethylmaleimide-Sensitive Factor) Attachment 
Protein) Receptor 
SQSTM1 Sequestosome 1 
SSB  Single-Strand Break 
SSC  Oral Cancer Cells 
STAT  Signal Transducer and Activator of Transcription 
STING Stimulator of Interferon Genes Protein 
STX17 Syntaxin 17 
SUN  Family Of 4 Yeast Genes (SIM1, UTH1, NCA3 And SUN4) 
SW480 Human Colorectal Adenocarcinoma Cell Line 
SYBR  Asymmetrical Cyanine Dye Used as A Nucleic Acid Stain in Molecular Biology 
T98G  Homo Sapiens Brain Glioblastoma Cell Line 
TAM  Protein Tyrosine Kinase Family (TYRO3, AXL and MER) 
TAP  Antigen Peptide Transporter 
TBST  Tris Buffer Saline (With 0.1% Tween-20 Detergent) 
TEMED Tetra Methyl Ethylene Diamine 
TIM  A Family of Cell Surface Phosphatidyl Receptors  
TLR  Toll-Like Receptor 
TM  Tunicamycin 
Tm  Primer Melting Temperature 
TMS  Trans-Membrane Domains 
TNF RI Tumor Necrosis Factor-α Receptor I 
TNF-α  Tumor Necrosis Factor-α 
TOPBP1 DNA Topoisomerase 2-Binding Protein 1 
TP53  Tumor Protein 53 
TRADD TNF-associated death domain 
TRAF  TNF receptor associated factor 
TRAIL TNF-α related apoptosis inducing ligand 
TRB3  Tribbles Homolog 3 
TSC2  Tuberous Sclerosis 2 
ULK1  Unc-51-Like Kinase 
UNC5A Netrin Receptor UNC5A 
UPR  Unfolded Protein Response 
UTH1  Member of The Yeast SUN Family 
VP  Vesicle Packets 
VP7  Rotavirus Capsid Protein 
VPS34  Vacuolar Protein-Sorting Protein 34 
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VSV  Vesicular Stomatitis Virus 
VZV  Varicella Zoster Virus 
WHO  World Health Organization  
WIPI  WD Repeat Domain, Phosphoinositide Interacting/ATG 18 Homolog 
WNV  West Nile Virus 
WNVKUN West Nile Virus Kunjin Strain 
XAF  XIAP-Associated Factor 1 
XBP1  X-Box-Binding Protein 1 
XIAP  X-linked inhibitor of apoptosis protein 
YFV  Yellow Fever Virus 
ZBP  Z-DNA binding protein 
ZIKV  Zika Virus 





































12.2. “Dengue-induced autophagy, virus replication and protection from cell death 
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